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ARTICLE 
Regulation of Chemical Risks: Lessons for 
Reform of the Toxic Substances Control Act 
from Canada and the European Union* 
Adam D.K. Abelkop** 
John D. Graham*** 
 
 
Industrial chemicals are ubiquitous. There are approximately 
100,000 chemical substances in commerce around the world.1  
About 30,000 substances are produced at a quantity greater than 
one metric tonne per year.2  In the United States (U.S.), of the 
84,000 chemicals listed on the federal government’s inventory, 
approximately 8,000 (non-polymeric) chemicals are produced in 
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 1. Derek C.G. Muir & Philip H. Howard, Are There Other Persistent Organic 
Pollutants? A Challenge for Environmental Chemists, 40 ENVTL. SCI. & TECH. 
7157, 7158 (2006). 
 2. Id. 
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volumes greater than eleven tonnes per year.3  A relatively small 
fraction of chemicals account for the vast majority of production 
volume, but consumers are nonetheless exposed to thousands of 
chemicals through products that they use every day. They are 
used in electronics, clothing, furniture, and carpets. They make 
up products such as cosmetics, detergents, paints, adhesives, and 
surfactants. 
Chemicals provide many benefits to consumers, but they also 
present risks. Identifying which uses pose significant risks can be 
a difficult process, as is deciding what should be done when 
significant risks are identified. Of the chemicals in commerce that 
have been tested, the majority have been shown to not be 
hazardous, but industry and government lack even basic data on 
the intrinsic properties, uses, and exposure pathways for a large 
number of substances.4  For decades, nations around the world 
have been updating their regulatory programs to address this 
worrisome gap in information because it hampers the 
effectiveness of regulatory risk management and impairs public 
confidence in the safety of the chemical industry.5 
Regulation of industrial chemicals is in a period of global 
maturation.6  In 2002, the United Nations World Summit on 
Sustainable Development (WSSD) established the goal that “by 
2020, . . . chemicals are used and produced in ways that lead to 
 
 3. U.S. GOV’T ACCOUNTABILITY OFFICE, GAO-13-249, TOXIC SUBSTANCES: EPA 
HAS INCREASED EFFORTS TO ASSESS AND CONTROL CHEMICALS BUT COULD 
STRENGTHEN ITS APPROACH 10 n.12 (2013) [hereinafter GAO TOXIC SUBSTANCES]. 
 4. See id. at 12–17; JOHN S. APPLEGATE & KATHERINE BAER, STRATEGIES FOR 
CLOSING THE CHEMICAL DATA GAP 1 (2006), available at 
http://www.progressivereform.org/articles/Closing_Data_Gaps_602.pdf; CHEM. 
MFRS. ASS’N, PUBLIC AVAILABILITY OF SIDS-RELATED TESTING DATA FOR U.S. HIGH 
PRODUCTION VOLUME CHEMICALS (1998); ENVTL. DEF. FUND, TOXIC IGNORANCE: 
THE CONTINUING ABSENCE OF BASIC HEALTH TESTING FOR TOP-SELLING 
CHEMICALS IN THE UNITED STATES (1997), available at http://www.edf. 
org/sites/default/files/243_toxicignorance_0.pdf; NAT’L RESEARCH COUNCIL, 
TOXICITY TESTING: STRATEGIES TO DETERMINE NEEDS AND PRIORITIES 19 (1984); 
John S. Applegate, Bridging the Data Gap: Balancing the Supply and Demand 
for Chemical Information, 86 TEX. L. REV. 1365, 1380–83 (2008). 
 5. See Michael Gilek et al., Introduction to REGULATING CHEMICAL RISKS: 
EUROPEAN AND GLOBAL CHALLENGES 1, 3 (Johan Eriksson et al. eds., 2010). 
 6. Gunnar Bengtsson, Global Trends in Chemicals Management, in 
REGULATING CHEMICAL RISKS: EUROPEAN AND GLOBAL CHALLENGES 192, 199–202 
(Johan Eriksson et al. eds., 2010); HENRIK SELIN, GLOBAL GOVERNANCE OF 
HAZARDOUS CHEMICALS: CHALLENGES OF MULTILEVEL MANAGEMENT 1–7 (2010). 
2http://digitalcommons.pace.edu/pelr/vol32/iss1/3
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the minimization of significant adverse effects on human health 
and the environment.”7  The WSSD goal constitutes one of several 
international responses to the need for coordinated assessment 
and management of the potential adverse effects from chemical 
exposures. In 1999, the government of Canada revised the 
Canadian Environmental Protection Act (CEPA) to accelerate the 
processes of chemical assessment and management. CEPA8 
mandated that the government categorize its inventory of 
existing substances to identify priorities for assessment, and the 
government completed the categorization on schedule in 2006.9  
That year, the Canadian government launched its Chemicals 
Management Plan (CMP) to meet the WSSD goal.10 
Also in 2006, the European Union (EU) enacted the 
Registration, Evaluation, Authorization, and Restriction of 
Chemicals (REACH) regulation to address gaps in data, to go 
beyond prior EU Directives in the control of industrial chemicals, 
to protect human health and the environment, and to enhance 
the sustainability and competitiveness of the European chemical 
industry.11 
Japan enacted revisions to its chemicals law in 2003 and 
2009, along with South Korea in 2008 and 2013, and China in 
 
 7. The World Summit on Sustainable Development, Johannesburg, S. Afr., 
Aug. 26–Sept. 4, 2002, Report of the World Summit on Sustainable Development, 
U.N. Doc. A/CONF.199/20. See also United Nations Conference on Environment 
and Development, Rio de Janeiro, Braz., June 3–14, 1992, Preliminary Report of 
the United Nations Conference on Environment and Development, U.N. Doc. 
A/CONF.151/26 (Vol. II), Annex II (Aug. 13, 1992). 
 8. See Canadian Environmental Protection Act, S.C. 1999, c. 33, available at 
http://www.ec.gc.ca/lcpe-cepa/default.asp?lang=En&n=24374285-1. The two laws 
are referred to as “CEPA 1988” and “CEPA 1999.” For our purposes, we use the 
acronym “CEPA” to refer to the 1999 legislation and specify “CEPA 1988” when 
referring to the earlier law. 
 9. CEPA § 73(1). Categorization of Existing Substances, ENV’T CAN., 
http://www.ec.gc.ca/lcpe-cepa/default.asp?lang=En&n=5F213FA8-1&wsdoc=169 
5F8D0-5CC4-EDA1-AF63-6F23A94064DD (last modified July 9, 2013). 
 10. Press Release, Prime Minister of Canada, Canada’s New Government 
Improves Protection against Hazardous Chemicals (Dec. 8, 2006), available at 
http://www.pm.gc.ca/eng/media.asp?category=1&id=1450. 
 11. Lucas Bergkamp & Mike Penman, Introduction to THE EUROPEAN UNION 
REACH REGULATION FOR CHEMICALS: LAW AND PRACTICE 3–4 (Lucas Bergkamp 
ed., 2013); Veerle Heyvaert, Regulating Chemical Risk: REACH in a Global 
Governance Perspective, in REGULATING CHEMICAL RISKS: EUROPEAN AND GLOBAL 
CHALLENGES 219–21 (Johan Eriksson et al. eds., 2010). 
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2010 and 2013, to name only a few.12  Additionally, U.S. states, 
prominently California, have enacted new programs aimed at 
assessing and reducing the potential for adverse effects from 
chemical exposures.13 
Meanwhile, the U.S. Congress has been slow to modernize 
the Toxic Substances Control Act of 1976 (TSCA), despite a broad 
consensus that the current design of TSCA is outmoded.14  
Recently, there have been some signs of progress in the TSCA 
reform effort. In May 2013, the late Senator Frank Lautenberg 
(Democrat–New Jersey) and Senator David Vitter (Republican–
Louisiana) released a bill entitled the Chemical Safety 
Improvement Act—the most significant of several recent TSCA 
reform bills because of its bipartisan sponsorship.15  The House of 
Representatives has recently held hearings on TSCA reform, and 
a draft reform bill has been circulated for comment.16  Although it 
is far from clear that Congress will pass TSCA reform in the near 
future, there is more legislative momentum for reform than there 
 
 12. Jean-François Tremblay, China Steps Up Toxin Controls, 91 CHEMICAL & 
ENGINGEERING NEWS 10 (Mar. 4, 2013); Korea Toxic Chemicals Control Act 
(TCCA), CHEM. INSPECTION & REGULATION SERV., http://www.cirs-
reach.com/KoreaTCCA/Korea_Toxic_Chemicals_Control_Act_TCCA.html (last 
visited Nov. 5, 2014); Speech by MEP Minister Zhou Shengxian at 2013 National 
Work Meeting on Environmental Protection, MINISTRY OF ENVTL. PROT. – CHINA 
(Feb. 4, 2013), http://english.mep.gov.cn/Ministers/Speeches/201303/t20130320 
_249648.htm; The Amended Japanese Chemical Substances Control Law, 
REACH24H CONSULTING GRP. (Mar. 17, 2011), http://www.reach24h.com/en-
us/cscl.html. 
 13. See, e.g., CAL. DEP’T OF TOXIC SUBSTANCES CONTROL, SAFER CONSUMER 
PRODUCTS, PROPOSED REGULATIONS, R-2011-02: ATTACHMENTS (2013), available 
at http://www.dtsc.ca.gov/LawsRegsPolicies/Regs/upload/2-SCP-REVISED-
Proposed-Regulations_APA-MARKUP-April-2013.pdf. 
 14. See, e.g., Revisiting the Toxic Substances Control Act of 1976: Hearing 
Before the Subcomm. on Commerce, Trade, & Consumer Prot. of the H. Comm. 
on Energy & Commerce, 111th Cong. 1 (2009) [hereinafter House, Revisiting 
TSCA], available at http://www.gpo.gov/fdsys/pkg/CHRG-111hhrg67095/ 
pdf/CHRG-111hhrg67095.pdf; MITCHELL P. SMITH, ENVIRONMENTAL AND HEALTH 
REGULATION IN THE UNITED STATES AND THE EUROPEAN UNION 26-27 (2012). 
 15. Chemical Safety Improvement Act, S. 1009, 113th Cong. (2013), available 
at http://cen.acs.org/content/dam/cen/91/web/S-1009-113th-Congress.pdf. 
 16. STAFF OF H.R. ENERGY & COMMERCE COMM., 113TH CONG., DISCUSSION 
DRAFT ON CHEMICALS IN COMMERCE ACT (Comm. Print 2014), available at 
http://docs.house.gov/meetings/IF/IF18/20140429/102160/BILLS-113pih-
TheChemicalsinCommerceAct.pdf. 
4http://digitalcommons.pace.edu/pelr/vol32/iss1/3
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has been since 1976 as evidenced by the serious bipartisan 
negotiations under way in both chambers of the U.S. Congress.17 
As the market for industrial chemicals is global, and because 
chemical releases can cross borders, future legislation and 
regulations will likely have international effects on industry 
management practices, trade patterns, and the global 
distribution of risks to human health and the environment. Thus, 
the TSCA reform effort is not an isolated national effort but can 
be viewed in the context of the global trend toward modernization 
of chemicals management. United States policymakers have the 
opportunity to learn from the experiences of other nations to craft 
legislation that will work in harmony with ongoing regulatory 
efforts. 
The cross-national diffusion of environmental policy 
innovation has been well documented.18  While one country rarely 
adopts verbatim the environmental reforms of another, key 
concepts and procedures are often borrowed and tailored. 
In that spirit, the purpose of this Article is to compare the 
regulatory systems in Canada and the EU, and use comparative 
 
 17. See Press Release, Senate Comm. on Env’t & Pub. Works, Vitter 
Announces Growing Support for Bipartisan TSCA Reform Bill (Apr. 15, 2014), 
available at http://www.epw.senate.gov/public/index.cfm?FuseAction=PressRo- 
om.PressReleases&ContentRecord_id=f88d6771-eafb-65e1-85bc-86dca0416958. 
 18. See generally ANNE-MARIE SLAUGHTER, A NEW WORLD ORDER (2004); 
David Lazer, Global and Domestic Governance: Modes of Interdependence in 
Regulatory Policymaking, 12 EUR. L.J. 455, 455 (2006). On environmental law, 
see Francesca Bignami & Steve Charnovitz, Transatlantic Civil Society 
Dialogues, in TRANSATLANTIC GOVERNANCE IN THE GLOBAL ECONOMY 270 (Mark 
A. Pollack & Gregory C. Shaffer eds., 2001); Gabrielle Bouleau & Matt Kondolf, 
Rivers of Diversity: Water Regulation in California and the EU, in 
TRANSATLANTIC REGULATORY COOPERATION: THE SHIFTING ROLES OF THE EU, U.S., 
AND CALIFORNIA 84 (David Vogel & Johan F.M. Swinnen eds., 2011); Mauro 
Pettricione, Reconciling Transatlantic Regulatory Imperatives with Bilateral 
Trade, in TRANSATLANTIC REGULATORY COOPERATION: LEGAL PROBLEMS AND 
POLITICAL PROSPECTS (George A. Bermann et al. eds., 2001); Per-Olof Busch & 
Helge Jörgens, The International Sources of Policy Convergence: Explaining the 
Spread of Environmental Policy Innovations, 12 J. EUR. PUB. POL’Y 860 (2005); 
Veerle Heyvaert, Globalizing Regulation: Reaching Beyond the Borders of 
Chemical Safety, 36 J.L. & SOC’Y 110 (2009); Noah M. Sachs, Jumping the Pond: 
Transnational Law and the Future of Chemical Regulation, 62 VAND. L. REV. 
1817 (2009); Joanne Scott, From Brussels with Love: The Transatlantic Travels 
of European Law and the Chemistry of Regulatory Attraction, 57 AM. J. COMP. L. 
897 (2009); Tseming Yang & Robert V. Percival, The Emergence of Global 
Environmental Law, 36 ECOLOGY L.Q. 615 (2009). 
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insights to draw some lessons that may be of interest to U.S. 
policy makers engaged in TSCA reform. CEPA and REACH are 
seen by stakeholders as state of the art in chemicals assessment 
and management, and thus the U.S. may draw useful insights 
from them. Indeed, the European Union and Canada have each 
been urging other countries to join in a globalization of the 
REACH or Canadian programs, respectively.19  Regardless of 
what TSCA reformers choose to learn from the Canadian and 
European experiences, a secondary objective of the Article is to 
provide comparative information that may be of interest to 
reformers in Canada, Europe, or other countries and regions 
where chemical risk management is under consideration for 
reform. Thus, the Article’s long-term value extends beyond the 
current U.S. debate over TSCA reform. 
The Article is organized in three Parts. In Part I, we describe 
the scope of our analysis, our research methods, and our 
analytical approach. In Parts II and III, we compare CEPA and 
REACH across two significant dimensions: (1) prioritization of 
existing chemicals for assessment and regulation; and (2) 
placement of the burdens to produce data and demonstrate safety 
of specific chemical uses. We conclude by summarizing the 
possible lessons for TSCA reform and highlighting some future 
research needs. 
I. COMPARATIVE ANALYSIS OF RISK 
REGULATION IN CEPA AND REACH 
Regulation of chemicals generally seeks to prevent or reduce 
adverse effects to human health and the environment. In a 
variety of ways, regulation facilitates the generation of safety-
related information and ensures that such information is made 
available to regulators and, where permissible, to the public. 
Safety information is also disseminated via material safety data 
sheets and labels throughout supply chains where chemicals are 
processed, transported, and used.20 Such information facilitates 
 
 19. Alex Scott, Global Approach to Chemical Regulations: A Worthy, But 
Difficult Goal, CHEMICAL & ENGINEERING NEWS, June 11, 2012, at 26. 
 20. See generally Material Safety Data Sheets (MSDSs) - General, CANADIAN 
CTR. FOR OCCUPATIONAL HEALTH & SAFETY, http://www.ccohs.ca/oshanswers 
/legisl/msdss.html (last visited Nov. 1 2014). 
6http://digitalcommons.pace.edu/pelr/vol32/iss1/3
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informed safety decisions and stimulates green market forces by 
encouraging safety in the design and selection of chemicals for 
use in products. Safety information also may spawn risk 
management measures that can range from guidance on safe 
handling practices and spill prevention measures to limitations or 
prohibitions on certain substances or particular uses of those 
substances.21 
Regulatory programs often pursue safety objectives through a 
process that includes some mechanism for identification of 
chemicals of concern, assessment of the environmental releases, 
exposures, and risks posed by those chemicals in specific uses, as 
well as the management of those releases, exposures, and risks.22  
If substitution of a different chemical is considered in the 
management phase, the risks of the target chemical may be 
compared to the risks of possible substitutes, including an 
evaluation of the utility of various chemical alternatives in 
accomplishing the function needed by industry and consumers.23  
Thus, the management phase of chemical regulation entails a 
variety of analyses that go beyond an inquiry into the intrinsic 
properties of a chemical. 
A. Risk Assessment and Safety 
Risk is present when there is a hazard and sufficient 
exposure to that hazard. Risk assessment, the primary tool used 
to make safety determinations, includes four primary 
components.24  We offer some depth in the review of the four 
 
 21. Bengt Bucht, Capacity Building for Chemicals Control: Legislation, 
Institutions, Public-Private Relationships, in REGULATING CHEMICAL RISKS: 
EUROPEAN AND GLOBAL CHALLENGES 283, 285 (Johan Eriksson et al. eds., 2010). 
 22. Andreas Klinke & Ortwin Renn, Risk Governance: Contemporary and 
Future Challenges, in REGULATING CHEMICAL RISKS: EUROPEAN AND GLOBAL 
CHALLENGES 9, 13–22 (Johan Eriksson et al. eds., 2010). 
 23. See Ragnar Löfstedt, The Substitution Principle in Chemical Regulation: 
A Constructive Critique, 17 J. RISK RES. 543 (2014). 
 24. See, e.g., NAT’L RESEARCH COUNCIL, RISK ASSESSMENT IN THE FEDERAL 
GOVERNMENT: MANAGING THE PROCESS 3 (1983) [hereinafter NRC 1983]. JOHN S. 
APPLEGATE ET AL., THE REGULATION OF TOXIC SUBSTANCES AND HAZARDOUS 
WASTES: CASES AND MATERIALS 3–4 (Robert C. Clark et al. eds., 2d ed. 2011); see 
also C.J. van Leeuwen, General Introduction, in RISK ASSESSMENT OF 
CHEMICALS: AN INTRODUCTION 2–6 (C.J. van Leeuwen & T.G. Vermeire eds., 2d 
ed. 2007); Celia Campbell-Mohn & John S. Applegate, Learning from NEPA: 
7
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components because it is critical for the reader to appreciate (a) 
how complex a comprehensive risk assessment can be and why 
rudimentary assessments are useful, (b) the significant degree of 
uncertainty that can accompany the findings of even well-done 
risk assessments, and (c) the role of risk assessment in assessing 
the effectiveness of alternative risk management measures. Since 
there are good textbooks on the basics of chemical risk 
assessment,25 we simply summarize the four basic components to 
set the stage for the comparison of CEPA and REACH with 
regard to risk assessment and management practices. 
First, hazard identification evaluates inherent chemical 
properties to determine the capacity of a substance to cause 
adverse effects in humans or the environment.26  Since regulatory 
resources are limited, governments tend to target chemicals that 
exhibit particularly troubling properties. Of special concern for 
human health are chemicals that have toxic effects at relatively 
low doses, or are known to be carcinogens, mutagens, or 
reproductive (CMR) toxins. More recently, emphasis has been 
given to chemicals that are known or suspected to disrupt the 
endocrine system of the body—endocrine-disrupting chemicals 
(EDCs).27  Greater priority for environmental wellbeing is also 
given to chemicals that may persist (P) in the environment rather 
than break down, that may bioaccumulate (B) in organisms, and 
that may be toxic (T). Chemicals that have all three properties 
are called PBTs.28  Chemicals that are very persistent and very 
 
Guidelines for Responsible Risk Regulation, 23 HARV. ENVTL. L. REV. 93, 95–98 
(1999). 
 25. See, e.g., RICHARD WILSON & EDMUND A.C. CROUCH, RISK-BENEFIT 
ANALYSIS 113–21 (2001); HUMAN AND ECOLOGICAL RISK ASSESSMENT: THEORY AND 
PRACTICE (Dennis J. Paustenbach ed., 2d ed. 2009). 
 26. NRC 1983, supra note 24, at 19–23. 
 27. See generally Laura N. Vandenberg et al., Hormones and Endocrine-
Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses, 33 
ENDOCRINE REV. 378 (2012), available at http://www.ncbi.nlm.nih.gov/ 
pmc/articles/PMC3365860/. 
 28. See generally ADAM D.K. ABELKOP, TODD V. ROYER & JOHN D. GRAHAM, 
PERSISTENT, BIOACCUMULATIVE, AND TOXIC (PBT) CHEMICALS: TECHNICAL 
ASPECTS, POLICIES, AND PRACTICES (forthcoming 2015); JOHN WARGO, GREEN 
INTELLIGENCE: CREATING ENVIRONMENTS THAT PROTECT HUMAN HEALTH 284–87 
(2009). 
8http://digitalcommons.pace.edu/pelr/vol32/iss1/3
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bioaccumulative are sometimes referred to as vPvBs and may 
also be regulated as a special class.29 
The Fifteenth Century German scientist Paracelsus (credited 
for founding the discipline of toxicology) explained that “the dose 
makes the poison.”30  Alcohol can kill people if ingested in 
excessive amounts, but alcohol can also improve health if 
consumed in moderation.31  All substances can cause toxic effects, 
but some cause toxic effects at much lower exposure levels than 
others. There is some evidence suggesting that some EDCs and 
reproductive toxins may cause effects at low doses that were 
previously considered safe.32  Thus, the hazard identification 
process, by itself, does not provide meaningful information about 
risk because knowledge of risk also requires knowledge of the 
amount of exposure in the real-world environment.33 
The second step of risk assessment is dose-response 
assessment, where the level of exposure to a substance (e.g., the 
dose) is related to the frequency and/or severity of adverse effects 
(the response).34  Sometimes the level of exposure is simply 
compared to the level of exposure that is considered safe, with the 
ratio of the exposure level to the safe dose serving as an indicator 
of risk. The dose-response relationship is influenced by how the 
chemical is taken up, distributed, and metabolized by the body 
and the biological mechanisms that relate dose to adverse effects. 
As the dosage to an organism increases, and other factors are 
held constant, the probability and/or severity of adverse effects is 
expected to increase. If large numbers of people are exposed to 
substances that exhibit toxic effects at relatively low doses, the 
 
 29. REACH, art. 14(3)(d); ABELKOP, ROYER & GRAHAM , supra note 28. 
 30. APPLEGATE ET AL., supra note 24, at 4. 
 31. See, e.g., Alcohol Use: If You Drink, Keep it Moderate, MAYO CLINIC (Feb. 
11, 2014), http://www.mayoclinic.org/healthy-living/nutrition-and-healthy-eating 
/in-depth/alcohol/art-20044551. 
 32. See TED SCHETTLER ET AL., GENERATIONS AT RISK: REPRODUCTIVE HEALTH 
AND THE ENVIRONMENT 63 (MIT Press Paperback ed. 2000). See generally 
Vandenberg et al., supra note 27. 
 33. On the importance of exposure in risk assessment, see ALISON C. CULLEN 
& H. CHRISTOPHER FREY, PROBABILISTIC TECHNIQUES IN EXPOSURE ASSESSMENT: A 
HANDBOOK FOR DEALING WITH VARIABILITY AND UNCERTAINTY IN MODELS AND 
INPUTS (1999). 
 34. NRC 1983, supra note 24, at 19, 21, 23–27. 
9
3_ABELKOP&GRAHAM FINAL 8/24/2015  12:05 PM 
2015 REGULATION OF CHEMICAL RISKS 117 
 
number of adverse health outcomes in the population can be 
substantial.35 
The concept of dose-response assessment applies to non-
human species as well as people, but the unit of analysis may be 
different. When dose-response analysis is performed to protect 
humans, the protection is modeled at the level of the individual 
human being (or even an organ or tissue). When applied 
ecologically, dose-response analysis is designed to inform 
protection at the population level, except in rare cases such as an 
endangered or threatened species.36 
When there is an exposure level that is sufficiently small to 
effectively eliminate any possible adverse effects on an organism, 
that dose is called a threshold.37  Since some individuals are more 
sensitive to chemical risks than others, the strict threshold for an 
entire population of human beings is the threshold for the most 
susceptible person in the population.38  In practice, sensitivity to 
chemical exposure is usually analyzed for groups of people rather 
than on an individual-by-individual basis. The “safe”39 dose of a 
 
 35. The low-dose effects of bisphenol-A, the primary component of many 
plastics, are a matter of intense scientific and public debate. See SARAH A. 
VOGEL, IS IT SAFE? BPA AND THE STRUGGLE TO DEFINE THE SAFETY OF CHEMICALS 
(2013); WARGO, supra note 28, at 272–76. 
 36. See David L. Eaton & Steven G. Gilbert, Principles of Toxicology, in 
CASARETT & DOULL’S TOXICOLOGY: THE BASIC SCIENCE OF POISONS 17, 19 (Curtis 
D. Klaassen & John B. Watkins eds., 7th ed. 2008). 
 37. Id. at 23, 23–24 (A threshold occurs when there is “some dose below 
which the probability of the individual responding is zero.”); NRC 1983, supra 
note 24, at 25 (“[B]elow a particular dose (the "threshold" dose of a given 
carcinogen) there is no adverse effect.”). 
 38. On the distinction between the individual and population dose-response 
function, see NAT’L RESEARCH COUNCIL, SCIENCE AND DECISIONS: ADVANCING RISK 
ASSESSMENT 141–43 (2009) [hereinafter NRC 2009]. 
 39. The term safe is in quotation marks because laboratory tests with limited 
numbers of animals cannot demonstrate safety in the strict sense that such a 
term may be understood by some citizens. In practice, toxicologists find a dose 
where there is no observable adverse effect, though there may by some effects 
that are not statistically significant or not adverse. A more modern procedure is 
to use the dose-response data in the animal test to calculate a lower confidence 
limit on the dose predicted to produce a defined incidence rate of adverse 
effect—usually about ten percent or so—or a change in a continuous 
physiological parameter of a pre-set magnitude. The important point is that a 
negative test result at a particular dose does not necessarily mean that the dose 
is completely safe. For a classic introduction to the issues in using animal data 
in risk assessment and safety determinations, see David P. Rall, The Use of 
10http://digitalcommons.pace.edu/pelr/vol32/iss1/3
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chemical in humans is typically assumed to be a fraction of the 
presumed threshold in laboratory animals because margins of 
safety—also known as uncertainty factors or assessment 
factors—are applied to account for possible uncertainties, 
including the imperfections in data quality, the extrapolation of 
data from the test species to humans, the extrapolation of effects 
from high experimental doses to low doses, and intra-species 
variability (e.g., some humans are more sensitive than others).40  
Historically, thresholds have been assumed to exist for non-
cancer effects but not for cancer; however, recent reviews suggest 
that this distinction is too simple since some non-cancer effects 
may not exhibit thresholds while some cancer effects may exhibit 
thresholds.41 
Third, exposure assessment aims to determine the extent to 
which human and non-human species will come into contact with 
a substance, whether via respiration, ingestion, or dermal 
contact.42  To quantify the exposure for a population of interest, 
the exposure assessor usually works with information on the 
production quantity of a chemical, the amount of the chemical 
dedicated to various uses, the quantity released into the 
environment (air, water, soil) during specific uses, the transport 
and fate of the chemical in the environment, and the ultimate 
population distribution of exposure.43 The behaviors of people on 
a day-to-day basis (e.g., dietary habits and indoor versus outdoor 
activity) can significantly influence the level of human exposure 
to a substance.44 Exposures may be measured directly (e.g., with 
air and water quality measurements or with personal exposure 
monitors) or estimated through the use of mathematical models. 
 
Laboratory Animal Carcinogenicity Data in Occupational Risk Assessment, in 
CHEMICAL RISK ASSESSMENT AND OCCUPATIONAL HEALTH: CURRENT APPLICATIONS, 
LIMITATIONS, AND FUTURE PROSPECTS 105, 105–11 (C. Mark Smith et al. eds., 
1994). For a basic statistical treatment of the issues, see CHARLES D. HOLLAND & 
ROBERT L. SIELKEN, QUANTITATIVE CANCER MODELING AND RISK ASSESSMENT 
(1993). 
 40. For a classic introduction to the determination of “safe” doses, see JOSEPH 
V. RODRICKS, CALCULATED RISKS: THE TOXICITY AND HUMAN HEALTH RISKS OF 
CHEMICALS IN OUR ENVIRONMENT (2d ed. 2006). 
 41. NRC 2009, supra note 38, at 177. 
 42. CULLEN & FREY, supra note 33, at 2. 
 43. See id. 
 44. Id. 
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A key statistic of growing importance to risk assessment is the 
“intake fraction,” the proportion of a released chemical that 
ultimately is taken in by people via ingestion, respiration, or 
dermal absorption.45 
Fourth, risk characterization generates a (usually) 
quantitative estimation of the magnitude of risk to human health 
and the environment from specific uses of a chemical.46  A simple 
version of characterization may be the ratio of an exposure from a 
specific use to a safe level. A more complex characterization is a 
quantitative indication of risk such as a probability of an adverse 
effect or a projected incidence rate of adverse effect in an exposed 
population.47  Characterization requires the examination of 
hazard and exposure data together, accounting for uncertainties 
and assumptions in test data, monitoring data, and data 
generated from computer modeling programs.48 
The same chemical may be characterized as high risk or low 
risk depending on how it is used by industry, how much of the 
chemical is released near population centers or downwind or 
downstream of population centers, or how much of the chemical 
may reach consumers via the use of specific products (e.g., 
dishwashing, detergents, paints, and flame retardants). Thus, for 
an industrial chemical with numerous uses, the risk 
characterization—and especially the exposure assessment—can 
be quite complex.49  The adoption of risk management measures 
also influences the risk characterization by reducing the 
exposures to the target chemical. Thus, the risk characterization 
may portray not only the current level of risk, but also the 
projected levels of risk under alternative risk management 
measures. 
Recently, the scientific committees of the European 
Commission’s Directorate-General for Health and Consumers 
produced an important document on the need for refinement of 
 
 45. See Deborah H. Bennett et al., Defining Intake Fraction, 36 ENVTL. SCI. & 
TECH. 3A, 5A (2002), available at http://ehs.sph.berkeley.edu/krsmith/ 
publications/02_bennett_1.pdf. 
 46. Id. at 4A. 
 47. Campbell-Mohn & Applegate, supra note 24, at 96–97. 
 48. See id. 
 49. On the complexities in exposure assessment, see CULLEN & CHRISTOPHER 
FREY, supra note 33. 
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risk assessment procedures.50  For ecological risk assessment, the 
document recommends moving toward approaches capable of 
better understanding and quantifying actual damages to the 
structure and functioning of ecosystems. For human risk 
assessment, the recommendation is to move from a substantially 
hazard-driven approach toward more exposure-driven 
assessments.51 
Exposure assessments on a chemical-by-chemical basis have 
an important limitation: they do not account for simultaneous 
exposure to more than one chemical. There may be adverse 
effects from cumulative exposure to multiple chemicals or even 
synergistic effects (e.g., where exposure to one chemical causes 
biological changes that render an organism vulnerable to 
exposures to another chemical). Thus, exposures to more than one 
chemical complicate the risk assessment process.52 
Any form of risk assessment may leave some questions 
unanswered due to the current limitations in scientific 
knowledge. For example, when humans are exposed to very small 
doses of chemical carcinogens, the doses may be too small to 
detect a possible elevation of cancer risk through either animal 
testing or epidemiological observation.53 More generally, 
uncertainties arise with regards to both the proper interpretation 
of hazard data on specific substances (e.g., scientific synthesis or 
interpretation of multiple studies concerning the toxicology 
and/or epidemiology of adverse effects from chemical exposures). 
The biological mechanisms that give rise to adverse effects may 
provide important clues to the shape of the dose-response curve 
at low doses and to the reliability and relevance of animal test 
data for human risk determination.54 It is not always easy to 
 
 50. See EUROPEAN COMM’N, ADDRESSING THE NEW CHALLENGES FOR RISK 
ASSESSMENT (2012), available at http://ec.europa.eu/health/scientific_committees 
/emerging/docs/scenihr_o_037.pdf. 
 51. Id. 
 52. See, e.g., M.E. Meek et al., Risk assessment of Combined Exposure to 
Multiple Chemicals: A WHO/IPCS Framework, 60 REG. TOXICOLOGY & 
PHARMACOLOGY S1, S1 (2011); Pamela R. D. Williams et al., Cumulative Risk 
Assessment (CRA): Transforming the way we Assess Health Risks, 46 ENVTL. SCI. 
& TECH. 10868, 10868 (2012). 
 53. See Rall, supra note 39, at 107–08. 
 54. See id. at 108. 
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determine whether only one biological mechanism is at work or 
whether multiple mechanisms are contributing to adverse effects. 
Since risk assessments are often conducted in the face of 
incomplete data and imperfection in basic scientific 
understanding, assumptions—based on professional judgment 
and policy values—are made throughout the process.55  There are 
a surprisingly large number of methodological choices 
(approximately fifty)56 in chemical risk assessment that can 
drastically affect the outcomes of the assessment,57 and those 
choices are associated with greater uncertainty for some 
chemicals than for others. Some of these choices are determined 
by a regulatory agency’s science-policy guidance (e.g., a general 
presumption has been established that chemicals shown to cause 
cancer in laboratory animals are an indication of potential human 
cancer risk) while others are left for professional judgment on an 
assessment-by-assessment basis (e.g., when should an 
assessment focus on the inhalation route of exposure and omit 
detailed consideration of the potential for dermal contact or 
ingestion of the substance).58 
Risk assessments contain inherent uncertainty, but risk 
assessors can still perform better in priority setting than lay 
citizens with no scientific training. Indeed, insights from risk 
assessments—like much of the knowledge in clinical medicine—
arise from professionals who have learned about real-world 
experiences with multiple chemicals in the past. Moreover, risk 
 
 55. Howard Latin, Good Science, Bad Regulation, and Toxic Risk Assessment, 
5 YALE J. ON REG. 89, 91–92 (1988). 
 56. For a tabular presentation of over fifty analytic choices in chemical risk 
assessment, see U.S. GOV’T ACCOUNTABILITY OFFICE, GAO-01-810, CHEMICAL 
RISK ASSESSMENT: SELECTED FEDERAL AGENCIES’ PROCEDURES, ASSUMPTIONS, AND 
POLICIES, 120–50 (2001). 
 57. See NAT’L RESEARCH COUNCIL, SCIENCE AND JUDGMENT IN RISK 
ASSESSMENT 106 (1994) [hereinafter NRC 1994]; Campbell-Mohn & Applegate, 
supra note 24, at 100–1; Oliver A. Houck, Tales from a Troubled Marriage: 
Science and Law in Environmental Policy, 17 TUL. ENVTL. L.J. 163, 167–68 
(2003); Latin, supra note 55, at 92–94; Howard Latin, Ideal Versus Real 
Regulatory Efficiency: Implementation of Uniform Standards and ‘Fine-Tuning’ 
Regulatory Reforms, 37 STAN. L. REV. 1267, 1267–71 (1985); Mark Eliot Shere, 
The Myth of Meaningful Environmental Risk Assessment, 19 HARV. ENVTL. L. 
REV. 409, 413–14 (1995). 
 58. See NRC 1994, supra note 57, at 7. 
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assessments become even more informative as critical data gaps 
on chemicals in commerce are filled and uncertainties reduced. 
Finally, the need for risk assessment does not end when it 
becomes clear that the risks of an existing chemical in specific 
uses are significant. Some form of risk assessment is also 
essential to inform the innovative process of green chemistry. 
Regulators and industry cannot be certain that replacing one 
chemical with another contributes to lower levels of health and 
environmental risk without carefully examining the relative risks 
of the target and substitute chemicals.59  Professional judgments 
about risk tradeoffs also play an important role in the process of 
chemical substitution. 
Since the science underpinning risk assessment is maturing 
and new data are constantly being collected on individual 
chemicals, real-world risk assessment should be a dynamic 
process. The results in one risk assessment report may need to be 
updated in response to new information. Sometimes the new 
information suggests greater risk than previously projected;60 in 
other cases, the new information is reassuring because it suggests 
less risk than previously predicted.61  Thus, risk assessment is a 
process that unfolds with changes in the available information 
base, in the amounts of chemicals used in different applications, 
and in scientific advancements.62  Although such adaptive 
 
 59. See George M. Gray & John D. Graham, Regulating Pesticides, in RISK 
VERSUS RISK: TRADEOFFS IN PROTECTING HEALTH AND THE ENVIRONMENT 173–92 
(John D. Graham & Jonathan B. Wiener eds., 1995); see generally Löfstedt, 
supra note 23. 
 60. The thresholds for some substances (e.g., lead) have been repeatedly 
lowered as new scientific information showed adverse effects at lower and lower 
doses. JOE THORNTON, PANDORA’S POISON: CHLORINE, HEALTH, AND A NEW 
ENVIRONMENTAL STRATEGY 79 (2001). This phenomenon has been provocatively 
called “shrinking thresholds.” Id. at 79–80. See generally Janna G. Koppe & 
Jane Keys, PCBs and the Precautionary Principle, in THE PRECAUTIONARY 
PRINCIPLE IN THE 20TH CENTURY: LATE LESSONS FROM EARLY WARNINGS 64, 71–74 
(Paul Harremoes et al. eds., 2002). 
 61. For case studies where new information shows less risk than previously 
predicted, see PHANTOM RISK: SCIENTIFIC INFERENCE AND THE LAW 6 (Kenneth R. 
Foster et al. eds., 1993); Aaron Wildavsky & Robert Owen Rye, Detecting Errors 
in Environmental and Safety Studies, in BUT IS IT TRUE? A CITIZEN’S GUIDE TO 
ENVIRONMENTAL HEALTH AND SAFETY ISSUES 410, 412–14 (1997). 
 62. Under TSCA’s new chemicals program, EPA has been creative in 
allowing new chemicals with low releases and low exposures to be marketed 
with less data than normal, but also with plans for continued monitoring to 
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approaches to risk assessment and management have appeal, 
they are not easy to incorporate into the adversarial legal 
environment that has characterized implementation of TSCA. 
B. Balancing Risk and Benefits in Various Uses 
The risk assessment process is designed to inform industrial 
managers as well as regulators about safety and the possible need 
for—and effectiveness of—risk management measures. The 
applicability of management measures will vary depending on 
how industry is using a chemical. 
There are a wide variety of measures that may reduce risk: 
application of new technologies to industrial processes to prevent 
or reduce emissions, leaks, and spills; performance standards 
that limit volume, concentration, or releases over time; 
information or educational interventions that alert consumers, 
workers, or other market actors to potential risks and greener 
alternatives; stricter handling and waste-disposal practices; 
restrictions on specific chemical uses; and complete prohibitions 
on  the manufacture and importation of substances. When 
regulators are considering a ban, it is not uncommon for 
manufacturers and users to undertake voluntary measures to 
either reduce risk with the existing chemical or to implement 
chemical substitution.63 
Since the benefits and risks of a chemical vary enormously by 
use, it is rare that useful chemicals are prohibited in all 
applications. Even a chemical such as dichloro-diphenyl-
trichloroethane (DDT), which has been known for decades to 
cause toxicity to wildlife when released into the environment, is 
still used in the developing world to control vectors for malaria.64  
 
ensure safety over time. Ortwin Renn & E. Donald Elliott, Chemicals, in THE 
REALITY OF PRECAUTION: COMPARING RISK REGULATION IN THE UNITED STATES AND 
EUROPE 223, 231–32 (Jonathan B. Wiener et al. eds., 2011). 
 63. The wisdom of relying on substitute chemicals is spawning an entire new 
field of analysis sometimes called “alternatives assessment.” Cheryl Hogue, 
Assessing Alternatives to Toxic Chemicals, CHEMICAL & ENGINEERING NEWS, Dec. 
16, 2013, at 19-20. Alternatives assessment is a close cousin of risk-tradeoff 
analysis. See generally Gray & Graham, supra note 59, at 178–89. 
 64. On the harmful effects of DDT (from its breakdown product DDE), see 
Jeffrey L. Lincer, DDE-Induced Eggshell- Thinning in the American Kestrel: A 
16http://digitalcommons.pace.edu/pelr/vol32/iss1/3
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But this is the only residual use of DDT permitted under the 
Stockholm Convention on Persistent Organic Pollutants, and the 
present uses of DDT on a global basis are substantially less than 
global use of DDT prior to the ban.65  The argument is that the 
benefits of DDT use for malaria control justify the environmental 
risk.66  Risk-reduction measures may be preferred to bans in 
situations where there are no effective, safe, or affordable 
substitutes and where the benefits of the chemical to industry, 
consumers, and the public are significant.67 
The regulatory approaches in Canada and the EU share 
much in common but also differ in significant ways. We thus turn 
to a comparison of the two regulatory systems, keeping in mind 
this background on how risk assessment is used to inform risk 
management. 
C. CEPA and REACH as a Basis for Comparison 
The Canadian and European approaches to chemicals 
governance lend themselves well to a comparative analysis. The 
CMP and REACH were both launched in late 2006, and U.S. 
policy makers can learn from an empirical investigation of how 
each program has proceeded. Significant work in assessment and 
management has been completed under both laws. Yet, 
implementation is not complete, as both have set 2020 as a 
tentative implementation milestone.68  Open questions remain as 
 
Comparison of the Field Situation and Laboratory Results, 12 J. APPLIED 
ECOLOGY 781 (1975). 
 65. Shobha Sadasivaiah, Yeşim Tozan & Joel G. Breman, 
Dichlorodiphenyltrichloroethane (DDT) for Indoor Residual Spraying in Africa: 
How Can It Be Used for Malaria Control?, 77 AM. J. TROPICAL MED. & HYGIENE 
249, 251 (2007). 
 66. See Tina Rosenberg, What the World Needs Now is DDT, N.Y. TIMES, Apr. 
11, 2004, http://www.nytimes.com/2004/04/11/magazine/what-the-world-needs-
now-is-ddt.html; WARGO, supra note 28, at 187–88. 
 67. See generally ORG. FOR ECON. COOPERATION & DEV., THE ECONOMIC 
APPRAISAL OF ENVIRONMENTAL PROJECTS AND POLICIES: A PRACTICAL GUIDE 145–
47, 150–51 (1995); MEG POSTLE, COST-BENEFIT ANALYSIS AND CHEMICAL RISK 
MANAGEMENT (1997). 
 68. EUROPEAN COMM’N, ROADMAP ON SUBSTANCES OF VERY HIGH CONCERN 2 
(2013) [hereinafter SVHC ROADMAP], available at http://register.consilium. 
europa.eu/doc/srv?l=EN&f=ST%205867%202013%20INIT; VIRGINIA POTER & 
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to how the CMP will proceed into its final years and how EU 
Authorities will implement REACH. Therefore, while our primary 
focus is on drawing lessons to inform the ongoing debate over 
TSCA reform, our report also sheds light on what Canadian and 
European lawmakers can learn from each other’s programs.69 
Canada and EU Member States are amongst the U.S.’s 
largest trading partners, and chemicals management can raise 
notable trade issues.70  The U.S. is already working to harmonize 
regulations with Canada and the EU through the Regulatory 
Cooperation Council and the Transatlantic Trade and Investment 
Partnership, respectively.71  The U.S. also has the opportunity 
with TSCA reform to design a regulatory program that acts in 
harmony with both CEPA and REACH. European and Canadian 
approaches to chemicals governance also make for a fruitful 
comparison because the Nordic countries and Canada have 
traditionally been among the most active nations in international 
chemicals governance due to their concern about adverse effects 
of pollutants on Arctic populations and ecology.72 
Finally, in congressional hearings on TSCA reform, 
legislators have shown a keen interest in regulatory activities in 
 
VINCENZA GALATONE, CHEMICALS MANAGEMENT PLAN: MOVING FORWARD IN 2013, 
ICG CEPA UPDATE CONFERENCE 3 (June 6, 2013). 
 69. See Jonathan B. Wiener & Alberto Alemanno, Improving International 
Regulatory Cooperation: TTIP as a Step Toward a Global Policy Laboratory, 78 
LAW & CONTEMPORARY PROBLEMS (forthcoming 2015) (examining regulatory 
variation as a learning exercise). 
 70. Lawrence A. Kogan, REACH and International Trade Law, in THE 
EUROPEAN UNION REACH REGULATION FOR CHEMICALS: LAW AND PRACTICE 315-
17 (Lucas Bergkamp ed., 2013). See, e.g., Lawrence A. Kogan, REACH Revisited: 
A Framework for Evaluating whether a Non-Tariff Measure has Matured into an 
Actionable Non-Tariff Barrier to Trade, 28 AM. U. INT’L L. REV. 489, 514-24 
(2013); SELIN, supra note 6, at 97–99. 
 71. See generally Hearing on the Regulatory Aspects of Trans-Atlantic Trade 
and Investment Partnership (TTIP), U.S.-EU Free Trade Agreement, Before the 
Committee on Trade, European Parliament, (2013) (testimony of John D. 
Graham, Ph.D., Dean, School of Public and Environmental Affairs, Indiana 
University, USA), available at http://www.europarl.europa.eu/document/ 
activities/cont/201310/20131015ATT72818/20131015ATT72818EN.pdf; UNITED 
STATES-CANADA REGULATORY COOPERATION COUNCIL, JOINT ACTION PLAN (2011), 
available at http://www.whitehouse.gov/sites/default/files/us-canada_rcc_joint 
_action_plan3.pdf. 
 72. SELIN, supra note 6, at 170–71. 
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both Europe and Canada.73  Testimony, however, has tended to 
focus on REACH, with only scant references to CEPA and the 
CMP. This report therefore fills a gap in the recent dialogue on 
TSCA reform by bringing Canadian experiences to the forefront of 
the discussion. 
There is already a comparative literature on TSCA and 
REACH. Professor John Applegate, for example, employs a 
Hegelian dialectic method, presenting TSCA as the thesis and 
REACH as its antithesis (the “anti-TSCA”).74  There are also a 
few reports that include CEPA in their comparative analyses.75  
 
 73. See, e.g., Assessing the Effectiveness of U.S. Chemical Safety Laws: 
Hearing Before the Sub. on Superfund, Toxics, & Envtl. Health of the S. Comm. 
on Env’t & Pub. Works, 112th Cong. 81 ( 2011), available at 
http://www.gpo.gov/fdsys/pkg/CHRG-112shrg85224/pdf/CHRG-
112shrg85224.pdf; Prioritizing Chemicals for Safety Determination: Hearing 
Before the Subcomm. on Commerce, Trade, & Consumer Prot. of the H. Comm. 
on Energy & Commerce, 111th Cong. 6 (2009) [hereinafter House, Prioritizing 
Chemicals], available at http://www.gpo.gov/fdsys/pkg/CHRG-111hhrg74851/pdf/ 
CHRG-111hhrg74851.pdf; House, Revisiting TSCA, supra note 14, at 130. 
 74. John S. Applegate, Synthesizing TSCA and REACH: Practical Principles 
for Chemical Regulation Reform, 35 ECOLOGY L.Q. 721, 724 (2008) [hereinafter 
Applegate, Synthesizing]. See also Mikael Karlsson, The Precautionary Principle 
in EU and US Chemicals Policy: A Comparison of Industrial Chemicals 
Legislation, in REGULATING CHEMICAL RISKS: EUROPEAN AND GLOBAL 
CHALLENGES (Johan Eriksson et al. eds. 2010); Ragnar E. Löfstedt & David 
Vogel, The Changing Character of Regulation: A Comparison of Europe and the 
United States, 21 RISK ANALYSIS 399 (2001) (comparing TSCA to REACH’s 
predecessor); James T.O. Reilly, What REACH Can Teach Us about TSCA: 
Retrospectives on America’s Failed Toxics Statute, 1 EUR. J. OF RISK REG. 40 
(2010); Renn & Elliott, supra note 62, at 223–56; U.S. GOV’T. ACCOUNTABILITY 
OFFICE, GAO-07-825, CHEMICAL REGULATION: COMPARISON OF U.S. AND RECENTLY 
ENACTED EUROPEAN UNION APPROACHES TO PROTECT AGAINST THE RISKS OF TOXIC 
CHEMICALS 4–5 (2007), available at http://www.gao.gov/new.items/d07825.pdf. 
 75. See RICHARD DENISON, NOT THAT INNOCENT: A COMPARATIVE ANALYSIS OF 
CANADIAN, EUROPEAN UNION, AND UNITED STATES POLICIES ON INDUSTRIAL 
CHEMICALS I-5 (2007), available at http://www.edf.org/sites/default/ 
files/6149_NotThatInnocent_Fullreport.pdf [hereinafter DENISON, NOT THAT 
INNOCENT]; U.S. GOV’T ACCOUNTABILITY OFFICE, GAO-06-217R, CHEMICAL 
REGULATION: APPROACHES IN THE UNITED STATES, CANADA, AND THE EUROPEAN 
UNION 6 (2005), available at http://www.gao.gov/new.items/d06217r.pdf; ANNE 
WORDSWORTH, CHEMICALS POLICY IN CANADA, THE EUROPEAN UNION AND THE 
UNITED STATES 7 (2007), available at http://s.cela.ca/files/555_EU.pdf; Richard 
Denison, Ten Essential Elements in TSCA Reform, 39 ENVTL. L. REP. 10020, 
10022 (2009) [hereinafter Denison, Ten Essential]; Daryl Ditz, Dialogue, Lessons 
from Canada and Europe, Toxic Substances Chemical Act Reform: Chemical 
Prioritization (pt. 2), 42 ENVTL. L. REP. 10316-17 (2013). 
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Dr. Richard Denison of the Environmental Defense Fund released 
a noteworthy report in 2007 reviewing the design of REACH, 
TSCA, and CEPA.76  He provides useful comparative insights on 
how the design of each program addresses prioritization, data 
production, risk management for new and existing substances, 
and information sharing and disclosure.77  Our Article builds on 
the work of Applegate, Denison, and others by drawing findings 
from empirical observations after seven years of CMP and 
REACH implementation. 
D. Research Method 
We gathered information from primary legislative and 
regulatory texts, regulatory guidance materials, secondary 
scientific and policy literatures, and notes from several rounds of 
interviews with dozens of specialists in government, industry, 
public interest organizations, and the academic community. We 
conducted interviews by phone, in person, and through e-mail 
exchanges. To encourage candor, we assured interviewees that we 
would not assign specific viewpoints to specific individuals. We 
list all of the interviewees and their organizational affiliations in 
Appendix A. 
To learn about REACH, we, along with Professor Lois Wise 
(Indiana University) and Ágnes Botos (REACH consultant in 
Budapest, Hungary), interviewed twenty-nine individuals, 
including officials in the European Commission in Brussels 
(Directorate-General for the Environment and Directorate-
General for Enterprise and Industry), the European Chemicals 
Agency (ECHA) in Helsinki, and public interest organizations in 
the U.S. and Europe. These interviews took place between 
December 2010 and June 2011. In addition to the more 
structured interviews, we attended the 2011 ECHA Stakeholder 
Day in Helsinki, Finland and the 2011 Helsinki Chemicals Forum 
in May of 2011.78  This initial round of research led to the 
 
 76. DENISON, NOT THAT INNOCENT, supra note 75, at I-5. 
 77. See generally id. 
 78. ECHA Sixth Stakeholders Day, EUROPEAN CHEMICALS AGENCY, 
http://echa.europa.eu/web/guest/view-article/-/journal_content/32e60e70-22ed-
4092-8b10-9c21f709306b (last visited Nov. 6, 2014). See Helsinki Chemicals 
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publication of an article in 2012 entitled, Regulating Industrial 
Chemicals: Lessons for U.S. Lawmakers from the European 
Union’s REACH Program.79 
We, along with Professor Todd Royer, Mallory Mueller (both 
from Indiana University), and an interdisciplinary panel of 
experts from Europe and the U.S., gathered more recent data 
through a second round of thirty-eight interviews conducted 
between November 2012 and June 2013. This project culminated 
in the publication of a book in 2015 entitled Persistent, 
Bioaccumulative, and Toxic (PBT) Chemicals: Technical Aspects, 
Policies, and Practices.80  Although the interviews focused on the 
science and policy of PBTs, we were also able to gather data from 
these interviews on the current state of assessment and 
management practices under REACH and other regulatory 
programs to inform our analysis. 
To learn about CEPA and the CMP, we interviewed fifteen 
individuals in Environment Canada, Health Canada, Canadian 
industry, academics, and a Canadian public interest organization. 
One of the authors also attended the 2013 CEPA Update 
Conference, organized by the Industry Coordinating Group for 
CEPA, in Mississauga, Ontario in June 2013.81  The conference 
featured detailed presentations from representatives of 
government and industry on the administration of CEPA and the 
CMP.82 
Altogether, we interviewed eighty-two individuals from 2010 
to 2014 who offered insight on chemicals regulation. Thus, our 
report draws significantly on stakeholder perspectives. 
 
Forum 2011: Presentations, FINNEXPO, http://finnexpo.multiedition.fi/gallery/ 
main.php?g2_itemId=618 (last updated May 20, 2011). 
 79. Adam D.K. Abelkop et al., Regulating Industrial Chemicals: Lessons for 
U.S. Lawmakers from the European Union’s REACH Program, 42 ENVTL. L. 
REP. 11042 (2012). 
 80. ABELKOP, ROYER & GRAHAM, supra note 28. 
 81. INDUS. COORDINATING GRP. FOR CEPA, 2013 CEPA UPDATE CONFERENCE, 
AGENDA (2013), available at http://www.intertek.com/icg-cepa-update-
conference-flyer/. 
 82. Id. 
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E. Scope and Dimensions of Comparison 
While the regulation of new substances is an important and 
somewhat contentious aspect of regulatory design (about 600 new 
industrial chemicals are introduced into U.S. commerce each 
year),83 our analysis is limited to existing substances because 
regulatory programs, prominently those under CEPA and TSCA 
as well as EU regulations that pre-date REACH, all treated new 
substances with greater scrutiny than existing substances. 
Historically, existing substances lacking a significant prior 
history of major health or environmental risks were simply 
grandfathered into acceptance under a presumption of safety, 
without a full set of basic data on uses, exposure pathways, and 
hazardous properties.84  REACH and the CMP are designed to 
address this disparity in assessment. The focus of TSCA reform is 
also on existing industrial chemicals.85 Moreover, regulation of 
existing chemicals is even more politically controversial than new 
chemicals because there are identifiable companies, workers, and 
consumers who derive their livelihood from existing substances. 
For these reasons, we focus on the legacy of existing industrial 
chemicals. 
We concentrate on industrial chemicals because agricultural 
chemicals, biocides, and pharmaceuticals tend to raise different 
policy and scientific issues. They are also regulated under 
different statutory regimes. 
Our analysis explores two aspects of regulatory design: 
prioritization of existing substances for risk assessment and 
regulation and the allocation of burdens to produce safety data 
and demonstrate safe use of chemicals. We have chosen these two 
dimensions for examination because (a) they are central to any 
chemical regulatory system, (b) they capture some of the most 
innovative features of the Canadian and European systems, and 
 
 83. GAO TOXIC SUBSTANCES, supra note 3, at 1. 
 84. APPLEGATE ET AL., supra note 24, at 281; DENISON, NOT THAT INNOCENT, 
supra note 75, at I-1. 
 85. See JERRY H. YEN, CONG. RESEARCH SERV., R43136, PROPOSED REFORM OF 
THE TOXIC SUBSTANCES CONTROL ACT (TSCA) IN THE 113TH CONGRESS: S. 1009 
COMPARED WITH S. 696 AND CURRENT LAW 1 (2013), available at 
http://fas.org/sgp/crs/misc/R43136.pdf. 
22http://digitalcommons.pace.edu/pelr/vol32/iss1/3
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(c) Canada and Europe differ significantly on these two 
dimensions. 
There are many other features of the two regulatory 
programs that could be compared: the legal definitions of safety, 
the treatment of confidential business information, the 
procedures for regulating new chemicals,86 the guidelines for 
measuring the benefits and risks of specific uses including the 
risks of possible substitutes, and the role of public participation 
and judicial review in the regulatory processes. We encourage 
application of a comparative approach to these issues as well. 
II. PRIORITIZATION AND SCREENING IN 
RISK ASSESSMENT 
Above we provided some basic information on the general 
steps involved in risk assessment. In this Part, we compare CEPA 
and REACH in their approaches to prioritization and risk 
assessment. We begin by providing additional detail on 
prioritization and the use of screening techniques in risk 
assessment. We then deliver empirical descriptions of these 
processes under CEPA and REACH, followed by lessons for U.S. 
policy makers. 
Risk assessment requires information on hazards and 
exposures; however, there are wide variations in the amount, 
type, and level of detail of data that assessors may include in 
their evaluations. A comprehensive risk assessment includes data 
on numerous matters such as degradation/persistence, 
bioaccumulation, toxicity (human health and ecological), dose-
response functions for various toxicological endpoints (e.g., 
reproductive effects and carcinogenicity), production and 
importation volume, commercial uses, concentrations present in 
various environmental media, releases from different uses, waste 
disposal methods, and potential pathways for exposure after 
release into the environment occurs.87  Sources of data vary. They 
may be generated from laboratory tests (e.g., toxicity tests on 
 
 86. REACH uses the same processes to govern new and existing chemicals. 
 87. John S. Applegate, The Government Role in Scientific Research: Who 
Should Bridge the Data Gap in Chemical Regulation?, in RESCUING SCIENCE 
FROM POLITICS 259–60 (Wendy Wagner & Rena Steinzor eds., 2006) [hereinafter 
Applegate, RESCUING]; see generally NRC 1983, supra note 24, at 19–20. 
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animals) or field observations (e.g., biomonitoring in human blood 
or remote sensing of chemicals in the environment).88  Data may 
also be estimated based on complicated computer modeling 
programs that employ statistical techniques.89 
The information necessary to support a comprehensive risk 
assessment can be difficult, time consuming, and expensive to 
obtain.90  Even a single component of the risk assessment, 
namely the hazard characterization of a chemical, has taken 
decades to complete in some cases, and the resulting 
management decisions have been highly contentious. For 
example, the Environmental Protection Agency’s (EPA) risk 
assessment process for formaldehyde under TSCA began in the 
early 1980s.91  Several draft risk assessments were released for 
peer review and public comment, including a most recent draft 
released in 2010.92  Likewise, the EPA assessment of 
trichloroethylene (a common groundwater contaminant) began in 
the 1980s, and while multiple drafts of the risk assessment have 
been produced, the final draft was issued in 2014.93  Indeed, both 
CEPA 1999 and REACH were enacted, in part, because 
assessment and management decisions under their predecessors 
 
 88. See id. at  20, 22–23. 
 89. See id. at 24–26. 
 90. See, e.g., Applegate, RESCUING, supra note 87, at 262–63; APPLEGATE ET 
AL., supra note 24, at 8–9; DENISON, NOT THAT INNOCENT, supra note 75, at A-15–
A-22; Klinke & Renn, supra note 22, at 10–13; NRC 1983, supra note 24; 
Campbell-Mohn & Applegate, supra note 24, at 99–102; Shere, supra note 57, at 
440–42. 
 91. JOHN D. GRAHAM ET AL., IN SEARCH OF SAFETY: CHEMICALS AND CANCER 
RISK 28–34 (1988). 
 92. See generally, NAT’L RESEARCH COUNCIL, REVIEW OF THE ENVIRONMENTAL 
PROTECTION AGENCY’S DRAFT IRIS ASSESSMENT OF FORMALDEHYDE R9 (2011), 
available at http://www.nap.edu/openbook.php?record_id=13142; Integrated Risk 
Information System: IRIS Toxicological Review of Formaldehyde (Inhalation) 
(External Review Draft 2010), EPA, http://cfpub.epa.gov/ncea/iris_drafts/ 
recordisplay.cfm?deid=223614 (last visited Nov. 4, 2014); Jeremy P. Jacobs, NAS 
Reviewers Slam EPA’s Formaldehyde Assessment, N.Y. TIMES (Apr. 8, 2011), 
http://www.nytimes.com/gwire/2011/04/08/08greenwire-nas-reviewers-slam-
epas-formaldehyde-assessmen-83879.html. 
 93. See EPA, NO. 740-R1-4002, TSCA WORKPLAN CHEMICAL RISK ASSESSMENT 
FOR TRICHLOROETHYLENE: DEGREASER, SPOT CLEANING, AND ARTS & CRAFTS USES 
(2014), available at http://www.epa.gov/oppt/existingchemicals/pubs/TCE_OPPT 
WorkplanChemRA_FINAL_062414.pdf. 
24http://digitalcommons.pace.edu/pelr/vol32/iss1/3
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took too long.94  TSCA reformers are also looking for a way to 
accelerate risk assessment and management and reduce the 
ossification that has plagued EPA decision-making under TSCA 
in the past. 
In an ideal world, complete data sets would be available for 
all chemicals that people and the environment may be exposed to. 
Yet, industry and regulatory agencies are faced with the legacy of 
tens of thousands of substances that appear on various 
inventories of existing chemicals in commerce. Given limited 
personnel and financial resources, there are two general 
approaches to streamline the risk assessment process to enable 
more expedient management decisions: the use of a screening, or 
a tiered approach to risk assessment, and systems for prioritizing 
which chemicals should be assessed first. 
An alternative to comprehensive risk assessment is a 
screening level assessment. Screening techniques can be 
accomplished much faster than comprehensive risk assessments 
since screening assessments require relatively limited data to 
implement.95  Screening assessments often rely on modeling and 
estimation techniques.96  If new data are generated for screening, 
tests may use “higher and fewer doses of the compound being 
studied, fewer test subjects, a shorter time period of observation, 
and less extensive evaluation of the toxic outcomes.”97  
 
 94. See Bjorn Hansen, Background and Structure of REACH, in THE 
EUROPEAN REACH REGULATION FOR CHEMICALS 17–18 (Lucas Bergkamp ed., 
2013); M.E. Meek & V.C. Armstrong, The Assessment and Management of 
Industrial Chemicals in Canada, in RISK ASSESSMENT OF CHEMICALS: AN 
INTRODUCTION 591, 597 (C.J. van Leeuwen & T.G. Vermeire eds., 2007). 
 95. NAT’L RESEARCH COUNCIL, APPLICATIONS OF TOXICOGENOMIC 
TECHNOLOGIES TO PREDICTIVE TOXICOLOGY AND RISK ASSESSMENT 73 (2007) 
[hereinafter NRC 2007] (“A screening test can be defined as one designed to 
detect a state or property more quickly and cheaply than more elaborate tests 
for that state or property. In predictive toxicology, the property being detected 
by screening tests is generally hazard. Screening tests may not give complete 
information on toxicity, such as the time course, chronic effects, or dose-response 
characteristics. Therefore, . . . screening data provide an input to the hazard 
identification step in risk assessment but do not allow full determination of 
risk.”) 
 96. Id. at 74 (“[T]he current practice of [EPA] under [TSCA], in the absence of 
more extensive preexisting data, is to screen new chemicals based solely on 
physicochemical data using quantitative structure-activity relationship 
models.”). 
 97. Id. 
25
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Comprehensive risk assessments, on the other hand, ideally rely 
on the generation of new data, higher quality tests (e.g., greater 
number of test subjects over a longer period of time), and a wider 
variety of data, as well as consideration of a richer suite of 
endpoints. 
A regulatory system might favor screening level assessment 
over comprehensive risk assessment to avoid “paralysis by 
analysis.” Value of information (VOI) analysis is a useful frame 
for intelligent priority setting and information gathering. “VOI is 
entirely decision-centric. In a VOI analysis, an information source 
is valued solely on the basis of the probability and magnitude of 
its potential impacts on a specific decision at a specific time with 
a specific state of prior knowledge.”98  In other words, regulators 
only need to gather just enough information that allows them to 
make a risk determination. If additional information would not 
likely lead to a different determination of risk, then obtaining 
that information might not be cost-effective. 
Whether a chemical’s governance regime emphasizes a 
comprehensive or screening approach to risk assessment, priority 
setting for assessment and management is essential to maximize 
the public health and environmental benefits of regulation. 
Effective prioritization requires regulators to apply science-based 
criteria to identify chemicals of concern and further prioritize 
among those chemicals—including numerous uses—for purposes 
of assessment and management.99 
A priority-setting system for risk assessment could start with 
a focus on chemicals with hazardous properties,100 or it could 
 
 98. NRC 2009, supra note 38, at 82. See generally ADAM FINKEL, 
CONFRONTING UNCERTAINTY IN RISK MANAGEMENT: A GUIDE FOR DECISION-
MAKERS (1990), available at http://digitalcollections.library.cmu.edu/awweb/ 
awarchive?type=file&item=438442; NAT’L RESEARCH COUNCIL, ENVIRONMENTAL 
DECISIONS IN THE FACE OF UNCERTAINTY 165–71 (2013) (discussing VOI for risk 
assessment) [hereinafter NRC 2013]; NRC 2009, supra note 38, at 82–84. 
 99. See generally Ditz, supra note 75. 
 100. Comments from Ortwin Renn, Professor, University of Stuttgart (Apr. 27, 
2014) (on file with author). In Europe, the hazard aspect is sometimes 
subdivided into four components: chemicals that threaten human health (e.g., 
toxic, carcinogenic, genotoxic, reproductive toxin, endocrine disruptor); 
chemicals that threaten environmental quality (e.g., ecotoxicity, endangered 
species, ecosystem integrity, purity of air, soil, and water, restriction of land 
use); chemicals with hazardous traits that could lead to damages over time (e.g., 
26http://digitalcommons.pace.edu/pelr/vol32/iss1/3
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start with a focus on chemicals that are commonly released into 
the environment (e.g., due to high-volume production and 
dispersive uses). If a priority-setting system starts with a focus on 
chemical properties, it must later consider uses and exposures or 
it may not address significant risks. If the system starts with an 
exposure focus, it must later consider hazard or it may also miss 
significant risks. Conceptually, priority setting for risk 
assessment could consider both hazard and exposure from the 
start, but such a risk-based priority-setting process is more 
complex, data intensive, time-consuming, and expensive for 
government and industry. Regardless of whether priority setting 
for risk assessment starts with consideration of hazard, exposure, 
or both, the result of priority setting is a manageable number of 
chemicals and/or uses that are subject to risk assessments. 
To be efficient, priority setting must use some rudimentary 
form of screening based on priority criteria. However, without 
hard data the priority-setting approach will leave a lingering 
uncertainty about whether the screening techniques have missed 
a bad actor. Thus, there is a tension between the desire for timely 
risk management decisions and the need to fill the data gaps that 
are a source of concern. A classic chicken-egg dilemma plagues 
the design of any priority-setting scheme.101  There is a 
temptation to wait for adequate data, since data are needed in 
order for the government to set evidence-based priorities. If risk 
assessments are delayed until adequate data are available, the 
resulting risk assessments and regulatory decisions might be 
made in a more informed and perhaps somewhat less contentious 
way.102  On the other hand, since it would take many years to 
develop adequate data on thousands of existing chemicals, there 
is a cogent argument for undertaking preliminary risk 
assessments promptly, to identify chemicals and uses of likely 
concern, before adequate data are available on all chemicals.103 
 
persistency, potential to bioaccumulate, potential to break down into more 
harmful substances, capability of being transported over long distances); and 
chemicals that can lead to harm if combined with other chemicals or if used in 
special contexts in which exposure and damage are likely to occur. Id. 
 101. Ditz, supra note 75, at 10317 (indicating that risk-based prioritization is 
problematic if data on risk are not available). 
 102. See id. 
 103. See id. at 10316. 
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The precautionary principle, which was introduced in the 
1992 Rio Declaration on Environment and Development, supports 
such an approach and was incorporated into CEPA through its 
preamble: “Where there are threats of serious or irreversible 
damage, lack of full scientific certainty shall not be used as a 
reason for postponing cost-effective measures to prevent 
environmental degradation.”104  CEPA section 76.1 directs EC 
and HC to consider the weight of evidence and to apply the 
precautionary principle in conducting and interpreting risk 
assessments.105  REACH is also based on precautionary 
reasoning.106  Screening level assessments can be precautionary 
by applying worst-case scenarios for exposure and conservative 
assumptions about toxicity (e.g., based on the known toxicity of 
structurally similar chemicals). We now assess how prioritization 
and tiered levels of assessment are incorporated into CEPA and 
REACH. 
A. CEPA 1999 and the CMP 
The government of Canada regulates industrial chemicals 
primarily under the authority of the Canadian Environmental 
Protection Act, which was first enacted in 1988 and revised in 
1999.107  CEPA 1999 formed the basis for present regulatory 
activities by requiring Environment Canada (EC) and Health 
Canada (HC) to categorize existing chemicals by the end of 2006 
in order to identify priority substances for risk assessment.108  In 
2006, the government of Canada launched the Chemicals 
Management Plan to submit the identified substances warranting 
 
 104. Canadian Environmental Protection Act, S.C.1999, c. 33, Preamble 
(Can.), available at http://www.ec.gc.ca/lcpe-cepa/default.asp?lang=En&n= 
24374285-1 [hereinafter CEPA]. 
 105. The Act Part 5: Controlling Toxic Substances, ENV’T CAN., 
http://www.ec.gc.ca/lcpe-cepa/default.asp?lang=En&n=24374285-1&offset=6 
(last visited Nov. 4, 2014). 
 106. Commission Regulation 1907/2006, Registration, Evaluation, 
Authorisation and Restriction of Chemicals, art. 1(3), 2006 O.J. (L 396) 1 (EC) 
[hereinafter REACH]. 
 107. The Canadian literature refers to the laws as CEPA 1988 and CEPA 
1999. Here, we use “CEPA” to refer to the 1999 legislation and specify when we 
are referring to the earlier law. 
 108. CEPA § 73(1). 
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further evaluation to various degrees of screening assessments 
(less than full risk assessments) to determine whether 
management is called for. Existing chemicals are listed on the 
Domestic Substances List (DSL)—a total of about 23,000 
substances that were manufactured in or imported into Canada 
in quantities equal to or greater than 100 kg/yr between January 
1, 1984 and December 31, 1986.109  The categorization identified 
each substance as a priority or non-priority, based on ecological 
and health criteria. The CMP further designated priority 
substances as high, medium, or low priorities.110  The 
relationship between categorization and the CMP is depicted in 
Figure 1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 109. See Domestic Substances List, ENV’T CAN., https://ec.gc.ca/lcpe-
cepa/default.asp?lang=En&n=5F213FA8-1 (last modified Sept. 17, 2013). 
 110. See id. 
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Figure 1. Overview of Prioritization and Risk Assessment 
under CEPA 
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~ 30 policy tools 
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1. Categorization 
CEPA section 73(1) established four criteria to categorize 
chemicals on the DSL: greatest potential for exposure (GPE) to 
individuals in Canada, persistence (P), bioaccumulation (B), and 
inherent toxicity (iT) to human beings and non-human 
organisms.111  The CMP also uses these criteria for further 
prioritization—PBiT as ecological criteria, and GPE and iT as 
human health criteria.112 
Under CEPA, there is a difference between inherently toxic 
and toxic. The “inherent toxicity” determination is equivalent to a 
toxicity determination in other contexts; it is solely a hazard-
based determination of whether a substance causes toxic effects 
at tested doses.113  Canada uses the iT designation, though, 
because “toxic”—without the preceding “i” for “inherent”—has a 
specific legal meaning under CEPA that does not correspond with 
the general scientific understanding of toxicity.114  The 
determination that a substance is “toxic”—often referred to as 
“CEPA-toxic”—is a purely legal finding and is distinct from 
whether the substance is “inherently toxic.”  A substance is 
CEPA-toxic “if it is entering or may enter the environment in a 
quantity or concentration under conditions that” may result in 
harm to human health or the environment.115  Thus, while 
inherent toxicity is a hazard-based determination, the formal 
“toxic” (CEPA-toxic) determination is risk-based, as it 
 
 111. CEPA § 73(1)(b). Separate bodies of regulations define persistence and 
bioaccumulation thresholds more precisely. See Persistence and 
Bioaccumulation Regulations, SOR/2000-107 (Can.), available at http://laws-
lois.justice.gc.ca/PDF/SOR-2000-107.pdf. 
 112. See generally Christine Norman, Healthy Env’ts & Human Safety 
Branch, Health Can., Prioritization and Assessment—Experience Under 
Canada’s Chemicals Management Plan at the SVOCs in the Indoor 
Environment Workshop 5, 6, 8 (Jan. 2011), available at http://epa.gov/ncct/ 
expocast/files/SVOC/12_NORMAN%20SVOC.pdf; Overview of the Existing 
Substances Program, ENV’T CAN. (Mar. 21, 2011), http://www.ec.gc.ca/lcpe-
cepa/default.asp?lang=En&n=EE479482-1&wsdoc=4AB637F0-A096-3237-14BA-
E034127B3A9A. 
 113. Id. 
 114. Meek & Armstrong, supra note 94, at 594. 
 115. CEPA § 64. 
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incorporates potential for exposure.116  Inherent toxicity is a 
categorization and prioritization criterion, while CEPA-toxicity is 
a legal designation that authorizes the initiation of the risk 
management process. 
Categorization of the DSL under CEPA constitutes an initial 
prioritization effort.117  Regulators applied the criteria through 
chemical-specific hazard profiles—rudimentary analyses based on 
existing data, modeling, expert judgments, and plausible 
assumptions. The agencies constructed these profiles by 
gathering and evaluating data themselves and through 
submissions by interested parties. The data collection and 
decision-making steps for EC and HC in the categorization 
process are depicted in Figure 2. 
EC and HC completed the categorization of the DSL on 
schedule in September 2006, identifying ~ 3,900 substances that 
met either or both of the human health and ecology criteria for 
categorization.118  In addition, HC determined that another 300–
400 substances, which met neither the human health nor ecology 
criteria, nonetheless warranted further attention from a human 
health perspective, bringing the total number of prioritized 
substances to ~ 4,300.119  That EC and HC completed DSL 
categorization on schedule is a remarkable achievement, given 
the scale and complexity of the task. The establishment of strict 
legislative time frames for prioritization and other assessment 
tasks is viewed as central to the success story. 
 
 116. G.C. GRANVILLE CONSULTING CORP., REPORT TO THE ICG ON SCREENING 
ASSESSMENTS UNDER THE CMP 3 (2012). 
 117. Categorization of Existing Substances, ENV’T CAN., http://www.ec.gc.ca/ 
lcpe-cepa/default.asp?lang=En&n=5F213FA8-1&wsdoc=169 5F8D0-5CC4-
EDA1-AF63-6F23A94064DD (last modified July 9, 2013). 
 118. See generally Search Engine for the Results of DSL Categorization, ENV’T 
CAN. (July 9, 2013), http://www.ec.gc.ca/lcpe-cepa/default.asp?lang=En&n=5F2 
13FA8-1&wsdoc=D031CB30-B31B-D54C-0E46-37E32D526A1F [hereinafter 
ENV’T CAN., Search Engine Results]. See also Summary of Government of 
Canada Categorization for Substances on the DSL, ENV’T CAN. Sept. 2006 (on file 
with authors). 
 119. See SUZANNE EASTON, GLBTS SUBSTANCE WORKING GRP., CANADA’S 
CHEMICALS MANAGEMENT PLAN (CMP) (DRAFT) 6 (2008), available at 
http://www.epa.gov/bns/integration/200804/Easton040808.pdf. For precise 
results of the DSL categorization, see ENV’T CAN., Search Engine Results, supra 
note 118. 
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Figure 2. DSL Categorization Process for Environment 
and Health Canada 
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Following the initial categorization, EC and HC examined 
industry data gathered from 2001 to 2006 to determine whether 
certain priority substances were still in commerce within Canada 
at or above the 100 kg/year DSL threshold.120  Through this 
process, EC removed 145 PBiTs that did not meet the criteria 
from priority consideration. 121  However, these substances are 
not completely free of regulation because they are subject to 
requirements under the CEPA Significant New Activity (SNAc) 
approach, which governs the re-introduction and new uses of 
existing substances.122 
For the remaining priority substances (more than 4,000), 
further assessment was warranted. The CEPA section 73 
“categorization-level” hazard profiles triggered a Screening Level 
Risk Assessment (SLRA) under section 74.123  Under CEPA, a 
SLRA assesses the weight of evidence and applies the 
precautionary principle to determine whether a substance is 
CEPA-toxic or capable of becoming so.124  Recall that the risk-
based determination that a substance is CEPA-toxic authorizes 
the initiation of the risk management process. 
 
 120. See ENVTL. DEF., CANADA’S CHEMICALS MANAGEMENT PLAN: PROGRESS 
ANALYSIS 2006–2011, at 12 (2011), available at http://environmentaldefence.ca/ 
reports/canadas-chemicals-management-plan. 
 121. See ENV’T CAN., SCREENING ASSESSMENT REPORT 14 (2008), available at 
http://www.ec.gc.ca/lcpe-cepa/documents/substances/pbti-pbit/final_145_PBiT-
eng.pdf; Gov’t of Can., Assessment Report on 145 PBiT Substances and Order 
Amending the Domestic Substances List, CHEMICAL SUBSTANCES, 
http://www.chemicalsubstanceschimiques.gc.ca/plan/approach-approche/pbit145-
eng.php (last modified May 16, 2014). 
 122. See CEPA § 80; Gov’t of Can., Significant New Activity (SNAc) Approach, 
CHEMICAL SUBSTANCES, http://www.chemicalsubstanceschimiques.gc.ca/plan/ 
approach-approche/snac-nac-eng.php [hereinafter SNAc Approach] (last 
modified Sept. 10, 2012). 
 123. See CEPA §§ 73, 74. 
 124. CEPA § 76.1 (mandating application of the precautionary principle); see 
HEALTH CAN., SCREENING ASSESSMENT OF EXISTING SUBSTANCES UNDER THE 
CANADIAN ENVIRONMENTAL PROTECTION ACT, 1999, at 1 (2004), available at 
http://www.hc-sc.gc.ca/ewh-semt/alt_formats/hecs-sesc/pdf/contaminants/existsu 
b/exist_substances-substances_existantes-eng.pdf; Meek & Armstrong, supra 
note 94, at 611 (for descriptions of the SLRA process); Norman, supra note 112, 
at 9. 
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The CMP constitutes the government of Canada’s strategy to 
further prioritize and assess the priority substances by 2020.125  
This represents a gargantuan task considering a single 
comprehensive risk assessment can take decades to complete. The 
CMP, therefore, embodies a compromise between making 
informed decisions and making expedient decisions. As such, the 
CMP strategy, discussed in greater detail below, is a response to 
Canada’s experience with conducting comprehensive risk 
assessments as part of its Priority Substances List mechanism. 
2. Priority Substances List 
The Priority Substances List (PSL) is a complex process that 
is no longer used in Canada; however, it is necessary to describe 
the PSL in order to explain why the government of Canada 
adopted the more streamlined CMP approach. Whereas the CMP 
is not formally mentioned in any legislation, CEPA 1988 and 
CEPA 1999 established and maintained the PSL framework for 
prioritization and risk assessment of industrial chemicals.126 
Under the PSL, EC and HC subjected listed substances to a 
more comprehensive risk assessment rather than a SLRA. Both 
forms of risk assessment are designed to inform the 
determination as to whether or not a substance is CEPA-toxic, 
but the SLRA approach tends to be much more focused, less 
resource-intensive, and more rapidly completed.127  The level of 
assessment in a SLRA is flexible and depends on the nature of 
the information available, as well as the potential risks, and can 
range from a lower tier to an in-depth assessment. SLRAs can 
rely heavily on modeling and estimation techniques and 
conservative (high) estimates of exposure. Full risk assessments, 
though, may require the generation of new data to determine, for 
 
 125. VIRGINIA POTER, Industry Coordinating Group CEPA Update Conference: 
Chemicals Management Plan – Progress Made and Lessons Learned (Oct. 8, 
2014) (on file with authors); GOV’T OF CAN., CHEMICALS MANAGEMENT PLAN: 
PROGRESS REPORT 1 (2013), available at http://www.ec.gc.ca/ese-ees/5C49C89D-
D6C2-48C2-A256-72870B4044AA/Progress%20Report%20%28December%202 
013%29_EN.pdf. 
 126. CEPA § 46(1)(a). 
 127. Id. 
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example, modes of action and more likely exposure scenarios.128  
Though these more comprehensive assessments conducted for 
PSL substances provided regulators with much more information 
than screening assessments, they were much more time and 
resource intensive, and therefore constrained the number of 
substances that authorities could evaluate expeditiously. 
The first PSL, published in 1989, listed forty-four 
chemicals.129  The PSL includes a five-year timeline to complete 
risk assessments.130  Risk assessments were completed in early 
1994, and twenty-five substances were identified as CEPA-
toxic.131  The government published the second PSL in 1995, this 
time listing twenty-five substances for risk assessment.132  
Authorities found eighteen of them to satisfy the criteria for 
CEPA-toxicity.133 
Through the CEPA PSL framework, Canada has addressed a 
number of substances of notoriety, including dioxins, furans, 
hexachlorobenzene (HCB), hexachlorobutadiene (HCBD), and 
chlorinated paraffins, to name a few.134  Nonetheless, the 
government, industry, and non-governmental organizations 
(NGOs) all considered the PSL process to be too slow and, 
ultimately, impractical.135  The excessive length of the 
assessment process was a major driver for the creation of the 
1999 update of CEPA, with its requirement for an allowable 
seven-year period to categorize substances on the DSL. Notably, 
the PSLs were established under the original CEPA 1988 
legislation. To date, the PSL mechanism has not been used under 
CEPA 1999, and it seems unlikely that it will be used in the 
 
 128. ABELKOP, ROYER & GRAHAM, supra note 28. 
 129. First Priority Substances List (PSL1), ENV’T CAN., http://www.ec.gc.ca/ese-
ees/default.asp?lang=En&n=95D719C5-1 (last modified June 21, 2013). 
 130. CEPA § 78. 
 131. ENV’T CAN., A GUIDE TO UNDERSTANDING THE CANADIAN ENVIRONMENTAL 
PROTECTION ACT, 1999, at 9 (2004), available at http://www.ec.gc.ca/lcpe-
cepa/E00B5BD8-13BC-4FBF-9B74-1013AD5FFC05/Guide04_e.pdf. 
 132. Id. 
 133. See id.; Second Priority Substances List (PSL2), ENV’T CAN., 
http://www.ec.gc.ca/ese-ees/default.asp?lang=En&n=C04CA116-1 (last modified 
June 21, 2013). 
 134. PSL2, supra note 133; PSL1, supra note 129. 
 135. Meek & Armstrong, supra note 94, at 596–97 (compare our previous 
comments about the length of time taken for EPA assessments). 
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foreseeable future. The PSL provides an informative contrast to 
Canada’s successor—the CMP. 
3. Chemicals Management Plan 
The government of Canada introduced the Chemicals 
Management Plan (CMP) in 2006, following the completion of the 
DSL categorization.136  The CMP is a strategy that is designed by 
EC and HC in cooperation with industry and NGO stakeholders. 
Its primary purpose is to protect human health and the 
environment while acting as Canada’s plan to achieve the sound 
management of chemicals in accordance with the WSSD 2020 
goal.137  A secondary purpose is to increase public confidence in 
industry and government chemical management.138 
Though the CMP is not formally mentioned in legislation, 
CEPA provides the primary legal authority for actions under the 
CMP.139  The CMP is designed to facilitate coordination between 
CEPA and other laws, including those that govern food and 
drugs, cosmetics, and pesticides.140  To that end, EC and HC also 
draw legal authority for CMP actions from a variety of laws in 
addition to CEPA. Though many decisions have been politically 
contentious,141 thus far, government, industry, and some NGO 
stakeholders seem to be pleased with the design and progression 
of the CMP.142  As such, the CMP has all but displaced the PSL 
as a prioritization mechanism for the assessment of chemicals in 
Canada. 
 
 136. Press Release, Prime Minister of Canada, supra note 10. 
 137. See U.N., DEP’T OF ECON. & SOCIAL AFFAIRS, DIVISION FOR SUSTAINABLE 
DEVELOPMENT, CANADA NATIONAL REPORTING TO CSD-18/19, THEMATIC PROFILE 
ON CHEMICALS 1 (2011), available at http://www.un.org/esa/dsd/dsd_aofw_ni/ 
ni_pdfs/NationalReports/canada/Chemicals.pdf. 
 138. Canadian Government Takes Action on Harmful Chemicals, NEWSLETTER 
(ECHA, Helsinki, Fin.), Oct. 16, 2014, at 23, available at 
http://newsletter.echa.europa.eu/documents/6362380/21743968/newsletter_2014
_issue_5_october_en.pdf. 
 139. See id. 
 140. U.N., DEP’T OF ECON. & SOCIAL AFFAIRS, supra note 137, at 1–2. 
 141. See generally Dayna Nadine Scott, Beyond BPA: We need to Get Tough on 
Toxics, GLOBE & MAIL, Jan. 4, 2012, http://www.theglobeandmail.com/globe-
debate/beyond-bpa-we-need-to-get-tough-on-toxics/article4085163/. 
 142. See ENVTL. DEF., supra note 120, at 15. 
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Authorities are scheduled to work through the CMP in 
phases from 2006 to 2020.143  The phases are somewhat 
overlapping but also address some distinct sectors. 
Phase I of the CMP included three primary initiatives. The 
first initiative of CMP Phase I was the industry “Challenge.”144  
It targeted nearly 200 of the substances identified in the 
categorization as highest priority.145  EC and HC first divided the 
challenge substances into twelve “batches” to be addressed 
sequentially.146  CEPA section 71 provides the government with 
the authority to compel businesses to provide information about 
the substances that they manufacture, import, and use.147  EC 
and HC published a list of each batch in the Canada Gazette 
approximately every three months beginning in February 2007, 
using authority under section 71 to challenge industry to provide 
data on the chemicals in the batch within six months of the 
publication.148  Much of the submitted information consisted of 
release and exposure data, since industry had only six months to 
provide it—generally not enough time to plan and carry out new 
laboratory tests.149  In some cases, however, additional data were 
supplied. After receiving the data, EC and HC conducted SLRAs, 
which they released for public comment.150 
 
 143. POTER, supra note 125. 
 144. Gov’t of Can., The Government of Canada “Challenge” for Chemical 
Substances That Are a High Priority for Action, CHEMICAL SUBSTANCES, 
http://www.chemicalsubstanceschimiques.gc.ca/challenge-defi/index-eng.php 
(last modified July 28, 2011). 
 145. See, e.g., Proposed Risk Management Approach for Benzenamine, N-
phenyl-, Reaction Products with Styrene and 2,4,4-Trimethylpentene (BNST), 
ENV’T CAN. (Aug. 2009), http://www.ec.gc.ca/ese-ees/default.asp?lang=En&n= 
136D3FBF-1. 
 146. See Gov’t of Can., supra note 144. 
 147. CEPA § 71. 
 148. See, e.g., Canadian Environmental Protection Act, 1999, C. Gaz. 141(5) 
162–77, available at http://publications.gc.ca/gazette/archives/p1/2007/2007-02-
03/pdf/g1-14105.pdf; Canadian Environmental Protection Act, 1999, C. Gaz. 
141(19) 1178–1201, available at http://publications.gc.ca/gazette/archives/ 
p1/2007/2007-05-12/pdf/g1-14119.pdf. 
 149. Dayna Nadine Scott, Testing Toxicity: Proof and Precaution in Canada’s 
Chemicals Management Plan, 18 REV. EUR. COMMUNITY & INT’L ENVTL. L. 59, 66 
(2009). However, the categorization process did provide industry with an 
indication of the substances that would be subject to risk assessment, giving 
businesses time to gather data. Id. 
 150. See id. at 164. 
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The ministries used the SLRA for each substance to 
determine whether or not it satisfied the criteria for CEPA-
toxicity. When the assessment led the ministries to conclude that 
the substance is CEPA-toxic, they developed a risk management 
proposal, which they finalized after considering public 
comments.151 In addition to being a vehicle to determine whether 
risk management is necessary, the Challenge also encouraged 
companies to voluntarily reduce emissions of high-priority 
substances and substitute, if possible, safer alternatives. 
The second initiative of CMP Phase I was a Rapid Screening 
Assessment of potential PiTs and BiTs that were manufactured 
or imported in quantities less than 1,000 kg/yr (under the 1986 
DSL)—a total of 1,066 substances.152  EC evaluated whether 
these substances were already being assessed through other 
programs, searched for red flags by determining if the substances 
appeared on priority or regulatory lists in other jurisdictions, and 
applied conservative ecological exposure scenarios to determine if 
further assessment was warranted. When the ecological exposure 
estimates were not of concern, HC then applied a rapid screening 
framework from a human health perspective.153  Through this 
process, EC and HC determined that 472 potential substances 
required further assessment, 533 required no further action 
because their estimated exposures were not of concern, and sixty-
one needed to be withdrawn from rapid screening either because 
they were removed from DSL (were no longer in commerce) or, 
the opposite—they were found to be manufactured or imported in 
quantities exceeding 1,000 kg/yr.154 
The third initiative of CMP Phase I, which now extends into 
Phase II, is the Petroleum Sector Stream Approach.155  EC and 
HC divided 164 high priority petroleum substances into five 
 
 151. See id. at 164–65. 
 152. ENV’T CAN. & HEALTH CAN., RAPID SCREENING OF SUBSTANCES OF LOWER 
CONCERN: RESULTS OF THE SCREENING ASSESSMENT, at ii. (2013), available at 
http://www.ec.gc.ca/ese-ees/2A7095CD-A88C-4E7EB089486086C4CBC4/RSI%20 
Final%20-%20EN.pdf. 
 153. See id. 
 154. Id. at ii–iii. 
 155. See Gov’t of Can., The Petroleum Sector Stream Approach, CHEMICAL 
SUBSTANCES, http://www.chemicalsubstanceschimiques.gc.ca/petrole/index-
eng.php (last modified Sept. 5, 2014). 
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streams and have proceeded to gather information from industry, 
conduct SLRAs, and propose risk management options where 
applicable, or as necessary, through the same processes as in the 
Challenge.156 
Phase II was announced in 2011 and includes an additional 
rapid screening effort based on exposure-related information,157 
an approach to address polymers,158 and the Substance 
Groupings Initiative (SGI).159  Under the SGI, EC and HC have 
placed an additional 500 substances into nine groups of similar 
chemicals—organic flame retardants, for example—and will 
proceed in the same spirit as in the Challenge and the Petroleum 
Sector Stream Approach.160  The rationale for assessing 
substances in groups is that they may share similar chemical 
properties or may be used in similar ways.161  This approach 
emphasizes the use of the “read-across” technique, whereby the 
characteristics of a chemical (without direct data) are estimated 
based on the characteristics of previously examined chemicals 
with similar molecular structures.162  Assessing like chemicals 
together, therefore, could facilitate the identification of safer 
substitutes and create efficiencies for risk assessment and 
management, and this appears to be the case, with a number of 
draft assessments on various groupings announced on the CMP 
 
 156. Id. 
 157. See ENV’T CAN., RAPID SCREENING OF SUBSTANCES FROM PHASE ONE OF THE 
DOMESTIC SUBSTANCES LIST INVENTORY UPDATE: RESULTS OF THE FINAL 
SCREENING ASSESSMENT 4–5 (2014), available at http://www.ec.gc.ca/ese-
ees/7340E1B7-1809-4564-8C49-F05875D511CB/FSAR_RSII_EN.pdf. To date, 
117 substances have been identified that may not require further risk 
assessment because of low exposure potential. Id. at 5. 
 158. See Gov’t of Can., Polymer Approach, CHEMICAL SUBSTANCES, 
http://www.chemicalsubstanceschimiques.gc.ca/plan/approach-approche/polymer 
-eng.php (last modified Mar. 19, 2012). 
 159. See Vincenza Galatone, ICG CEPA Update Conference: Chemicals 
Management Plan: Moving Forward in 2013 (June 6, 2013) (conference 
presentation on file with authors); Gov’t of Can., The Substance Groupings 
Initiative, CHEMICAL SUBSTANCES, http://www.chemicalsubstanceschimiques. 
gc.ca/group/index-eng.php (last modified Aug. 15, 2014) [hereinafter Gov’t of 
Can. SGI]. 
 160. See id. 
 161. Id. 
 162. Steven J. Enoch, Chemical Category Formation and Read-Across for the 
Prediction of Toxicity, in 8 RECENT ADVANCES IN QSAR STUDIES 209 (Tomasz 
Puzyn et al. eds., 2010). 
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website.163  However, an aggressive use of this approach might 
test the limits of the read-across screening technique, which could 
ultimately undermine confidence in the assessment process.164 
Following the first two phases of the CMP, the Canadian 
government will still have to conduct SLRAs for about 1,700 
priority substances identified in categorization.165  How the 
ministries will execute the next phase of the CMP is uncertain, 
but it seems clear that, regardless of the outcomes of the next 
prioritization activities, the government will proceed in the same 
fashion as in the Challenge, Petroleum Sector Stream Approach, 
and SGI, with information gathering, screening assessment, and 
risk management. The CMP and DSL categorization embody VOI 
principles by soliciting a limited amount of information on a 
specific, manageably sized group of prioritized substances with a 
strict deadline for information submission. Each phase of the 
CMP is presented in Figure 3. 
 
  
 
 163. See generally Gov’t of Can. SGI, supra note 159. 
 164. See CHEM. SENSITIVITIES MANITOBA & CAN. ENVTL. LAW ASS’N, A RESPONSE 
TO THE PROPOSED RISK MANAGEMENT APPROACH FOR CHEMICALS MANAGEMENT 
PLAN INDUSTRY CHALLENGE BATCH 3 SUBSTANCES, PUBLISHED IN CANADA GAZETTE 
PART I, VOL. 143, NO. 10 - MARCH 7, 2009 at 3–4, (2009) [hereinafter CSM & 
CELA], available at http://www.cela.ca/sites/cela.ca/files/652%20CMP%20 
batch%203.pdf (critiquing overreliance on analogue data). 
 165. Galatone, supra note 159, at 4. 
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Figure 3. Chemicals Management Plan 
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The various initiatives under the CMP are designed to 
further prioritize substances to undergo SLRAs, which in turn 
are designed to determine whether or not a substance satisfies 
the criteria for CEPA-toxicity.166  There are three potential 
outcomes if a SLRA leads authorities to determine that a 
substance is CEPA-toxic.167  First, the government may opt to 
take no further action.168  In practice, this has been a rare 
conclusion and appears to be avoided if possible. Second, the 
ministries may add the substance to a PSL, triggering a more 
detailed and comprehensive risk assessment.169  As noted above, 
this approach has been all but abandoned because it is seen as an 
unnecessary iteration. Third, the ministries may recommend that 
a substance be added to Schedule 1 of CEPA, the Toxic 
Substances List (TSL), and where applicable, the Virtual 
Elimination List (VEL) as well.170 
Not all outcomes of the SLRA process, however, are 
discretionary. If the government finds that a substance “may 
have a long-term harmful effect on the environment,” satisfies the 
PBiT criteria, and its presence in the environment “results 
primarily from human activity,” it must be recommended for 
addition to the TSL.171  For any substance recommended for 
addition to the TSL—discretionary or mandatory—the 
government may also have to recommend it for addition to the 
VEL if it meets certain criteria.172 
The addition of a substance to the TSL provides the 
ministries with the authority to propose and initiate risk 
management, including a possible phase out of the substance. If a 
substance is also added to the VEL, the ministries must enact a 
restriction on its emissions by “prescrib[ing] the quantity or 
concentration of the substance that may be released into the 
environment . . . from any source. . . .”173  In practice, if a SLRA 
 
 166. CEPA § 74. 
 167. Id. § 77(2). 
 168. Id. § 77(2)(a). 
 169. Id. § 77(2)(b). 
 170. Id. § 77(2)(c). 
 171. Id. § 77(3); Toxic Substances List, ENV’T CAN., http://www.ec.gc.ca/lcpe-
cepa/default.asp?lang=En&n=0DA2924D-1 (last modified Nov. 6, 2013). 
 172. CEPA § 77(4). 
 173. Id. § 65(3). 
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indicates that a substance is CEPA-toxic, it is routinely added to 
the TSL. As of November 2013, there are 132 substances on the 
TSL and, as of February 2009, only two substances on the 
VEL.174  We elaborate on some risk management techniques 
below in Part III A as part of our discussion of how CEPA 
allocates the burdens of producing data and proving safety. In the 
following sub-section, we continue the discussion of prioritization 
and assessment processes by introducing the European Union’s 
REACH regulation. 
B. REACH 
The Registration, Evaluation, Authorization, and Restriction 
of Chemicals (REACH) regulation is a compilation of four 
separate bodies of regulation that govern the cradle-to-grave 
manufacture, importation, and use of industrial chemicals in the 
EU.175  The European Chemicals Agency (ECHA), in cooperation 
with Member State governments and the European Commission, 
administers REACH. Though all of the components of REACH 
are related to one another, each serves a distinct function and is 
somewhat independent of the others. 
The prioritization processes under REACH are not analogous 
with those under CEPA. While Canada’s categorization and CMP 
identified a subset of chemicals that warrant further assessment, 
the underlying principle of REACH is that almost all chemicals 
warrant further assessment.176  Context is important here: 
Europe’s political environment is different from Canada’s (and 
the United States’), and REACH serves the entire EU 
marketplace rather than that of a single nation. Whereas 
Canada’s DSL lists about 23,000 existing substances, there are 
about 100,000 substances listed on the EUs various chemicals 
 
 174. Toxic Substances List – Schedule 1, ENV’T CAN., http://www.ec.gc.ca/lcpe-
cepa/default.asp?lang=En&n=0DA2924D-1&wsdoc=4ABEFFC8-5BEC-B57A-
F4BF-11069545E434 (last modified Aug. 4, 2014); Virtual Elimination List, 
ENV’T CAN., http://www.ec.gc.ca/lcpe-cepa/default.asp?lang=En&n=768FCB63-1 
(last modified Mar. 7, 2013). 
 175. REACH, Preamble 3, 4, 7.  For a description of the processes under 
REACH, see generally Nicolas Herbatschek et al., The REACH Programmes and 
Procedures, in THE EUROPEAN UNION REACH REGULATION FOR CHEMICALS: LAW 
AND PRACTICE 82, 82–170 (Lucas Bergkamp ed., 2013). 
 176. See id. 
44http://digitalcommons.pace.edu/pelr/vol32/iss1/3
3_ABELKOP&GRAHAM FINAL 8/24/2015  12:05 PM 
152 PACE ENVIRONMENTAL LAW REVIEW [Vol.  32 
 
inventories.177  REACH is designed to facilitate industry 
assessment and subsequent voluntary management through 
registration, to identify Substances of Very High Concern 
(SVHCs) for authorization, and to identify uses of concern for 
restriction.178  The following sub-sections discuss prioritization 
for assessment and management under registration, evaluation, 
authorization, and restriction. 
1. Registration 
Registration is based on the principle of “no data, no 
market”179 —the notion that nearly all chemicals on the market 
warrant complete risk assessments. Given that there are more 
than 100,000 substances in commerce in the EU, and many of 
them lack even basic data sets on hazard characteristics and 
potential exposure pathways, the development of data constitutes 
a gargantuan task.180  The REACH registration process does set 
some priorities. As explained below, the schedule for registration 
is sequenced by firm production level and by certain hazard 
characteristics. 
The general registration provision requires that “any 
manufacturer or importer of a substance . . . in quantities of one 
tonne or more per year shall submit a registration to the 
[European Chemicals] Agency.”181  Downstream users—often 
small or large companies that make use of a chemical in 
consumer products or services—may also provide use and safety 
 
 177. EUR. CHEM. AGENCY (ECHA), GUIDANCE FOR IDENTIFICATION AND NAMING 
OF SUBSTANCES UNDER REACH AND CLP 10 (2014), available at 
http://echa.europa.eu/documents/10162/13643/substance_id_en.pdf [hereinafter 
ECHA, IDENTIFICATION]. About 150,000 substances were pre-registered for the 
2008 pre-registration deadline. Press Release, ECHA, List of Pre-Registered 
Substances Published (Dec. 19, 2008), available at http://echa.europa.eu/ 
documents/10162/13585/pr_08_59_publication_pre-registered_substances_list_ 
20081219_en.pdf. 
 178. See Lucas Bergkamp & Dae Young Park, The Organizational and 
Administrative Structures, in THE EUROPEAN UNION REACH REGULATION FOR 
CHEMICALS: LAW AND PRACTICE 23, 37 (Lucas Bergkamp ed., 2013). 
 179. REACH, art. 5. 
 180. See generally ECHA, IDENTIFICATION, supra note 177, at 10. 
 181. REACH, art. 6(1). 
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information on their own or assist in the preparation of 
registration dossiers through a lead registrant.182 
The registration must take the form of a technical dossier, 
which includes information on: the identity of the manufacturer, 
importer, or producer; the identity, including chemical and 
physical properties, of the substance; the manufacture and uses 
of the substance; environmental fate and pathways; 
(eco)toxicological information; guidance on safe use; and research 
summaries.183  Ideally, registration dossiers including this data 
will contain comprehensive risk assessments. Empirical 
investigations of the amount and quality of information included 
within registration dossiers, however, suggest that some dossiers 
leave much to be desired and may be more analogous to screening 
level assessments due to their heavy reliance on modeling and 
estimation techniques rather than hard data.184 
REACH contains a tiered phase-in period for registration 
that is based partly on production volume of individual firms 
(rather than the marketplace as a whole) and partly on toxicity. 
The first registration deadline in December 2010 applied to 
companies that manufactured or imported any substances at 
volumes of 1,000 tonnes per year or more, substances that are 
“very toxic” to aquatic organisms at volumes of 100 tonnes per 
year or more, and CMRs at volumes of one tonne per year or 
more.185  In response to this first deadline, ECHA received 
roughly 25,000 registration dossiers covering about 3,400 
substances.186  The second registration deadline was in June 
2013 and applied to companies that manufactured or imported 
substances at volumes of 100 tonnes per year or more.187  The 
third and last registration deadline is June 2018, when all 
 
 182. Id. art. 37. 
 183. See REACH, art. 10(1)(a). 
 184. See generally, e.g., Greta Stieger et al., Assessing the Persistence, 
Bioaccumulation Potential and Toxicity of Brominated Flame Retardants: Data 
Availability and Quality for 36 Alternative Brominated Flame Retardants, 116 
CHEMOSPHERE 118 (2014). 
 185. See REACH, art. 23(1). 
 186. First REACH registration was a success!, ECHA NEWSLETTER (ECHA, 
Helsinki, Finland), Dec. 2010, at 5, available at http://echa.europa.eu/ 
documents/10162/13585/echa_newsletter_2010_6_en.pdf. 
 187. REACH, art. 23(2). 
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substances manufactured or imported in quantities of one tonne 
or more are to be registered.188  As of September 2014, the 
REACH database contains information on 12,735 substances 
from 49,100 registration dossiers.189 
The registration dossier under REACH must contain a 
minimum set of data, or the substance may not be put on the 
market in Europe.190  The tiers in the registration process 
influence the data requirements that are applicable. Chemicals 
produced or imported in higher volumes and chemicals that 
exhibit certain hazardous properties (e.g., CMR properties and 
aquatic toxicity) have not only earlier registration deadlines, but 
also have more demanding data requirements.191  For example, 
once the ten-tonne threshold is reached for a registrant, the 
registration dossier must include a Chemical Safety Report 
(CSR), which details potential exposure scenarios and risk 
management measures.192  Additional information on potential 
exposures and risk characterization is also required for PBT, 
vPvB, and other substances classified as “dangerous” under the 
European Council’s Dangerous Substances Directive relating to 
the classification, packaging, and labeling of dangerous 
substances.193 
 
 188. Id. art. 23(3). 
 189. Registered Substances, ECHA, http://echa.europa.eu/information-on-
chemicals/registered-substances (last updated Sept. 24, 2014). 
 190. Id. art. 5. 
 191. See REACH, art. 12(1), 23. 
 192. See id. arts. 10(a)(x), (b), 14(1)(3). 
 193. See id. art. 14(4); Directive 67/548, of the European Parliament and the 
Council of 27 June 1967 on the Approximation of Laws, Regulations and 
Administrative Provisions Relating to the Classification, Packaging and 
Labelling of Dangerous Substances 67/548/EEC, 1967 O.J. (L 196) 235.  The 
Dangerous Substances Directive will be replaced by the Classification, Labelling 
and Packing Regulation.  See Regulation (EC) 1272/2008 of the European 
Parliament and of the Council of 16 December 2008 on Classification, Labelling 
and Packaging of Substances and Mixtures, Amending and Repealing Directives 
67/548/EEC and 1999/45/EC, and Amending Regulation (EC) No 1907/2006, 
2008 O.J.  (L 353) 1. 
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2. Evaluation 
REACH contains two distinct evaluation processes: dossier 
and substance evaluation.194  Dossier evaluation entails ECHA 
evaluation of a specific registration dossier. Dossier evaluation is 
a compliance check that is meant to verify that the registration 
dossiers submitted by industry fulfill all of the registration data 
requirements.195  REACH mandates that ECHA must conduct a 
compliance check on no less “than [five percent] of the total 
[number of dossiers] received by the Agency for each tonnage 
band . . . .”196  REACH does not obligate ECHA to examine the 
other ninety-five percent of registration dossiers for substantive 
compliance. From this five percent baseline, ECHA prioritizes its 
selection of dossiers to examine through random selection 
(twenty-five percent) as well as a mix of hazard and exposure 
characteristics and technical concerns (seventy-five percent), 
including potential PBT, vPvB, or CMR characteristics; wide 
dispersive use; or excessive confidentiality claims.197 
The compliance check process is procedurally straightforward 
but can be scientifically intensive.198  When ECHA carries out an 
overall compliance check, it assigns the task to a team of about 
five specialists, including physical chemists, environmental 
experts, and human health experts.199  Experts are responsible 
for a substantive examination of the portions of the dossier in 
their area of specialization. The experts determine whether the 
registrant provided the required and appropriate data. They 
analyze the quality of the data by evaluating the reliability and 
validity of the study reports included within the dossier. The 
 
 194. See Herbatschek et al., supra note 175, at 126–33. 
 195. See generally ECHA, DOSSIER EVALUATION, 1-5 (2013), available at 
http://echa.europa.eu/documents/10162/13607/pro_0017_03_dossier_evaluation_
en.pdf. 
 196. REACH, art. 41(5). 
 197. Id. 
 198. For a detailed description of the steps involved in dossier evaluation, see 
ECHA, DOSSIER EVALUATION (2014), available at http://echa.europa.eu/ 
documents/10162/13607/procedure_dossier_evaluation_en.pdf. 
 199. See Evaluation process: Safeguarding the scientific quality of registration 
information, ECHA, http://newsletter.echa.europa.eu/home/-/newsletter/entry/6 
_11-evaluation-process;jsessionid=49BAC7F58F48304C08629EB038A4B67F. 
live2 (last visited Oct. 28 2014). 
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team also examines any exposure scenarios, which are required 
for PBTs, vPvBs, CMRs, and all “classified” (dangerous)200 
substances manufactured or imported at volumes greater than 
ten tonnes per year (i.e., those classified under the EU’s version 
of the Globally Harmonized System for one hazardous property or 
another). Finally, the team evaluates the risk management 
measures described in the dossier and may consider whether the 
measures are likely to be sufficient to achieve “adequate control” 
of exposures.201  The team may request more data to support the 
effectiveness of risk management measures or suggest that 
alternative measures be considered. 
Not all compliance checks review the entire dossier. Targeted 
compliance checks are also employed frequently by ECHA.202  
They are typically automated (i.e., through use of screening of 
dossiers with information technology tools) and focused on 
portions of the dossier that are of special concern to ECHA (e.g., 
substance identification information or nano-materials).203  In 
many cases, only a small fraction of a dossier is reviewed during a 
compliance check, and only those experts necessary for the 
targeted review are employed.204 
Substance evaluation is an altogether different process, 
carried out by Member States in collaboration with ECHA and 
the European Commission.205  It involves evaluation of a specific 
 
 200. Directive 67/548, of the European Parliament and the Council of 27 June 
1967 on the Approximation of Laws, Regulations and Administrative Provisions 
Relating to the Classification, Packaging and Labelling of Dangerous 
Substances 67/548/EEC, 1967 O.J. (L 196) 235. 
 201. See REACH, Annex I, § 5.1.1. See also REACH, Annex I § 6.4 (indicating 
that risk is adequately controlled if the estimated exposure levels will not exceed 
the derived no effect level or the predicted no effect concentration for the 
substance, and the likelihood and severity of an event occurring due to a 
physiochemical property of the substance (e.g., flammability, explosivity) is 
negligible). 
 202. See Target met for 5% compliance checks of the 2010 registration 
dossiers, ECHA, http://echa.europa.eu/view-article/-/journal_content/title/target-
met-for-5-percent-compliance-checks-of-the-2010-registration-dossiers (last 
visited Oct. 28, 2014). 
 203. See Herbatschek et al., supra note 175, at 130. 
 204. See generally id. at 126. 
 205. See ECHA, SUBSTANCE EVALUATION 1 (2013), available at 
http://echa.europa.eu/documents/10162/13607/pro_0023_01_substance_evaluatio
n_en.pdf. 
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substance rather than a specific dossier.206  Substance evaluation 
is not itself a regulatory process, but the outcomes of a substance 
evaluation can trigger regulations under other provisions of 
REACH or other EU legislation. 
The aim of the substance evaluation process is to clarify the 
risks to human health and the environment associated with the 
use of specific chemical substances.207  As a result, it is expected 
that the substance evaluation processes will be triggered by risk-
based or hazard-based concerns. A Member State is expected to 
draw from registration dossiers prepared by industry, but may 
also request additional information from registrants that extends 
beyond the minimum data requirements that REACH specifies 
for registration.208  If a registration dossier is missing 
information on certain hazards (e.g., types of toxicity), the 
substance evaluation process may be employed to obtain the 
necessary information from industry, which can then be used for 
both classification and labeling.209  Substance evaluation is 
important because it can lead to enactment of new risk 
management measures through the authorization or restriction 
processes in REACH or instruments under other European 
chemicals legislation.210  For example, substance evaluation could 
lead to the setting of a new occupational exposure limit to protect 
workers throughout Europe or it could lead to a proposal for 
harmonized classification of the substance under the EU 
Classification, Labelling and Packing (CLP) Regulation.211 
ECHA, through its Member State Committee, determines 
which substances will undergo substance evaluation, and lists 
them on the Community Rolling Action Plan.212  The selection of 
substances is based on criteria that are related to human health 
 
 206. See generally Herbatschek et al., supra note 175, at 131. 
 207. Id. at 1. 
 208. See  id. at 7–8. 
 209. See id. 
 210. See id. at 7. 
 211. See Regulation (EC) 1272/2008 of the European Parliament and of the 
Council of 16 December 2008 on Classification, Labelling and Packaging of 
Substances and Mixtures, Amending and Repealing Directives 67/548/EEC and 
1999/45/EC, and Amending Regulation (EC) No 1907/2006, 2008 O.J.  (L 353) 
20. 
 212. REACH, art. 44(2). 
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and environmental quality, including the chemical’s hazardous 
properties, the potential for exposure, and aggregated tonnage of 
production (registration data).213  Political concerns may play a 
role in a Member State’s decision to nominate a chemical or 
substance for evaluation.214  Compared to the registration 
process, the substance evaluation process under REACH has been 
the subject of very limited practical implementation by EU 
Authorities, although this could change due to recent 
commitments in the Community Rolling Action Plan for 
substance evaluation.215 
3. Authorization 
The authorization process is intended to protect human 
health and the environment by facilitating the substitution of 
SVHCs with suitable, safer alternatives.216  A SVHC is defined by 
Article 57 as a CMR, a PBT, a vPvB, or a substance of equivalent 
concern, such as an endocrine disruptor.217  A variety of priority-
setting issues have arisen in the assessment and management of 
these substances given the number of potential SVHCs—about 
1,500—and legislative ambiguity in how to prioritize substances 
at various stages of the authorization process and other risk 
management processes. 
Under authorization, a SVHC is placed on a Candidate List, 
denoting that the substance is a “candidate” to be placed on the 
 
 213. See id. art. 44(1). See also ECHA, SELECTION CRITERIA TO PRIORITISE 
SUBSTANCES FOR SUBSTANCE EVALUATION 1-2 (2011), available at 
https://echa.europa.eu/documents/10162/13628/background_doc_criteria_ed_32_
2011_en.pdf. 
 214. See Herbatschek et al., supra note 175, at 152–55 (indicating that 
political preferences of Member States influence the prioritization of substances 
for consideration of inclusion on the Candidate List). 
 215. See generally Community Rolling Action Plan, ECHA, 
http://echa.europa.eu/web/guest/information-on-chemicals/evaluation/communit 
y-rolling-action-plan (last visited Nov. 7, 2014) 
 216. See REACH, art. 55, 58(2). 
 217. See id. art. 55, 57, 58(1), (3) (laying out the parameters for what 
constitutes a substance of very high concern). For a description of potential 
harm to human health and the environment from endocrine disruptors, see 
Patricia Hunt, Toxins All Around Us, SCI. AM. (Sept. 11, 2011), 
http://www.scientificamerican.com/article.cfm?id=toxins-all-around-us. 
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formal Authorization List (REACH Annex XIV).218  Substances 
on the Authorization List must be phased out, though exceptions 
for specific uses may be authorized based on certain 
socioeconomic and risk factors, depending on the characteristics 
of the substance.219 
ECHA, at the request of the Commission, or a Member State 
government may request that a substance be placed on the 
Candidate List by submitting a dossier in accordance with Annex 
XV of REACH to identify the substance as a SVHC.220  ECHA’s 
Member State Committee, a committee of experts comprised of 
representatives from the Member States, evaluates each 
substance that has been proposed for inclusion on the Candidate 
List.221  A unanimous decision of the Committee places the 
substance on the Candidate List, while a split vote turns the 
listing decision over to the Commission.222  ECHA may then 
recommend substances on the Candidate List for inclusion on the 
Authorization List to the Commission, which may place 
substances on the Authorization List through comitology.223  
Comitology is the process by which the Commission adopts 
implementing acts to apply uniformly throughout the EU without 
each individual Member State government having to adopt 
implementing legislation.224 
 
 218. See REACH, art. 59(1). 
 219. See id. art. 55. 
 220. See id. art. 59(2). See ECHA, GUIDANCE FOR THE PREPARATION OF AN 
ANNEX XV DOSSIER FOR THE IDENTIFICATION OF SUBSTANCES OF VERY HIGH 
CONCERN (2014) [hereinafter ECHA, GUIDANCE], available at 
http://echa.europa.eu/documents/10162/13638/svhc_en.pdf. 
 221. See Role of the Member State Committee in the Authorisation Process, 
ECHA, http://echa.europa.eu/role-of-the-member-state-committee-in-the-
authorisation-process (last visited Nov. 7, 2014). 
 222. Herbatschek et al., supra note 175, at 157. To date, all Member State 
Committee decisions on candidate listing have been unanimous, with 
contentious negotiation occurring prior to voting. Id. 
 223. See ECHA, PRIORITISATION AND ANNEX XIV RECOMMENDATION 1–2, 4 
(2013), available at http://echa.europa.eu/documents/10162/13607/prioritisation_ 
annex_xiv_recommendation_en.pdf; Herbatschek et al., supra note 175, at 135–
38. 
 224. See generally Regulation (EU) 182/2011 of the European Parliament and 
of the Council of 16 February 2011 Laying Down the Rules and General 
Principles Concerning Mechanisms for Control by Member States of the 
Commission’s Exercise of Implementing Powers, 2011 O.J. (L 55/13). Under 
comitology, the Commission drafts an implementing act for submission to a 
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The authorization process begins with the identification of 
SVHCs.225  As of 2014, 175 Annex XV dossiers have been 
submitted to formally identify substances as SVHCs, 161 
substances have been placed on the Candidate List, and thirty-
one substances have been placed on the Authorization List.226  
Based on existing classifications of substances under various EU 
regulations, the CLP Regulation for example, early estimates 
indicated that there might be as many as 1,500 substances 
eligible for classification as a SVHC.227  In 2013, the Commission 
estimated that, at most, 440 substances will need to be assessed 
for SVHC classification by 2020.228  Each SVHC may undergo a 
rudimentary or screening-level assessment prior to a 
management decision on how to proceed.229 
To determine which Candidate List substances should be 
evaluated first to determine if they should be included on the 
Authorization List, REACH specifies prioritization criteria in 
Article 58 as PBT and vPvB characteristics, wide dispersive uses, 
significant market level production and importation volume, and 
ECHA’s capacity to deal with the authorization applications.230  
ECHA has developed a scoring system based on those criteria to 
 
committee of representatives of the Member States referred to as the REACH 
Comitology Committee (distinct from the ECHA Member State Committee). See 
generally id. The Comitology Committee then decides whether an implementing 
act should be adopted through a majority vote. See id. 
 225. Herbatschek et al., supra note 175, at 152. 
 226. Authorisation List, ECHA, http://echa.europa.eu/addressing-chemicals-of-
concern/authorisation/recommendation-for-inclusion-in-the-authorisation-
list/authorisation-list (last visited Nov. 7, 2014); Candidate List of Substances of 
Very High Concern for Authorisation, ECHA, http://echa.europa.eu/candidate-
list-table (last updated Dec. 17, 2014); Submitted SVHC Proposals, ECHA, 
http://echa.europa.eu/registry-of-submitted-svhc-intentions (last visited Mar. 16, 
2015). 
 227. Herbatschek et al., supra note 175, at 152. See C&L Inventory, ECHA, 
http://echa.europa.eu/regulations/clp/cl-inventory (last visited Jan. 18, 2015) 
(providing various lists of chemical inventories, including those with hazardous 
properties). 
 228. SVHC ROADMAP, supra note 68, at 12. 
 229. Id. at 15. 
 230. See REACH, art. 58. See also ECHA, PRIORITISATION OF SUBSTANCES OF 
VERY HIGH CONCERN (SVHCS) FOR INCLUSION IN THE AUTHORISATION LIST (ANNEX 
XIV) 4  (2014) [hereinafter PRIORITISATION FOR AUTHORISATION], available at 
http://echa.europa.eu/documents/10162/13640/gen_approach_svhc_prior_in_reco
mmendations_en.pdf. 
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prioritize substances on the Candidate List.231  However, prior to 
2013, no comprehensive, formal procedure had been specified for 
setting priorities among potential SVHCs to determine which of 
the ~1,500 should first be evaluated to determine if they actually 
are SVHCs that require risk management.232  The lack of clarity 
in REACH about how to set priorities among numerous potential 
SVHCs has been a source of confusion for government and 
stakeholders.233 
To further complicate the process, the full implications of 
placing a substance on the Candidate List is partially an open 
question. Inclusion on the Candidate List triggers some 
unambiguous legal requirements for companies (e.g., notification 
requirements throughout the supply chain).234  Placement of a 
chemical on the Candidate List may also elicit some market de-
selection of the chemical due to the stigma of being listed, as well 
as the potential for further regulation. Many believed that 
REACH envisioned that all substances placed on the Candidate 
List would—with perhaps only a few exceptions—eventually be 
placed on the Authorization List, but that perception may not 
prove to be a reality. 
A drawback of placing many potential SVHCs on the 
Candidate List is that the list was intended to send a market 
signal for de-selection listed substances, even before they are 
placed on the Authorization List.235  To avoid unnecessary de-
selection, some suggested that a screening assessment should 
precede placement of a substance on the Candidate List.236  An 
additional motivating factor for pre-Candidate List screening is 
that REACH does not provide for a de-listing process for 
Candidate List substances that are not added to the 
Authorization List.237  In other words, once a substance is placed 
on the Candidate List, the substance cannot be removed until 
 
 231. See PRIORITISATION FOR AUTHORISATION, supra note 230. 
 232. Herbatschek et al., supra note 175, at 152–54. 
 233. Id. at 152. See generally REACH, arts. 7, 31, 33. 
 234. See Summary of Obligations Resulting from Inclusion in the Candidate 
List of Substances of Very High Concern for Authorisation, ECHA, 
http://echa.europa.eu/candidate-list-obligations (last visited Nov. 7, 2014). 
 235. Herbatschek et al., supra note 175, at 133–34. 
 236. See id. at 135. 
 237. Id. at 136. 
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after it is placed on the Authorization List, and a scientific case 
for removal from the Authorization List has been made.238  
ECHA and the Commission have taken the position that a 
substance on the Candidate List can be de-listed (using the same 
criteria for de-listing that applies to substances on the 
Authorization List), but the legal viability of this position is 
arguable.239 
Given the unclear repercussions and potential drawbacks of 
placing all SVHCs on the Candidate List, the Commission 
introduced the concept of risk management options (RMO) 
analysis prior to candidate-listing decisions. Figure 4 below 
depicts the authorization listing process, including where in the 
process RMO analysis occurs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 238. Id. at 139 (see “procedure for de-listing” from the Authorization List). 
 239. Id. at 136. 
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Figure 4. Process for Inclusion of Substances on the 
REACH Authorization List 
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To fulfill the goal of considering all SVHCs for inclusion on 
the Candidate List by 2020, the Commission released the 
Roadmap on Substances of Very High Concern in February 
2013.240  In December 2013, ECHA released the SVHC Roadmap 
to 2020 Implementation Plan detailing a proposal for prioritizing 
SVHCs for screening assessment, conducting screening 
assessments, and considering various risk management 
options.241 
The Roadmap identifies the Commission’s criteria for 
identifying “relevant SVHCs” for prioritization to undergo RMO 
analysis.242  Relevant SVHCs are those that meet the SVHC 
criteria listed in Article 57 (PBT, vPvB, CMR, or equivalent 
concern), that are registered for the non-intermediate uses, for 
which the prima facie case of unacceptable risk (triggering 
restriction) cannot be currently made, that are not exempt from 
authorization, and that are not subject to regulation under other 
EU legislation.243 
ECHA’s Implementation Plan outlines a screening process by 
which substances will be selected for RMO analysis. The 
registration database will constitute the primary source of 
information, and chemicals registered for non-intermediate uses 
will be prioritized for RMO analysis.244 Authorities will initially 
identify potential SVHCs by applying an automated program to 
search the registration database for chemicals that potentially 
satisfy the Article 57 criteria.245  Authorities will then apply an 
automated screening program to the potential SVHCs that are 
registered for non-intermediate uses to screen for selection 
criteria, including high volume, highest potential for fulfilling the 
Article 57 criteria, structural similarity to chemicals on the 
Candidate List, and additional informational needs.246  The 
 
 240. See SVHC ROADMAP, supra note 68, at 4. 
 241. See ECHA, SVHC ROADMAP TO 2020 IMPLEMENTATION PLAN 6 (2013) 
[hereinafter SVHC IMPLEMENTATION PLAN], available at http://echa.europa.eu/ 
documents/10162/19126370/svhc_roadmap_implementation_plan_en.pdf. 
 242. SVHC ROADMAP, supra note 68, at 8–10. 
 243. Id. 
 244. SVHC IMPLEMENTATION PLAN, supra note 241, at 12. 
 245. Id. at 12–13. 
 246. Id. at 11–12. 
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outcome of the screening will yield a pool of “substances of 
potential concern.”247 
Screened chemicals will be sorted into various hazard groups 
(e.g., potential PBTs, CMRs, etc.).248  Expert and coordinating 
groups within ECHA will assess the chemicals in each group to 
determine if they satisfy the criteria to be considered SVHCs 
and/or assist Member States and ECHA.249  For example, the 
PBT Expert Group is responsible for determining whether 
potential PBTs meet the Annex XIII criteria for classification as a 
PBT, vPvB, or substance of equivalent concern to a PBT/vPvB.250 
If an expert group determines that a chemical meets the 
SVHC criteria, the chemical will be added to the pool of chemicals 
subject to RMO analysis.251  If the group determines that there is 
not enough information or that existing information is of too poor 
of quality to make a determination on the criteria, then the 
chemical may be subjected to additional information gathering 
(e.g., substance evaluation) to gain data sufficient to make a 
determination.252  The Implementation Plan notes that chemicals 
requiring additional information will be subject to further 
prioritization. As additional information is added to the 
registration database, screening will undergo regular 
reiterations.253 
The next tier of analysis entails an evaluation of risk 
management options to determine if risk management is 
necessary and, if it is, to determine the most appropriate 
approach to risk management.254  This process is shown below in 
Figure 5. The details of RMO analysis are ambiguous, but the 
available documents seem to envision a consideration of whether 
or not authorization is an appropriate or optimal regulatory 
strategy, given consideration of hazard and exposure data as well 
 
 247. Id. at 12. 
 248. Id. at 13. 
 249. Id. 
 250. SVHC IMPLEMENTATION PLAN, supra note 241, at 29–30. 
 251. See id. at 23, 26, 29. 
 252. Id. at 29–30. 
 253. Id. at 13. 
 254. See SVHC ROADMAP, supra note 68, at 8–10. 
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as consideration of the restriction process and other regulations 
that might already apply.255  
 
Figure 5. SVHC Identification Roadmap256 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 255. See generally EU Commission to Propose Five Substance Restrictions 
Under RoHS2, CHEM. WATCH (Feb. 7, 2014), http://chemicalwatch.com/18294/eu-
commission-to-propose-five-substance-restrictions-under-rohs2 (illustrating EU 
Authorities exhibiting a preference for restrictions over authorization for some 
chemicals). 
 256. Adapted from SVHC IMPLEMENTATION PLAN, supra note 241, at 9 (fig.1). 
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It appears that each substance that is placed on the 
Candidate List will undergo at least an assessment to determine 
if it should be placed on the Authorization List.257  ECHA is 
responsible for drafting a proposed recommendation for 
additional listings at least once every two years.258  After public 
consultation and dialogue with the Member State Committee, 
ECHA forwards a recommendation to the European Commission, 
which makes final decisions about the Authorization List.259 
The Implementation Plan provides some clarity as to the 
screening assessments and RMO analyses that substances will 
undergo prior to risk management. Moreover, updated guidance 
from ECHA provides some indication of factors that will be 
considered when evaluating whether to place potential SVHC on 
the Candidate List.260  Nonetheless, the European Authorities 
have a large degree of discretion on how priorities will be set and 
stakeholders do not have a clear understanding of which 
substances will undergo screening assessments/RMO analyses 
first.261 
4. Restriction 
The restriction authority under REACH is essentially a 
carry-forward risk management approach that European 
Authorities possessed prior to the enactment of REACH. It is 
seen as the “safety net” under REACH to address risks that are 
not adequately addressed through registration, evaluation, and 
authorization.262 
The European Commission is authorized to issue restrictions 
on the production, placement on the market, and use of selected 
chemicals to address “unacceptable risks” to human health and 
 
 257. See PRIORITISATION FOR AUTHORISATION, supra note 230, at 3–4. 
 258. See Role of the Member State Committee in the Authorisation Process, 
supra note 221. 
 259. See id. 
 260. See ECHA, GUIDANCE, supra note 220, at 6–7. 
 261. See Herbatschek et al., supra note 175, at 152–54. 
 262. ECHA, GUIDANCE, supra note 220, at 10. 
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the environment.263  The restrictions may entail a wide variety of 
measures, but are generally applied on a use-by-use basis. When 
issuing a restriction, the analytic burden of proof rests with the 
Commission. 
The restriction authority is particularly suitable for dealing 
with risks that arise from the aggregate production and use of a 
chemical or a group of chemicals by multiple manufacturers and 
users. The restriction authority has several advantages for the 
Commission compared to the authorization process. Only 
substances that are shown to be SVHCs can be listed in the 
authorization process whereas restrictions can be applied to any 
chemical and use that poses unacceptable risks to human health 
and the environment. Moreover, authorization operates on a 
chemical-by-chemical basis whereas the Commission may be able 
to address groups of chemicals or target narrow uses through the 
restriction authority. 
The Commission has already decided to regulate some 
chemicals under its restriction authority rather than under 
authorization.264  Additionally, the RMO seems to envision that 
substances on the Candidate List could be subjected to 
restrictions rather than authorization. Yet, the Commission has 
not put forward any formal procedure for determining which 
chemicals and uses should be a priority for regulation under the 
restriction approach.265  The following sub-section draws lessons 
from the Canadian and EU approaches to prioritization and 
assessment. 
C. Lessons 
1. Some Form of Formal Prioritization for Risk 
Assessment and Management is Essential 
Though both CEPA and REACH represent the state of the 
art in chemicals governance, they take very different approaches. 
 
 263. REACH, art. 68(1). See European Comm’n, Restrictions, ENTERPRISE & 
INDUSTRY, http://ec.europa.eu/enterprise/sectors/chemicals/reach/restrictions/ 
index_en.htm (last updated Aug. 29, 2014). 
 264. See Bergkamp & Penman, supra note 11, at 8; Herbatschek et al., supra 
note 175, at 146. 
 265. Herbatschek et al., supra note 175, at 152–54. 
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CEPA is designed to facilitate governmental decision-making on 
whether substances are CEPA-toxic. The emphasis of REACH, at 
its present stage of implementation, is on encouraging adequate 
control of risk through registration and on identifying SVHCs for 
management. We must emphasize that those processes are not 
directly analogous to one another, and a substance that is CEPA-
toxic will not necessarily be a SVHC under REACH and vice 
versa. What’s more, the complexity of these laws is a product of 
the political contexts within which they are being implemented—
REACH in particular with its separate programs and distribution 
of authority between the Commission, ECHA, and Member 
States. 
Nonetheless, the experiences of both Canada and the EU 
make abundantly clear the desirability and necessity of 
prioritization in assessment and management.266  Thousands of 
existing chemicals lack data on basic properties, uses, 
environmental releases, and exposures. Through its 
categorization process, Canada identified 4,300 priority chemicals 
for more in-depth assessment while tens of thousands of 
substances must be registered with ECHA.267  The European 
Commission projects a need to make SVHC decisions on as many 
as 440 substances by 2020.268 
The approaches to priority setting under CEPA and REACH 
differ, but both systems recognize a need to focus public and 
private sector resources on a limited number of chemicals. The 
priorities set in Canada seem to be manageable, but the 
tractability of the EU approach is better demonstrated for 
registration than it is for authorization. Indeed, the resources and 
workload for the EU Authorities were a major consideration in 
the development of the EU Roadmap on Substances of Very High 
Concern.269 
Once large numbers of registration dossiers were submitted 
under REACH, EU Authorities realized that they needed 
 
 266. See generally Ditz, supra note 75 (describing that one of the persistent 
flaws in U.S. regulatory programs is lack of priority setting); CASS SUNSTEIN, 
THE COST-BENEFIT STATE: THE FUTURE OF REGULATORY PROTECTION 6 (2002). 
 267. See infra Part III.A.1. 
 268. SVHC ROADMAP, supra note 68, at 12. 
 269. See id. at 12–13. 
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mechanisms to set some priorities to review registration dossiers. 
Targeted compliance checks on registration dossiers have a sound 
priority-setting rationale, since ECHA can focus on those portions 
of dossiers where the potential value of a compliance check is 
high.270  The priority-setting procedures for authorization, 
substance evaluation, and restriction under REACH are not yet 
fully worked out.271  NGOs have raised concerns that ECHA and 
the Commission are too slow at formally listing substances as 
SVHCs.272  The recent SVHC Roadmap and RMO analysis 
proposed by the EU may help set priorities for authorization in 
the future. 
Interestingly, both Canada and Europe are setting priorities 
based on hazard and exposure, but they are doing so in different 
ways. The CMP incorporated information on hazard and exposure 
in the categorization and CMP prioritization processes. Under 
REACH, hazard and exposure both play a role in the tiered 
registration process and in the design of registration dossiers. 
Hazard characteristics certainly drive decisions about which 
substances are placed on the Candidate List in the REACH 
authorization process, but exposure potential is also exerting a 
subtle role, as described in the SVHC Roadmap and 
Implementation Plan.273 Priorities for substance evaluation and 
restrictions under REACH may also be based on exposure as well 
as hazards, but the details have not yet been worked out. 
Based on the experiences in Canada and Europe, it is 
apparent how critical priority setting is for the practical 
management of existing chemicals. Any TSCA reform effort 
would be wise to encourage or require, at a minimum, some 
rudimentary form of priority setting, presumably a scheme that 
considers both elements of hazard and exposure. Furthermore, 
both Canadian and European experiences suggest that the U.S. 
might do well to either include as much clarity on prioritization 
criteria and processes as possible in the legislation itself and/or 
 
 270. See Herbatschek et al., supra note 175, at 130. 
 271. Id. at 152. 
 272. See The EU Regulation of Chemicals, INT’L CHEM. SECRETARIAT, 
http://www.chemsec.org/what-we-do/influencing-public-policy/eu-chemicals-
regulation/reach (last visited Nov. 7, 2014). 
 273. See generally SVHC IMPLEMENTATION PLAN, supra note 241; SVHC 
ROADMAP, supra note 68. 
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delegate EPA wide authority to determine its own prioritization 
scheme for assessment and management. Since EPA already has 
a workable scoring system to assist in priority setting, detailed 
legislative language may not be necessary.274  Some legislative 
clarity would reduce the potential for practical implementation 
problems and uncertainty that Europe is facing. The Canadian 
experience, though, is not a perfect guide for the U.S., as it is 
unlikely that EPA could enact a strategy analogous to the CMP 
through rulemaking without years of litigation. A prioritization 
scheme for assessment and management should be formalized in 
legislation, be stated plainly and unambiguously, and should 
provide EPA with a broad degree of technical and policy 
discretion. 
2. Prioritization with Limited Data is Feasible 
The most interesting lesson from the Canada-Europe 
comparison is that it is feasible, based on CEPA’s experience, to 
undertake a large-scale, credible prioritization process with 
extremely limited data,275 thereby avoiding the time and expense 
associated with the numerous required information submissions 
under REACH. Instead of waiting for (or requiring) hard data on 
each chemical in commerce, the Canadian authorities have been 
executing their professional judgment in the use of existing data 
and screening/modeling exercises, in effect allowing information 
for some chemicals to serve as a basis for predicting information 
for other chemicals. 
Government officials and stakeholders mostly report that 
Canada’s prioritization effort through the CMP has been effective 
in identifying chemicals of concern from a risk perspective and in 
stimulating more in-depth assessments of the risks associated 
with the specific uses of those chemicals.276  However, the 
 
 274. See OFFICE OF POLLUTION PREVENTION & TOXICS, EPA, TSCA WORK PLAN 
CHEMICALS: METHODS DOCUMENT 6 (2012), available at http://www.epa.gov/oppt/ 
existingchemicals/pubs/wpmethods.pdf [hereinafter OPPT]. 
 275. See generally Ditz, supra note 75; ENVTL. DEF., supra note 120. 
 276. See generally ENVTL. DEF., supra note 120; GRANVILLE, supra note 116; 
Letter from Peter Goodhand, Chief Exec. Officer, Can. Cancer Soc’y, Richard 
Paton, President & Chief Exec. Officer, Chemistry Indus. Ass’n of Can., Peter 
Robinson, Chief Exec. Officer, David Suzuki Found., & Rick Smith, Exec. Dir., 
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political environment in Canada may not be as receptive to NGO 
analysis and critique of chemicals management as it is in the U.S. 
Thus, the lack of heavy criticism in Canada of a judgment-laden 
process may be somewhat misleading. Nonetheless, the 
stakeholders seem to consider CEPA 1999 and the CMP notable 
improvements over prior approaches.277  Key ingredients of the 
CEPA success in prioritization are the widespread use of 
screening and modeling techniques, consideration of both health 
and environmental impacts, the use of rudimentary exposure 
information as well as hazard characteristics, and strict 
legislative deadlines in the categorization process. 
Based on the CEPA model, a simplified tiered approach to 
risk assessment of a single chemical might proceed as follows. 
The first tier is a preliminary assessment that can be performed 
even if very few data are available, by applying worst-case 
scenarios for exposure and conservative assumptions about 
toxicity. If risk is absent using these inputs, there is no need for 
more detailed information. If risk is present, regulatory 
authorities may require industry to refine the exposure and 
toxicity estimates in a second tier, based on hard data or more 
realistic, validated models. If risk is not present in the second 
tier, no more information is required. If risk is present, industry 
is required to implement risk management measures that reduce 
exposures until safety is accomplished. Under this approach, risk 
assessment is iterative: simple risk assessments are updated as 
better data become available.278 
Whereas CEPA begins with a prioritization of risk 
assessment based on limited data, REACH first fills the 
information gap and then employs a prioritization mechanism for 
 
Envtl. Def., to James Flaherty, Minister of Fin., Peter Kent, Minister of Env’t, 
Leona Aglukkaq, Minister of Health, & Stockwell Day, President, Treasury, Bd. 
& Minister of Asia-Pacific Gateway (Jan. 21, 2011) (on file with author) 
(supporting funding for CMP Phase 2). 
 277. See ENVTL. DEF., supra note 120. 
 278. See PRESIDENTIAL/CONGRESSIONAL COMM’N ON RISK MGMT & RISK 
ASSESSMENT, FRAMEWORK FOR ENVIRONMENTAL HEALTH RISK MANAGEMENT 26 
(1997), available at http://www.riskworld.com/nreports/1997/risk-rpt/pdf/ 
epajan.pdf; see generally NRC 2013, supra note 98, at 7, 138, 224. 
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risk management that makes use of risk assessments.279  The 
CEPA and REACH approaches have advantages and 
disadvantages from a priority-setting perspective. 
An advantage of the CEPA approach is that priorities are set 
rapidly because they can be based on the limited available data 
and screening/modeling.280  Because CEPA is based on the 
precautionary principle, a lack of data does not constitute a 
barrier to risk assessment, and the risk assessment process is 
conducted with conservative assumptions. Industry can respond 
to conclusions drawn from risk assessments that use estimation 
techniques by generating additional data. Moreover, the 
information-collection burdens on industry are limited because 
they face data-submission requirements only for the small share 
of existing chemicals that are identified as a priority for risk 
assessment. 
A disadvantage of the CEPA approach in its reliance on 
screening/modeling techniques is that it does little to address 
data gaps. REACH, on the other hand, compiles a huge volume of 
information through the registration dossiers, but the database is 
so large that much of it may never be fully examined.281  
Moreover, during the initial phase of registration, only a small 
number of chemicals were regulated under REACH (via 
restrictions or authorization), in part because industry was in the 
process of preparing dossiers for registration.282  Now that 
numerous registrations have been submitted (and many more 
will be submitted in 2018), ECHA faces a priority-setting 
dilemma in addressing imperfections in the dossiers. For sure, 
REACH was designed to achieve a level of quality in the dossiers: 
all companies manufacturing or importing the same chemical are 
expected to pool their expertise, registrants know they may face 
quality checks by ECHA, NGOs and the public can review the 
dossiers on ECHA’s website, ECHA is performing compliance 
checks, and European Authorities can apply penalties for 
 
 279. Ditz, supra note 75, at 10317 (indicating that the purpose of registration 
is to generate data rather than prioritize chemicals for assessment and 
management); Renn & Elliott, supra note 62, at 242. 
 280. See generally Ditz, supra note 75. 
 281. Abelkop et al., supra note 79, at 11056. 
 282. See Herbatschek et al., supra note 175, at 90–94. 
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violations under REACH.283  Nonetheless, there are already 
indications that there are significant quality problems with 
registration dossiers.284 
Another potential disadvantage of the CEPA approach is that 
some errors will inevitably occur in the priority-setting process 
because of the heavy reliance on limited data and 
screening/modeling exercises. Both false-positive and false-
negative errors are expected to occur.285 
A false-positive error occurs when a chemical is treated as a 
priority or is determined to be CEPA-toxic when it should not 
be.286  False-positive errors are of some concern because both 
government and industry will waste resources evaluating a 
chemical that does not pose a health or ecological risk. The rapid 
screening component of the program was introduced to, in part, 
address this concern. Based on the latest exposure information, 
substances can enter a streamlined risk assessment process, so 
that both industry and government resources can be focused on 
substances of higher potential concern. Beyond the prioritization 
process, industry can also provide data to aid in further refining 
risk assessments. Additionally, the affected companies may 
experience some unjustified market de-selection of their products 
due to the adverse publicity that the government creates for their 
products. However, the adverse consequences of false-positive 
errors may be limited and temporary, especially if the process 
constitutes prioritization of a substance for assessment without 
placing it on a formal list. The review processes in Canada, which 
can be buttressed by additional data from industry, may expose 
any false-positive errors and allow safe chemicals—or at least 
safe chemical uses—to be removed from the government’s 
priorities. 
 
 283. See generally id. at 94–95. For a description of how penalties are applied, 
see MILIEU ENVTL. LAW & POLICY, REPORT ON PENALTIES APPLICABLE FOR 
INFRINGEMENT OF THE PROVISIONS OF THE REACH REGULATION IN THE MEMBER 
STATES 7 (2010), available at http://ec.europa.eu/enterprise/sectors/chemicals 
/files/reach/docs/studies/penalties-report_en.pdf. 
 284. See, e.g., Stieger et al., supra note 184. 
 285. For the classic paper that conceptualized the error problem in chemical 
priority-setting procedures, see Talbot Page, A Generic View of Toxic Chemicals 
and Similar Risks, 7 ECOLOGY L. Q. 207, 219–39 (1978). 
 286. See id. at 220. 
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A false-negative error occurs when a chemical is classified as 
low priority when it should be classified as high priority, or 
determined to not pose a risk when it should be classified as 
CEPA-toxic.287  False-negative errors are more serious because 
they are errors that are less likely to be corrected at a later stage, 
as industry has little incentive to produce data that are not 
required.288  Notably, public interest organizations have raised 
concerns over false-negative errors about the way that HC and 
EC conduct SLRAs under the CMP, including insufficient 
consideration of certain toxicity endpoints and low dose effects 
(especially endocrine disrupting effects), deficiencies in data, 
failure to consider differences in exposure to higher risk groups 
(e.g., women), failure to consider cumulative effects of exposures 
to multiple chemicals, and inadequate application of 
precautionary approaches to assessment.289  On the other hand, 
HC and EC note that they have made considerable efforts to 
incorporate the precautionary principle into their assessment 
processes and to consider endocrine disrupting effects, differential 
risk to certain groups (including women and children), and 
cumulative effects of exposure to multiple chemicals when data 
are available.290  These critiques do not seem to be inherent to 
 
 287. Id. 
 288. See Ditz, supra note 75, at 10316-17. On why false-negative errors are 
particularly intolerable for public health, see Mara E. Long, Predicting 
Carcinogenicity in Humans: The Need to Supplement Animal-Based Toxicology, 
14 AATEX 553, 553–57 (2007). 
 289. Dayna Nadine Scott & Sarah Lewis, Regulating Toxics: Sex and Gender 
in Canada’s Chemicals Management Plan, in OUR CHEMICAL SELVES: GENDER, 
TOXICS, AND ENVIRONMENTAL HEALTH (Dayna Nadine Scott ed.) (forthcoming 
Dec. 2014); Scott, supra note 149, at 59. See CSM & CELA, supra note 164, 6, 9. 
 290. On the consideration of endocrine disrupting effects, see Federal Research 
on Hormone Disrupting Substances as Required Under the Canadian 
Environmental Protection Act, 1999, OFF. OF THE AUDITOR GEN. OF CAN. (Dec. 14, 
2012), http://www.oag-bvg.gc.ca/internet/English/pet_340_e_37607.html. On 
combined exposures and cumulative effects, refer to the screening assessments 
for PBDEs and phthalates, see generally Gov’t of Can., Phthalate Substance 
Grouping, CHEMICAL SUBSTANCES, http://www.chemicalsubstanceschimiques.gc 
.ca/group/phthalate/index-eng.php (last modified Aug. 15, 2014); Gov’t of Can., 
Polybrominated Diphenyl Ethers (PBDEs), CHEMICAL SUBSTANCES, 
http://www.chemicalsubstanceschimiques.gc.ca/fact-fait/glance-bref/pbde-
eng.php (last modified Feb. 14, 2013). On the precautionary principle, see 
Health Canada’s Adherence to the Precautionary Principle, OFF. OF THE AUDITOR 
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the way that CEPA is designed, but rather in the way that 
screening assessments are conducted. Should EPA conduct 
screening risk assessments under a reformed TSCA, it would do 
well to perform evaluations with these points in mind with the 
expectation that reasonable minds will differ on the adequacy of 
particular methodological approaches to risk assessment. 
Reliance on limited hazard data and screening/modeling will 
suffer from some false-negative errors, but the rate of error is 
likely to be relatively small if the screening and modeling 
exercises are conservative (i.e., health protective) in their design, 
which means that the exercises would be generally biased in 
favor of pushing borderline cases into the priority category.291  
There are ways to combine multiple screening exercises in order 
to minimize the false-negative error rate.292  Moreover, for 
existing chemicals that have been used for decades without any 
demonstration of adverse effects, there is a practical upper 
boundary on the possible magnitude of impacts from any false-
negative error and continued use. There is also a strong body of 
statistical evidence supporting the use of read-across techniques, 
in vitro tests, and acute toxicity as surrogates for, or predictors of, 
chronic toxicity.293  There is a similar body of statistical evidence 
supporting PBT determinations based on limited data, chemical 
 
GEN. OF CAN. (Mar. 1, 2010), http://www.oag-bvg.gc.ca/internet/English/ 
pet_289_e_33553.html. 
 291. For a useful case study illustrating the conservatism in Quantitative 
Structure Activity Relationships (QSARs), see Patricia Ruiz et al., Prediction of 
Acute Mammalian Toxicity Using QSAR Methods: A Case Study of Sulfur 
Mustard and Its Breakdown Products, 17 MOLECULES 8982, 8993 (2012). But for 
a skeptical view of the utility of QSAR approaches, see SCHETTLER ET AL., supra 
note 32, at 242–43. An additional concern is that industry-generated risk 
assessments might be less conservative than government-generated 
assessments. 
 292. Long, supra note 288, at 557. It is important to have flexibility to allow 
new information to enter the process as science and information evolve and to 
identify new priorities not identified by particular prioritization criteria. For 
example, CEPA has various, tiered information feeders for assessment. 
Overview of the Existing Substances Program, ENV’T CAN., supra note 112. 
 293. For a readable discussion of alternatives to full-scale animal testing that 
can predict human risk, see Toxicity Testing Overview, NON-ANIMAL METHODS 
FOR TOXICITY TESTING, http://alttox.org/mapp/toxicity-testing-overview/ (last 
updated Aug. 8, 2014). For a more in-depth discussion, see NAT’L RESEARCH 
COUNCIL, TOXICITY TESTING IN THE 21ST CENTURY: A VISION AND A STRATEGY 1 
(2007). 
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structure, and modeling.294  To the extent possible, risk 
assessment should also emphasize assessing groups of similar 
chemicals together, as in the CMP’s SGI and petroleum sector 
approaches. Group approaches have a better chance of accounting 
for cumulative exposures and also build efficiency into the 
assessment process. Even if SLRA methods improve, the CEPA 
approach is vulnerable to a higher rate of false-negative error 
than a system that would operate with full information. 
The REACH approach is not, however, a full-information 
approach because: (1) it is using rudimentary (rather than full) 
data sets, and (2) REACH is implemented in ways that permit 
registrants, under certain conditions, to use some of the same 
screening/modeling exercises that were employed in Canada (to 
reduce the number of animal tests).295  Thus, it seems possible 
that the REACH approach could have a lower rate of false 
negatives than the CEPA approach, but it is difficult to know in 
practice whether such an advantage exists or how large the 
advantage may be. 
It is also useful to compare the Canadian and EU approaches 
from the perspective of public confidence.296  CEPA may have an 
advantage over REACH in the near term, since Canada has 
moved much faster than Europe to focus on priority chemicals. In 
the long run, the REACH approach could garner more public 
 
 294. See ABELKOP, ROYER & GRAHAM, supra note 28 (estimation methods for 
measuring persistence, bioaccumulation, and toxicity are described in chapter 
2). See also HENRIK TYLE ET AL., DANISH EPA, IDENTIFICATION OF POTENTIAL 
PBTS AND VPVBS BY USE OF QSARS 2 (2002), available at 
http://eng.mst.dk/media/mst/69087/QSAR%20PBT%20final%20clean.pdf. 
 295. See ECHA, GROUPING OF SUBSTANCES AND READ-ACROSS APPROACH - PART 
I: INTRODUCTORY NOTE 5 (2013), available at http://echa.europa.eu/documents/ 
10162/13628/read_across_introductory_note_en.pdf. See generally Nicholas Ball 
et al., The Challenge of Using Read-Across within the EU REACH Regulatory 
Framework; How Much Uncertainty Is Too Much? Dipropylene Glycol Methyl 
Ether Acetate, an Exemplary Case Study, 68 REG. TOXICOLOGY & PHARMACOLOGY 
212 (2014); Grace Patlewicz et al., Use of ‘‘Read-Across’’ for Chemical Safety 
Assessment Under REACH, 65 REG. TOXICOLOGY & PHARMACOLOGY 226 (2013); 
Marta A. Sobanska, Analysis of the Ecotoxicity Data Submitted Within the 
Framework of the REACH Regulation, 470 SCI. OF TOTAL ENV’T 1225 (2014). 
 296. On the case for public confidence as a valid criterion to consider in 
regulatory reform, see generally DAVID VOGEL, THE POLITICS OF PRECAUTION: 
REGULATING HEALTH, SAFETY, AND ENVIRONMENTAL RISKS IN EUROPE AND THE 
UNITED STATES 63, 252 (2012). 
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trust if the practical difficulties in implementation of assessment 
and management diminish and if the registration data yield risk 
assessments that produce meaningful gains in health and 
environmental protection. Given its purported reliance on hard 
data, REACH may not require the same degree of public trust in 
the screening/modeling techniques and associated expert 
judgments that are inherent to the CEPA approach. 
On the other hand, REACH may fail to generate public 
confidence if it does not meet public expectations for timely 
conclusions, or if it becomes apparent that most of the large 
volume of information in registration dossiers is never reviewed 
by public officials through a rigorous process. If some of the 
registration data prove to be unreliable, which is likely,297 and if 
those errors are not detected and corrected through ECHA’s 
review processes, then REACH may be perceived as a regulation 
with significant error, particularly a potential for false-negative 
errors (since registrants are unlikely to submit dossiers with 
known false-positive errors). The pace of implementation may 
also become a public-confidence problem, since multiple rounds of 
registration dossiers and evaluations of potential SVHCs may 
overwhelm the technical capabilities and resources of European 
Authorities. Thus, on the whole, it is not apparent which system, 
CEPA or REACH, will earn more public confidence in the long 
run. 
With respect to TSCA reform, it is encouraging that EPA has 
already developed a scoring system for chemical priority setting 
that has been published and subjected to public comment.298  It is 
also beginning to be used in priority-setting applications.299  The 
 
 297. Ball et al., supra note 295; Natasha Gilbert, Data Gaps Threaten 
Chemical Safety Law, 475 NATURE 150, 150-51 (2011). See Costanza Rovida et 
al., How are Reproductive Toxicity and Developmental Toxicity Addressed in 
REACH Dossiers?, 28 ALTEX 273 (2011); Christina Rudén & Sven Ove 
Hansson, Registration, Evaluation, and Authorization of Chemicals (REACH) is 
but the First Step—How Far Will It Take Us? Six Further Steps to Improve the 
European Chemicals Legislation, 118 ENVTL. HEALTH PERSP. 6, 10 (2010); 
Stieger et al., supra note 184; Martin Scheringer, PBT Assessment, Workshop 
on PBT Science and Policy, December 4, 2013, Brussels, Belgium, at 7. 
 298. OPPT, supra note 274 (describing EPA’s prioritization approach to 
chemical risk assessment); ABELKOP, ROYER & GRAHAM, supra note 28 (chapter 
5). 
 299. OPPT, supra note 274, at 2. 
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EPA system has subtle differences from the Canadian and 
European approaches that need to be examined carefully before it 
is mandated in a legislative context. For example, EPA’s system 
places relatively greater weight on toxicity than persistence and 
bioaccumulation compared to the EU’s and Canada’s use of the 
PBT concept. Like Canada and Europe, EPA sees a role in 
priority setting for information on both hazard and exposure.300  
Thus, there is some reason for optimism that the U.S. can devise 
a credible priority-setting system for application to existing 
chemicals. 
We conclude with a cautionary remark: the Canadian 
regulatory culture is more cooperative and less adversarial than 
that in the U.S. TSCA reformers who seek to replicate the 
Canadian priority setting process in the U.S. may need to 
reconsider some of the legalistic aspects of the current TSCA 
regime (e.g., hybrid rulemaking and the substantial evidence test 
of judicial review).301  If TSCA reform cannot achieve a somewhat 
more cooperative regulatory culture between EPA, industry, and 
environmental groups, then a fragile priority setting process 
based on limited data, modeling, and professional judgment may 
not survive the brutal forces of administrative litigation in the 
U.S. 
3. Ample Opportunity to Review/Appeal Initial 
Listing Decisions is Important 
A heavy reliance on screening data necessitates the 
incorporation of institutions for adaptive management and 
flexibility into chemicals governance.302  That is, once a decision 
is made based on evidence that is inherently imperfect and 
incomplete, stakeholders should be given opportunities to provide 
additional information as it becomes available, especially through 
advancements in the science of risk assessment. A difficulty is 
balancing the need to move forward with the desire of certain 
stakeholders to circle back. For example, how much data is 
 
 300. Id.; ABELKOP, ROYER & GRAHAM, supra note 28 (chapter 5). 
 301. 15 U.S.C. §§ 2605(c), 2618(c)(1)(B)(i) (2012). 
 302. On the importance of incorporating institutions for adaptive management 
into regulatory programs, see Robin Kundis Craig & J.B. Ruhl, Designing 
Administrative Law for Adaptive Management, 67 VAND. L. REV. 1, 15 (2014). 
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sufficient to warrant an appeal? To the extent possible, a 
regulatory system should encourage stakeholder input into the 
assessment process at an early stage so as to avoid unnecessary 
appeals. However, the generation of hard data and precaution-
based regulation do not necessarily move at the same speed. 
Appeals or reviews of previous decisions may be necessary. Such 
processes should be incorporated into the assessment processes, 
prior to  management decisions, as well as into priority-setting 
decisions. 
Once a chemical is officially listed by the government as a 
priority chemical for risk assessment and regulation, the 
chemical may become stigmatized in the marketplace.303  Lists of 
chemicals for management (e.g., the REACH Candidate List) are 
likely to have more of a stigmatizing effect than priority lists of 
substances for assessment.304  Chemical users in the chrome 
plating and industrial tooling sectors, for example, have already 
been impacted by de-selection pressures under REACH.305  In the 
United States, stigma may cause market de-selection of the 
chemical,306 may prompt state and local regulation of the 
 
 303. Herbatschek et al., supra note 175, at 134. 
 304. See id. 
 305. See CTR. FOR STRATEGY & EVALUATION SERVS., INTERIM EVALUATION: 
IMPACT OF THE REACH REGULATION ON THE INNOVATIVENESS OF THE EU CHEMICAL 
INDUSTRY (2012), available at http://ec.europa.eu/enterprise/sectors/chemicals/ 
files/reach/review2012/innovation-final-report_en.pdf; KERSTIN HEITMAN & 
ANTONIA REIHLEN, TECHNO-ECONOMIC SUPPORT ON REACH: CASE STUDY ON 
“ANNOUNCEMENT EFFECT” IN THE MARKET RELATED TO THE CANDIDATE LIST OF 
SUBSTANCES SUBJECT TO AUTHORIZATION (2007), available at 
http://ec.europa.eu/environment/chemicals/reach/pdf/background/report_announ
cement_effect.pdf; Guido Grunwald & Phillipp Hennig, Impacts of the REACH 
Candidate List of Substances Subject to Authorisation: The Reputation 
Mechanism and Empirical Results on Behavioral Adaptations of German Supply 
Chain Actors, 11 J. BUS. CHEMISTRY 53 (2014); REACH, ROWAN TECH. GROUP, 
http://www.rowantechnology.com/US-and-European-rules/european-regulations/ 
reach/ (last visited Nov. 8, 2014) (arguing the listings under REACH can lead to 
product de-selection; such pressures are already impacting sectors such as 
chrome plating and industrial tooling; there are replacement chemicals for the 
substances listed under REACH but companies fear that the replacement 
chemicals may also be listed as SVHC; the chemicals, such as chromic acid and 
cobalt salts, serve as coatings and are used for corrosion control on aircraft). 
 306. Retailers such as Wal-Mart are inclined to use official lists of chemicals of 
concern when pressuring their suppliers for greener products. See Melody M. 
Bomgardner, Wal-Mart Details Chemicals Policy, CHEMICAL & ENGINEERING 
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substance,307 and may elicit product liability claims related to the 
chemical’s alleged hazards.308  Previous literature on 
technological stigma suggests that once a technology is 
stigmatized, it is difficult for the stigma to be removed based on 
additional evidence or a revised governmental determination.309  
Thus, it is important that the initial listing determinations by 
agencies are subject to appeals that can detect and reverse 
erroneous false-positive listings. 
The design of REACH was somewhat sensitive to this 
concern. Before a substance is placed on the Candidate List, there 
is a comment period under Article 59(4) that allows any 
stakeholder to make a case in favor or in opposition to the 
listing.310  This is a consultation process rather than an appeal 
mechanism. A candidate listing can also be appealed to the 
European Court of Justice.311 
REACH does not contain a mechanism whereby stakeholders 
can obtain an independent, transparent scientific review of a 
listing decision. The regulatory personnel who propose a chemical 
for listing under REACH are the same personnel who evaluate 
any comments that are received from stakeholders during 
consultation. Appeals to the European Court of Justice are 
legalistic in nature, and the European Authorities are accorded 
significant discretion by the Court.312 
 
NEWS, Mar. 10, 2014, at 19–21, http://cen.acs.org/articles/92/i7/Walmart-Target-
Take-Aim-Hazardous.html. 
 307. On the growing activism among state regulators, see Cheryl Hogue, State 
Lawmakers Introducing Bill to Restrict Chemicals, CHEMICAL & ENGINEERING 
NEWS, Feb. 18, 2013, at 37, available at http://www.environmentalandturf.com/ 
pdf/CEN-Online_State%20Lawmakers%20Introducing%20Bill%20To%20Restri 
ct%20Chemicals_February,%202013.pdf. 
 308. See, e.g., Roger Meiners & Bruce Yandle, Common Law and the Conceit of 
Modern Environmental Policy, 7 GEO. MASON L. REV. 923, 961–62 (1999); Gary 
T. Schwartz, Reality in the Economic Analysis of Tort Law: Does Tort Law 
Really Deter?, 42 UCLA L. REV. 377, 418–19 (1994). 
 309. Robin Gregory et al., Technological Stigma, 83 AM. SCIENTIST 220, 220–23 
(1995). See generally RISK, MEDIA, AND STIGMA: UNDERSTANDING PUBLIC 
CHALLENGES TO MODERN SCIENCE AND TECHNOLOGY (James Flynn et al., eds., 
2001). 
 310. REACH, art. 59(4). 
 311. Id. art. 94. 
 312. See id. art. 94; Consolidated Version of the Treaty on the Functioning of 
the European Union, art. 263, Oct. 26, 2012, 2012 O.J. (C 326) 162, available at 
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CEPA, on the other hand, has a scientific appeal procedure: 
CEPA authorizes the Minister of the Environment to establish a 
Board of Review made up of expert scientists to revisit decisions 
on whether substances are CEPA-toxic or not, for example, when 
new information becomes available.313  The most notable example 
to date is Siloxane D5, which EC and HC determined to be CEPA-
toxic, thereby authorizing risk management.314  In 2009, industry 
stakeholders requested the establishment of a Board of Review to 
revisit the determination on Siloxane D5.315 The Minister agreed 
to establish a board to review the determination, and industry 
submitted additional data that was not previously available to 
the government.316  Reviewing the new data, the board suggested 
that the government reverse its determination that Siloxane D5 
is CEPA-toxic, and the government accepted the recommendation 
and reversed its determination. Although this particular case 
involved industry submission of new data, an appeal procedure is 
also available in Canada when the interpretation of existing data 
is the sole point of controversy. The appeal procedure in Canada 
may garner more widespread political support if it is also 
available for use by the NGO community to reverse a 
questionable decision that a chemical is not toxic under CEPA. 
The absence of an appeal procedure (other than judicial 
review) for decisions to identify substances as SVHCs and to 
place them on the Candidate List and Authorization List is a 
salient issue. Even without a substance evaluation, Member 
States can propose a substance for restriction or nominate a 
substance for inclusion on the Candidate List. Member States, 
through REACH’s substance evaluation process, also have the 
 
https://www.ecb.europa.eu/ecb/legal/pdf/c_32620121026en.pdf. REACH art. 91 
lists certain decisions that are subject to appeal, but the scope of the art. 91 is 
quite limited. REACH, art. 91. 
 313. See generally SILOXANE D5 BOARD OF REVIEW, REPORT OF THE BOARD OF 
REVIEW FOR DECAMETHYLCYCLOPENTASILOXANE (SILOXANE D5) (2011), available 
at http://www.ec.gc.ca/lcpe-cepa/515887B7-AF58-45B7-ADA9-B4ADF8F204DB/ 
CdR-BoR-D5_eng.pdf. 
 314. SILOXANE D5 BOARD OF REVIEW, REPORT OF THE BOARD OF REVIEW FOR 
DECAMETHYLCYCLOPENTASILOXANE (SILOXANE D5) 16 (2011), available at 
http://www.ec.gc.ca/lcpe-cepa/515887B7-AF58-45B7-ADA9-B4ADF8F204DB/ 
CdR-BoR-D5_eng.pdf. 
 315. Id. 
 316. Id. at 17. 
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authority to influence SVHC listing decisions, and such decisions 
do not have to rely on—or be consistent with—the scientific data 
and determinations made by industry scientists in the 
registration dossier.317 
On the other hand, the information in the registration 
dossiers may be used by industry to persuade ECHA, the 
Commission, and other Member States that a provocative Annex 
XV dossier prepared by one Member State should not be accepted. 
Although the time and resources invested in registration dossiers 
are substantial, the presence of the registration dossier under 
REACH may provide a valuable tool for industry that is not 
available in the CEPA process (which does not require industry to 
submit registration dossiers at the outset). The advantage that 
industry gains through registration may be heightened if the 
quality of the dossier (i.e., the reliability and completeness of the 
information on hazard, uses, exposure pathways, and risk 
management measures) is strong. 
Finally, the formal incorporation of external expert peer 
review of draft risk assessments should be considered.318  Peer 
review of risk assessments need not take a substantial amount of 
time—a few weeks to a few months—and could greatly reduce the 
risk of false positive and false negative outcomes. Peer review 
may be especially warranted when there is either a high chance 
of a decision-making error or when the impact of an error would 
be particularly troublesome in terms of human and ecological 
health on the one hand and economic impacts on the other. 
For TSCA reformers, a challenge might be to design a 
scientific appeal procedure that would not unduly delay or chill 
the priority-setting process but would offer industry and NGOs a 
viable mechanism to override—or compel reconsideration of—
decisions that lack adequate scientific support.319  To a great 
 
 317. Herbatschek et al., supra note 175, at 131 (Substance evaluation may 
proceed based on information in the registration or dossier or “any other 
appropriate source.”). 
 318. NRC 1983, supra note 24, at 144. 
 319. In the United States, TSCA reformers have decades of experience with 
independent review bodies such as the EPA Science Advisory Board, the 
National Research Council of the National Academy of Sciences, and the Health 
Effects Institute. For a description of the origins and early work of these groups 
in chemical risk assessment, see generally HARNESSING SCIENCE FOR 
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extent, the notice and comment requirements for informal 
rulemaking (and threat of judicial review) may accomplish this 
task without the need for an additional appeal procedure. 
Stakeholders may generate and submit additional data in 
response to a rulemaking notice from EPA. EPA would then have 
to consider the data prior to its final decision, lest the agency risk 
its decision being overruled under judicial review as arbitrary 
and capricious. In the alternative, if a review mechanism is built 
into the risk assessment and management processes, judicial 
review may not be necessary at all or Congress may prescribe a 
particularly deferential standard of review. 
Additionally, the distinction between prioritization decisions 
as opposed to assessment and management decisions is crucial. 
Prioritization decisions should not be considered final agency 
actions that are subject to judicial review unless stakeholders can 
demonstrate the priority-setting determination per se triggers 
significant real-world impacts. Thus, here again, reformers must 
keep in mind that EPA’s regulatory culture is much more 
influenced by litigation risk than either the Canadian or 
European regulatory cultures. 
4. Discretionary Risk Management Accelerates 
Priority Setting 
Once a priority-setting process has determined that a 
chemical is of concern and requires further scrutiny, the system 
can be designed to have either automatic (mandatory) or 
discretionary risk management outcomes. One can certainly 
argue on policy grounds that risk management discretion is 
appropriate because a variety of measures are available, and a 
measure that is appropriate (i.e., effective and cost-effective) for 
one use may not be for another. Here, we make a second 
argument for risk-management discretion based on the fact that 
priority setting appears to progress rapidly when it is known that 
regulators have some discretion in risk management at the 
conclusion of a priority-setting process. 
 
ENVIRONMENTAL REGULATION (John D. Graham ed., 1991); SHEILA JASANOFF, 
THE FIFTH BRANCH: SCIENCE ADVISERS AS POLICYMAKERS 181 (1998). 
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Canada’s prioritization scheme is designed to separate the 
risk assessment and management processes. Recall that under 
CEPA, the government conducts SLRAs to inform a 
determination as to whether or not a substance is CEPA-toxic.320  
The determination that a substance is CEPA-toxic provides EC 
and HC with the legal basis for adding the substance to the Toxic 
Substances List, and the addition of the substance to the TSL in 
turn provides EC and HC with the legal authority and obligation 
to recommend and enact risk management. The determination 
that a substance is CEPA-toxic, though, does not automatically 
lead to any particular management measure. 
The legislative choice to separate assessment and 
management decisions in Canada has allowed the Canadian 
chemical categorization and CMP to work as quickly as they 
have. A similar outcome may be desired by TSCA reformers. 
Indeed, the speed with which EC and HC are completing the 
assessments under the CMP is a large part of what makes the 
Canadian approach attractive as a potential model for TSCA 
reform. Attaching mandatory management measures, especially 
highly stringent ones, to the outcomes of risk assessments might 
have been problematic because it would have elevated the weight 
of prioritization and assessment decisions, resulting in more 
contention and lobbying about the information and analysis 
supporting those decisions.321  Since the CMP process is 
separated from risk management decision-making, it may not 
have withstood the intense stakeholder scrutiny that would have 
resulted from mandatory risk-management measures, such as 
phase-outs and substitution. 
On the other hand, the initial reluctance of the European 
Commission to list a large number of SVHCs may have been due 
to a fear that a literal, legalistic reading of REACH calls for 
automatic phase-out of all chemicals designated as a SVHC.322  
 
 320. CEPA § 74. 
 321. In the U.S. regulatory system, highly stringent regulatory mandates have 
induced reluctance among regulators to open rulemakings. See generally John 
D. Graham, Saving Lives Through Administrative Law and Economics, 157 U. 
PA. L. REV. 395, 441 (2008). 
 322. A similar behavioral pattern was observed in the U.S. under the Clean 
Air Act. When the U.S. Congress mandates a highly stringent risk-management 
approach for a listed chemical, regulators are unlikely to list chemicals under 
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The EU’s approach in the SVHC Roadmap provides an indication 
that the EU will build more flexibility into both the listing and 
risk management phases. Also, the pace of SVHC listings under 
REACH accelerated only after the RMO approach in the SVHC 
Roadmap was formulated and proposed.323  However, the pace of 
SVHC listings might have accelerated only temporarily to meet 
short-term political commitments rather than as a response to 
additional clarity provided by the SVHC Roadmap. 
An alternative approach that was rejected would have 
ensured that all potential SVHCs were added to the Candidate 
List, and all chemicals on the Candidate List were added to the 
Authorization List,324 even though the risk management 
ramifications would have been dramatic. The SVHC Roadmap 
and Implementation Plan seem to envision consideration of risk 
management options prior to considering substances for inclusion 
on the Candidate List.325 The lack of legislative clarity on this 
question creates confusion as to the precise roles of prioritization 
and assessments under REACH.326  Indeed, litigation may be 
required to fully resolve this question.327  In general, the extreme 
complexity of REACH may place unnecessary burdens on both 
government and stakeholders.328 
Overall, the experiences of Canada and the EU suggest that 
for prioritization and assessment to move quickly, the choice of 
risk management measures should be preserved as a separate 
 
the provision. Such behavior was observed under section 112 of the Clean Air 
Act, which regulates toxic air pollution. John D. Graham, The Failure of Agency 
Forcing: The Regulation of Airborne Carcinogens Under Section 112 of the Clean 
Air Act, 34 DUKE L.J. 100 (1985). See generally JOHN MENDELOFF, THE DILEMMA 
OF TOXIC SUBSTANCE REGULATION: HOW OVERREGULATION CAUSES 
UNDERREGULATION 134–37 (1988). 
 323. On ECHA’s most recent additions to the Authorization List, see 
Herbatschek et al., supra note 175, at 135; ECHA Proposes Five Substances for 
Authorisation, CHEMICAL WATCH (Feb. 10, 2014), http://chemicalwatch.com/ 
18322/echa-proposes-five-substances-for-authorisation. 
 324. See REACH, Preamble (77), art. 58. 
 325. See SVHC IMPLEMENTATION PLAN, supra note 241, at 13–14. 
 326. Herbatschek et al., supra note 175, at 152–55. 
 327. See generally EUROPEAN ENVTL. BUREAU & CLIENT EARTH, IDENTIFYING 
THE BOTTLENECKS IN REACH IMPLEMENTATION: THE ROLE OF ECHA IN REACH’S 
FAILING IMPLEMENTATION 42–43 (2012), available at http://www.eeb.org/EEB/ 
?LinkServID=53B19853-5056-B741-DB6B33B4D1318340. 
 328. See Abelkop et al., supra note 79, at 11045. 
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question. For TSCA reformers, preserving a range of options for 
risk management of different uses (as a part of legislative design) 
may help accelerate the priority setting and risk assessment 
processes. 
Decoupling risk management from risk assessment 
necessitates deadlines for both processes. Both CEPA and 
REACH incorporate strict deadlines into their assessment and 
management processes. Experience with CEPA in particular 
demonstrates the importance of strict deadlines for categorization 
and for screening assessment. Risk management instruments 
must also be introduced according to specified time periods as 
prescribed in CEPA sections 91 and 92: following a decision to 
recommend a substance for inclusion on the TSL, the ministries 
have two years to propose a risk management instrument and 
another eighteen months to finalize it.329  Thus, TSCA reform 
legislation may benefit from the inclusion of mandatory deadlines 
for prioritization and assessment of priority chemicals and 
associated management decisions. The harder challenge for TSCA 
reformers is to design deadlines that are practically enforceable, 
since the agency and stakeholders bypass many deadlines in U.S. 
regulatory systems when there is no penalty on anyone for 
missing the deadlines. 
Additionally, we noted above that prioritization decisions 
should not be considered final agency actions that are subject to 
judicial review, at least if there are no demonstrated real-world 
impacts of the priority-setting determination. If assessment and 
management decisions are separated, the drafters of TSCA 
reform legislation should give careful thought to legislating 
burdens of proof for assessment and management decisions that 
do not impair EPA’s ability to reach scientifically sound decisions 
within an expeditious timeframe. Given that assessment and 
management decisions have different implications, burdens of 
proof for assessment and management decisions should not be the 
same. 
Lastly, the separation of assessment and management 
decisions should not give license to extra stages of litigation that 
drain public and private resources and impede expeditious and 
 
 329. CEPA §§ 91(1), 92(1). 
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scientifically sound risk assessment and management decisions. 
TSCA reformers may consider focusing judicial review at either 
the assessment or the management stage, but not both unless it 
can be demonstrated that the priority-setting determination has 
real-world impacts such as market de-selection, tort litigation, or 
state and local regulatory actions. That is, if assessment decisions 
analogous to CEPA-toxicity findings are subject to judicial review, 
then EPA should have permissive authority to apply risk 
management tools following notice and comment. In the 
alternative, TSCA reformers may want to provide EPA with 
permissive authority to determine that risk management of a 
particular substance or use is warranted, but focus judicial 
review efforts on EPA’s risk management decisions. 
5. Adequate Public Resources are Necessary 
Both Canada and the EU have dedicated substantial public 
funding to their prioritization and assessment processes. In fiscal 
year 2014, ECHA’s budget was approximately €119 million (~ 
$160 million U.S).330  The EU Member States also expend public 
resources on REACH to oversee ECHA and Commission 
activities, conduct substance evaluations, and administer other 
functions. The Netherlands alone spends approximately four to 
five million Euros per year, apart from REACH enforcement 
activities. If the activities of all twenty-eight Member States are 
counted, the public investment in REACH in the Member States 
may be ten to fifteen times the level of the investment in the 
Netherlands.331  The Canadian government has allocated about 
$500 million Canadian (~ $450 million U.S.) for each of the first 
two five-year phases of the CMP,332 and accounts from 
government and stakeholders in Canada report that this level of 
 
 330. ECHA, PRELIMINARY CONCLUSIONS, 32ND MANAGEMENT BOARD MEETING 2 
(2013), available at http://echa.europa.eu/documents/10162/13608/preliminary 
_conclusions_mb32_en.pdf; ECHA, WORK PROGRAMME 2014, at 68 (2014), 
available at http://echa.europa.eu/documents/10162/13608/final_mb_39_2013_ 
wp_2014_en.pdf. 
 331. These numbers reflect personal estimates from peer reviewers. 
 332. Backgrounder: Canada’s Chemicals Management Plan, HEALTH CAN. (Oct. 
2011), http://hc-sc.gc.ca/ahc-asc/media/nr-cp/_2011/2011-128bk-eng.php. 
81
3_ABELKOP&GRAHAM FINAL 8/24/2015  12:05 PM 
2015 REGULATION OF CHEMICAL RISKS 189 
 
funding has been necessary for EC and HC to meet legislative 
goals. 
Public resources committed to REACH are larger than those 
committed to the CMP. Perhaps that is to be expected since the 
European economy is many times larger than that of Canada. 
Chemicals sales in 2012 were €539 billion in the EU and $45 
billion (Canadian) in Canada.333  ECHA experienced early budget 
shortfalls, though they were largely due to infrastructural and 
implementation difficulties that have now been mostly 
addressed.334  Regardless of how they are compared, both Canada 
and the EU provide substantial public funds to chemicals 
assessment and regulatory decision-making. 
TSCA reformers need to find creative ways to generate 
additional revenue for EPA to implement TSCA reform. Taking a 
cue from ECHA, which collects registration fees, EPA could 
partially fund risk assessment with fee-generated revenue. 
Reliance on general federal revenue is probably the least 
attractive approach, since there are so many competing claims for 
those dollars. Fees on companies that manufacture, process, 
and/or use high-priority chemicals would be a sensible “user-fee” 
approach.335  Although the amount of public sector resources that 
are required will vary by system design, any credible system 
aimed at addressing the large volume of existing chemicals will 
require significant public sector resources. 
 
 333. Chemicals, EUR. COMMISSION, http://ec.europa.eu/enterprise/sectors/ 
chemicals/index_en.htm (last visited Nov. 8, 2014); Manufacturing Sales, by 
Subsector, STATISTICS CAN., http://www.statcan.gc.ca/tables-tableaux/sum-
som/l01/cst01/manuf11-eng.htm (last modified Oct. 16, 2014). 
 334. See, e.g., Industry Bodies Surprised by ECHA Funding Concerns, 
CHEMICAL WATCH (July 25, 2008), http://chemicalwatch.com/931/industry-bodies-
surprised-by-echa-funding-concerns. 
 335. See Charles M. Auer, Periodic Reporting of Hazard Data, Exposure 
Information on Existing Chemicals, BNA DAILY ENV’T REP., Apr. 14, 2010, at B-
7, available at http://www.actagroup.com/uploads/docs/00059082.pdf; Lynn L. 
Bergeson, Do It Now, or It May Never Be Done, ENVTL. F. (Washington, D.C.), 
May/June 2014, at 446. 
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III. BURDEN OF DATA GENERATION AND 
SAFETY DETERMINATION 
Any plausible reform of TSCA needs to address two 
fundamental questions: Where should the burdens of generating 
data and of making safety determinations be placed?336  At a high 
level of abstraction, TSCA, CEPA, and REACH all call on 
government and stakeholders to identify chemicals of concern, 
prioritize them for assessment and management decisions, 
conduct risk assessments, and make risk management decisions. 
Thus, in this part we compare the Canadian and European 
burdens as we draw insights about how TSCA reform legislation 
might structure the legal obligations and related formal 
relationships between government and industry. Given the way 
that TSCA has been interpreted in previous litigation, some legal 
commentators believe that one or more of the burdens of proof 
under TSCA need to be reconsidered through reform.337 
Legislation can place the burden of data production for 
assessment wholly on the government, wholly on industry, or 
some hybrid combination. In theory, legislation could require the 
government to generate much of the toxicity data or predictions 
on its own. The government could also utilize public funds to 
estimate releases and exposures for specific uses by undertaking 
inspection and monitoring programs throughout the supply chain 
of chemical production from use to disposal. In today’s world of 
severe constraints on public sector resources and expertise, 
neither TSCA, CEPA, nor REACH have put the data burden 
primarily on government. In one way or another, all three 
regimes envision industry as the data generator. 
Placement of the burden of proof of safety is also a 
fundamental feature of chemicals regulation that can affect the 
design and function of the entire regulatory program: 
 
 336. In the legal community, these burdens are known as “the burden of going 
forward” and the “risk of non-persuasion.” Fleming James, Jr., Burdens of Proof, 
47 VA. L. REV. 51 (1961). The burden of going forward places the obligation on a 
certain party to produce evidence. Id. Here, we refer to this burden as the 
burden of data generation. Id. The risk of non-persuasion indicates which party 
loses if the evidence does not meet the relevant standard of proof. Id. We refer to 
this as the burden of making safety determinations. Id. 
 337. Applegate, Synthesizing, supra note 74, at 736–37. 
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The allocation of burden of proof is more than just a means to a 
regulatory end; it is also a normative position. Burden of proof 
expresses a fundamental public policy by placing responsibility 
for determining a chemical’s safety either with the manufacturer 
or with the government, making it either an essentially private 
or essentially public decision, respectively. The normative burden 
of proof also gives direction to regulators in their substantive 
evaluation of a chemical, telling them how selective to be, how 
doubts are to be resolved, and how judgment is to be exercised.338 
Indeed, who holds the burden of making safety 
determinations is a central issue that must be resolved in TSCA 
reform: Do companies in the industry have any legal obligation to 
make an affirmative technical case that their uses of existing 
chemicals satisfy the prevailing safety standard in legislation? 
Under the laws of the fifty states that govern products liability, 
companies already have some safety obligations, but here we 
refer to an additional legal obligation that would arise from a 
safety standard in TSCA reform legislation. 
With regard to proving the safety of existing chemicals, 
REACH is often seen as accomplishing a reversal of the burden of 
proof from government to industry whereas the Canadian 
approach leaves much of the burden of making safety 
determinations in the hands of government. As clear as the legal 
theory may be, the realities of both CEPA and REACH are more 
complex than the previous sentence suggests. If our research has 
revealed anything, it is a confirmation of what risk managers 
have known for decades—that successful chemicals risk 
management requires an enormous amount of cooperation 
between government and stakeholders in industry and public 
interest organizations. Thus, while CEPA and REACH do have 
quite different allocations of legal responsibility, implementation 
of both legislative designs has been a cooperative effort. At a 
practical level, both CEPA and REACH share burdens among 
government and stakeholders, shifting them back and forth, 
depending on the nature and stage of the regulatory process. 
Since there are interesting interconnections between the 
burden of data generation and the burden of proving safety under 
 
 338. Id. at 745. 
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a legislated safety standard, we discuss the two burdens together. 
If manufacturers or downstream users must affirmatively show 
that the ways in which they use chemicals meet a legislated 
safety standard, then they have an added incentive to generate 
additional information beyond that provided by marketplace 
competition and duties of care under tort law.339  If the burdens 
of producing data and proving unacceptable risk rest with the 
government, then manufacturers and downstream users may be 
inclined to refrain from making scientific investments in data 
generation until they are compelled to do so. Given this 
conceptual background, we turn to a look at how Canada and the 
EU have resolved these difficult issues. 
A. CEPA 1999 and the CMP 
CEPA primarily places the burden of data production on 
industry but maintains the burden of proof of risk (that a 
substance or use is unsafe) on the government.340  The burdens 
are structured to facilitate cost-effective decision-making and 
flexibility in the application of risk management. Since data 
generation and analysis are expensive, CEPA is designed to 
produce only the amount of data and analysis that are necessary 
to reach a management decision. In this respect, the CEPA 
approach reduces the risk of information overload on government 
at the same time that it places the burden of making safety 
determinations on government. Moreover, the spirit of the CMP 
is that of a cooperative endeavor between stakeholders and 
government in identifying and managing risks. Although this 
may seem idealistic, CEPA and the CMP have operated 
effectively through iterative processes of interaction and feedback 
between government and stakeholders. 
CEPA section 71 authorizes EC to require the submission of 
data from any person who “may reasonably be expected to have 
access” to it for the purpose of determining “whether a substance 
is . . . or is capable of becoming [CEPA-]toxic, or for the purpose of 
 
 339. Id. 
 340. See ERICA CRAWFORD & TIM WILLIAMS, PARLIAMENTARY INFORMATION & 
RES. SERV., LIBRARY OF PARLIAMENT, INTERNATIONAL MANAGEMENT OF CHEMICALS 
9 (2006). 
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assessing whether to control, or the manner in which to control, a 
substance.”341  Recall that a substance is CEPA-toxic “if it is 
entering or may enter the environment in a quantity or 
concentration or under conditions that” may result in harm to 
human health or the environment.342  A finding that a substance 
is CEPA-toxic constitutes the government’s burden of 
demonstrating that a risk exists. The statute, therefore, directly 
links the burdens of data production and proof of (un)safety. 
Under CEPA sections 71 and 72, authorities can require the 
submission of existing and new data through surveys (mandatory 
data submissions) of companies.343  There is no substantial 
burden of proof or procedural hurdle that EC must surpass to 
issue a data submission survey under section 71 other than that 
the purpose must be to inform risk assessment or management 
decision-making. EC publishes a notice of the data submission 
requirement in the Canada Gazette, similar to the U.S. Federal 
Register.344 
The notice describes the parameters of the survey, including 
what substances the survey applies to, who must respond (e.g., 
those who imported or used a quantity of the substance in a 
calendar year greater than 100 kilograms at a concentration of 
0.001 % by weight in a product or mixture intended for 
residential use), the total quantity imported or used, the Function 
Code and the Consumer and Commercial Code (as used in the 
U.S. by EPA), a description of the generic name of the substance, 
a description of the mixture or product containing the substance, 
studies on hazard characteristics (e.g., as persistence, 
bioaccumulation, and toxicity), confidentiality requests, and the 
date by which the information must be submitted to the 
 
 341. CEPA § 71. 
 342. Id. § 64. 
 343. Id. §§ 71, 72. CEPA section 72 conditions authority to require generation 
of new information under CEPA section 71(c) on authorities having a reason to 
suspect that a substance could be CEPA-toxic, or if the substance has been 
determined as a CEPA-toxic or is able to become one. Id. § 72. Therefore, the 
government cannot require the generation of new information for a priori 
information gathering. 
 344. See id. § 71(1)(a)-(b). 
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government.345  For the Challenge, the notices applied to batches 
of fifteen to thirty substances and addressed substances alone as 
well as in products or mixtures.346  Other surveys can also be 
mandated, for example, a “one-off” update on quantities 
manufactured, imported, and exported for a large number of 
substances, referred to as an “Inventory Update.”347 
Some stakeholders have reported difficulty due to a lack of 
clarity in requests (e.g., regarding the level of detail required) or 
from the limitations they face accessing certain data (e.g., uses 
throughout the supply chain).348  EC, however, has been diligent 
in gathering feedback on data submission challenges and has 
included stakeholders in the design of section 71 notices.349  EC 
has encouraged companies to cooperate in submitting data on 
their own and/or through industry organizations.350 
Interestingly, information collected under REACH is finding 
its way into Canada, though not directly through government-to-
government exchange. The Canadian government has in certain 
instances entered into agreements with groups of REACH 
registrants (called consortia) to collect data from REACH 
registration dossiers from the registrants themselves rather than 
from ECHA because the registrants own the data.351 
Under the CMP, EC and HC use the information gathered in 
section 71 surveys to conduct SLRAs to determine whether or not 
substances are CEPA-toxic. In addition, some data are generated 
 
 345. Id. § 71(2). See, e.g., ENV’T CAN. GUIDANCE FOR RESPONDING TO THE NOTICE 
WITH RESPECT TO CERTAIN SELENIUM-CONTAINING SUBSTANCES (NOTICE) 5, 17–18, 
22 (2013), available at https://www.ec.gc.ca/ese-ees/default.asp?lang=En 
&n=ECA8FF32-1. 
 346. Elpi Karalis & Daren Kelland, Presentation at the Industry Coordinating 
Group CEPA Update Conference in Mississauga, Ontario: Information 
Gathering Under the Chemicals Management Plan (CMP) 3 (June 6, 2013) (on 
file with authors). 
 347. Gov’t of Can., Domestic Substances List Inventory Update, CHEMICAL 
SUBSTANCES, http://www.chemicalsubstanceschimiques.gc.ca/plan/approach-
approche /dsl-lis-eng.php (last modified June 12, 2013). 
 348. Karalis & Kelland, supra note 346, at 4–6. 
 349. Id. at 7, 12. 
 350. Karalis & Kelland, supra note 346, at 15. 
 351. Id. at 16; Daren Kelland & Elpi Karalis, Presentation at the Industry 
Coordinating Group CEPA Update Conference in Mississauga, Ontario: 
Information Gathering Under the Chemicals Management Plan (CMP) 6 (Oct. 9, 
2014) (on file with authors). 
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directly through contracts with the government or by the 
government itself (e.g., biomonitoring studies, mining of existing 
data, and development of predictive tools). Although industry has 
expressed some difficulty in gathering and submitting data in 
response to requests from the Canadian government, the data 
submissions required under CEPA section 71 do not rise to the 
level of detail or comprehensiveness of REACH registration 
dossiers. The requests for data in Canada are far more limited 
and targeted to exactly what Canadian regulators think they 
need. 
As noted above, the standard for authorizing risk 
management is whether or not a substance is CEPA-toxic. The 
placement of the burden of proof is squarely on the government. 
EC and HC must find that a substance is CEPA-toxic in order to 
apply risk management. The assessment process, which entails a 
screening level risk assessment, is explicitly structured to answer 
this question: whether a substance “is entering or may enter the 
environment in a quantity or concentration or under conditions 
that” may cause harm to human health or the environment.352  
This is a risk-based standard, though it is certainly vague 
compared to what a risk assessor would demand for practical 
implementation. It does require the consideration of both hazard 
and exposure. Regulators do not need to find that the use or 
disposal of a substance actually presents a risk or likely presents 
a risk, but rather that it may present a risk. Though there are 
regulations that specify methods for determining persistence and 
bioaccumulation,353 no guidance has been released that specifies 
the ministries’ burden of proof in determining whether or not a 
substance may enter the environment or may cause harm. In 
other words, if use or disposal of a substance raises the plausible 
possibility of a risk to human health or the environment, then 
authorities are empowered to determine that the substance is 
CEPA-toxic and initiate the risk management process. 
Further, under certain evidentiary circumstances, CEPA 
compels authorities to add a substance to the Toxic Substances 
List. For example, if a SLRA indicates that a substance is CEPA-
toxic, persistent, bioaccumulative, and its presence in the 
 
 352. CEPA § 64. See id. §§ 65(3), 77(4) (emphasis added). 
 353. Persistence and Bioaccumulation Regulations, supra note 111, at 1–2. 
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environment “results primarily from human activity,” it must be 
recommended for addition to the TSL and is automatically 
considered for “Virtual Elimination”354 —prohibition on the 
release of a substance beyond a certain threshold under which the 
substance cannot be accurately measured in emissions and 
effluents.355  On the other hand, a determination that a substance 
is CEPA-toxic, by itself does not automatically trigger the 
application of any particular risk management instrument. 
Further risk-management considerations are necessary to make 
sure an appropriate response is made. 
Recall that there are three potential outcomes if a SLRA 
leads authorities to determine that a substance is CEPA-toxic.356  
Authorities may opt to take no further action if, for example, they 
determine that voluntary measures by industry, market de-
selection, or another action is appropriate to control the risks.357  
They may add the substance to the Priority Substances List, 
though this path has been all but abandoned as a risk assessment 
provision.358  Finally, the ministries may recommend that a 
substance be added to the TSL, which is a formal step toward risk 
management measures.359 
CEPA provides EC and HC with a wide variety of risk 
management options to control exposure to CEPA-toxic 
substances at any point in the chemical’s lifecycle. Once a 
substance is recommended for addition to the TSL, the ministries 
have two years to issue a “proposed regulation or instrument 
respecting preventive or control actions in relation to a 
 
 354. CEPA, § 77(3); Toxic Substances List, ENV’T CAN., http://www.ec.gc.ca/ 
lcpe-cepa/default.asp?lang=En&n=0DA2924D-1 (last modified Nov. 6, 2013). 
 355. See generally The Canadian Environmental Protection Act, 1999 and 
Virtual Elimination, ENV’T CAN., https://www.ec.gc.ca/lcpe-cepa/default.asp? 
lang=En&n=BB1FDE0A-1 (Mar. 3, 2013). 
 356. CEPA § 77(2). 
 357. See id. § 77(2)(a). 
 358. See id. § 77(2)(b). 
 359. Id. § 77(2)(c). Substances that would have been determined to be CEPA-
toxic, but the demonstrated absence of exposure in the Canadian context 
prevented that conclusion, are controlled by the government’s policy of issuing a 
SNAc, which effectively means the substance will need to be assessed as a new 
substance should a manufacturer or importer wish to use it. SNAc Approach, 
supra note 122. 
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substance.”360  As of November 2013, there are 132 substances or 
types of substances on the TSL.361 
CEPA provides authority for EC and HC to adopt any of 
about thirty different policy tools, including restrictions on the 
quantity of manufacture, sale, import, or export; amount, 
location, and conditions of releases; labeling, handling, and 
storage; and the generation and submission of information.362  
The agencies may also issue guidelines, standards, or codes of 
practice or may facilitate voluntary risk management efforts.363  
For example, authorities have issued regulations that pertain to 
specific TSL substances (e.g., polybrominated diphenyl ethers and 
PCBs),364 certain sources of TSL substances (e.g., pulp and paper 
mill effluent containing chlorinated dioxins and furans),365 
certain uses and products that contain TSL substances (e.g., 
 
 360. CEPA § 91(1). 
 361. Toxic Substances List – Schedule 1, ENV’T CAN., http://www.ec.gc.ca/lcpe-
cepa/default.asp?lang=En&n=0DA2924D-1&wsdoc=4ABEFFC8-5BEC-B57A-
F4BF-11069545E434 (last modified Aug. 4, 2014). 
 362. CEPA § 93. 
 363. Id. § 93 (risk management tools); id. § 95 (requirement to report 
releases); id. § 98 (liability for remedial efforts after a release); id. § 100 (export 
controls). See  Meek & Armstrong, supra note 94, at 598;  U.N., DEP’T OF ECON. & 
SOC. AFFAIRS, supra note 137, at 8. 
 364. ENV’T CAN., PROPOSED RISK MANAGEMENT MEASURE FOR POLYBROMINATED 
DIPHENYL ETHERS (PBDES) (2013), available at http://www.ec.gc.ca/ese-
ees/92B7DD05-793A-4E4C-9742-3A25EB2529BE/PBDEs_Consultation_EN.pdf; 
PCB Regulations (SOR/2008-27), ENV’T CAN., http://www.ec.gc.ca/lcpe-
cepa/eng/regulations/detailReg.cfm?intReg=105 (last modified Aug. 26, 2014; 
Polybrominated Diphenyl Ethers (PBDEs), ENV’T CAN., 
http://www.ec.gc.ca/toxiques-toxics/Default.asp?lang=En&n=98E80CC6-
1&xml=5046470B-2D3C-48B4-9E46-735B7820A444 (last modified Oct. 3, 2013); 
Risk Management of DecaBDE: Commitment to Voluntary Phase-Out Exports to 
Canada, ENV’T CAN., http://www.ec.gc.ca/toxiques-toxics/default.asp?lang 
=en&n=F64D6E3B-1 (last modified July 23, 2013). 
 365. Polychlorinated dibenzodioxins, ENV’T CAN., http://www.ec.gc.ca/toxiques-
toxics/Default.asp?lang=En&n=98E80CC6-1&xml=1794091E-5FC5-40F9-BB0B-
E823BFC418C6 (last modified July 23, 2013); Pulp and Paper Mill Effluent 
Chlorinated Dioxins and Furans Regulations (SOR/92-267), ENV’T CAN., 
http://www.ec.gc.ca/lcpe-cepa/eng/regulations/detailReg.cfm?intReg=21 (last 
modified Aug. 26, 2014). 
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concentration limits for 2-butoxyethanol in products for indoor 
use),366 and more general risk management tools. 
One such tool is the Prohibition of Certain Toxic Substances 
(PCTS) regulations.367 Authorities developed the PCTS 
regulations because “it was suggested that it would be simpler 
and more effective administratively to develop a generic banned-
substances regulation to which substances would be scheduled 
rather than having separate regulations.”368  The PCTS 
regulations include several sub-lists, also called schedules.369  At 
present, the twelve substances listed on Schedule 1 are prohibited 
from manufacture, import, sale, and use.370 
PCTS Schedule 2 functions somewhat like REACH 
authorization: listed substances are prohibited from manufacture, 
import, and sale, unless exemptions are provided under limited 
authority.371  However, Canada’s exemption mechanism may be 
more flexible. The Minister of the Environment must issue a 
permit if “there is no technically or economically feasible 
alternative,” “the applicant has taken the necessary measures to 
minimize or eliminate any harmful effect of the toxic substance 
on the environment and human health,” and the applicant has 
prepared a plan to phase out the use of the substance within 
three years after the permit is issued.372  Schedule 2 lists five 
substances with permanent permitted uses, one substance with a 
temporary permitted use, two with permitted concentration 
limits, and two with reporting thresholds. Thus, although the 
CEPA-toxicity standard does not necessarily mandate the 
consideration of socio-economic data, consideration of substitutes, 
or differentiation in uses, such factors are built into the risk 
 
 366. 2-Butoxyethanol Regulations (SOR/2006-347), ENV’T CAN., 
http://www.ec.gc.ca/lcpe-cepa/eng/regulations/detailReg.cfm?intReg=97 (last 
modified Aug. 26, 2014). 
 367. Prohibition of Certain Toxic Substances Regulations, SOR/2012-285 
(Can.), available at http://laws-lois.justice.gc.ca/PDF/SOR-2012-285.pdf 
[hereinafter PCTS Regulations]. 
 368. Polybrominated Biphenyls, ENV’T CAN., http://www.ec.gc.ca/toxiques-
toxics/Default.asp?lang=En&n=98E80CC6-1&xml=7194BA9D-887F-4426-A2BE-
E7E20560B67B (last modified Aug. 8, 2013). 
 369. PCTS Regulations, supra note 367, at 3. 
 370. Id. at Schedule 1, Part 1. 
 371. Id. at Schedule 2, Parts 1–3. 
 372. Id. § 10. 
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management decision-making process that follows a finding that 
a substance is CEPA-toxic and its addition to the TSL. 
Under an alternative tool, the agency may require industry 
to develop Pollution Prevention (P2) Plans, programs to minimize 
the release of substances listed on the TSL.373 Through P2 plans, 
EC develops a risk management objective for a particular 
substance and compels businesses to develop their own 
management strategies for preventing releases of the 
substance.374  EC has used P2 plans as precursors to or in lieu of 
other risk management strategies, especially those where 
information asymmetries make it difficult for the agency to 
determine what the most effective or efficient management option 
might be.375 
Another risk management instrument that is gaining 
momentum is the use of a Significant New Activity (SNAc) 
requirement, which is very similar in concept to the TSCA 
Significant New Use Rules, for substances whose current use(s) is 
either extremely limited and well-controlled, or if quantities in 
current Canadian commerce are zero or very low.376  The SNAc is 
applied to enforce notification of new or increased use (with an 
associated requirement to provide risk-related information as per 
a New Substance Notification), which allows the regulator to 
conduct an updated risk assessment.377 
Some criticize the Canadian approach for not fully reversing 
the burden of proof of safety on to industry.378  The legislation 
does not require industry to make a safety determination, but 
CEPA does authorize EC and HC to compel industry to provide 
 
 373. See Pollution Prevent (P2) Plans, ENV’T CAN., http://www.ec.gc.ca/lcpe-
cepa/default.asp?lang=En&n=BC71EA4E-1 (last modified Sept. 24, 2013). 
 374. ENV’T CAN., POLLUTION PREVENTION PLANNING PROVISIONS OF PART 4 OF 
THE CANADIAN ENVIRONMENTAL PROTECTION ACT, 1999, FREQUENTLY ASKED 
QUESTIONS 1-3 (2008), available at http://publications.gc.ca/ 
collections/collection_2009/ec/En4-91-2-2008E.pdf [hereinafter ENV’T CAN., 
POLLUTION PREVENTION]. 
 375. See generally id. at 3. 
 376. See generally SNAc Approach, supra note 122. 
 377. Policy on the Use of Significant New Activity Provisions of the Canadian 
Environmental Protection Act, 1999, ENV’T CAN., https://www.ec.gc.ca/ese-
ees/default.asp?lang=En&n=5CA18D66-1 (last modified Dec. 24, 2013). 
 378. See, e.g., Adam Briand, Reverse Onus: An Effective and Efficient Risk 
Management Strategy for Chemical Regulation, 53 CAN. PUB. ADMIN. 489 (2010). 
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data in specific cases379 and, in fact, this is an integral first step 
to the assessments done under the CMP. Moreover, the SLRAs 
utilize a tiered approach starting with upper-bound exposure 
estimates and refine those estimates, as necessary and where 
possible, depending on the level of information available.380 P2 
plans also reverse the burden of proof of safety onto industry by 
establishing a risk management objective that industry is 
responsible for meeting.381 
The spirit of the CMP is that it is a cooperative endeavor 
between government, industry, and NGO stakeholders. To be 
sure, praise of CEPA and the CMP is certainly not universal, as 
many specific decisions have raised controversy. Nonetheless, 
many stakeholders, including both industry and NGOs, seem to 
be pleased with the degree of activity under CEPA and the CMP, 
especially as compared to the level of activity prior to the 
enactment of CEPA 1999.382  As of 2013, none of the stakeholders 
are seeking to overhaul the system to the degree they are 
currently in the United States.383 
B. REACH 
REACH places the data-generation and risk-assessment 
burdens primarily on industry. The obligations vary depending on 
the quantity of the substance to be imported or manufactured, the 
potential for the substance to cause harm to persons or the 
natural environment (toxicity), and whether the substance is an 
existing substance or a new substance. Recall that greater 
amounts of information are required for chemicals that are 
manufactured or imported in higher volume. Once the 10-tonne 
threshold is reached for a registrant, a Chemical Safety Report 
(CSR) for the substance must be added to the registration 
 
 379. CEPA § 71(1). 
 380. This is a technical process that is motivated by value-of-information 
thinking. See generally NAT’LRESEARCH COUNCIL, UNDERSTANDING RISK: 
INFORMING DECISIONS IN A DEMOCRATIC SOCIETY 110–11 (1995). 
 381. See ENV’T CAN., POLLUTION PREVENTION, supra note 374, at 2–3. 
 382. See ENVTL. DEF., supra note 120, at 15; Goodhand et al., supra note 276. 
 383. Cheryl Hogue, Support Grows for Chemical Law Reform, CHEMICAL & 
ENGINEERING NEWS, June 10, 2013, at 22–23. 
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dossier.384  The CSR must include a chemical safety assessment, 
including information on hazards to human health and the 
environment, physiochemical hazards, and an assessment on 
whether the substance qualifies as PBT or vPvB.385  If the safety 
assessment reveals that the substance is hazardous or qualifies 
as a PBT or vPvB, then additional information is required, 
including exposure scenarios and risk characterization.386  
Information on substances makes its way through the supply 
chain via documents called Safety Data Sheets.387 
One of the common misconceptions about REACH is that it 
compels numerous new toxicity tests on thousands of chemicals 
that have been marketed for years without any toxicity 
information.388  REACH does require basic information regarding 
hazards,389 but REACH is designed to minimize the number of 
new animal toxicity tests. ECHA and the Member States have 
issued detailed guidance on the numerous avenues that 
registrants can pursue to avoid the time and expense of animal 
toxicity testing.390  They can report previously conducted tests (if 
they are applicable and sufficient), they can make inferences 
based on structurally similar chemicals, they can allow a test of 
one chemical to serve for an entire category of chemicals, and 
they can perform modeling exercises to predict acute and chronic 
ecotoxicity.391  The registrants bear the full responsibility for 
justifying these “adaptations,” and the process of obtaining ECHA 
approval for adaptations is burdensome for industry, since it 
 
 384. REACH, arts. 10(b), 14(1). 
 385. Id. art. 14(3). 
 386. Id. art. 14(4). 
 387. See id. arts. 31-32. 
 388. See, e.g., WARGO, supra note 28, at 287 (The “REACH testing program” is 
“an important step” because it “will require toxicity testing by manufacturers of 
more than 30,000 compounds.”). 
 389. REACH, Annex VII–X. 
 390. See generally ECHA, GUIDANCE ON INFORMATION REQUIREMENTS AND 
CHEMICAL SAFETY ASSESSMENT (2012), available at http://echa.europa.eu/ 
documents/10162/13632/information_requirements_r7b_en.pdf (discussing as an 
example, aquatic toxicity to sediment organisms). See also UK REACH 
COMPETENT AUTH., MINIMIZATION OF ANIMAL TESTING (2012), available at 
http://www.hse.gov.uk/reach/resources/18animaltesting.pdf. 
 391. See generally Herbatschek et al., supra note 175, at 127, 150 (for 
example, Quantitative Structure-Activity Relationships). 
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involves preparation of detailed justification documents and a 
laborious process of answering questions from ECHA.392  In some 
cases, registrants decide it is less onerous to perform tests—even 
if they are expensive—than to seek ECHA acceptance of 
adaptations.393 
One indication of the limited quantity of animal testing that 
is induced by REACH is the proportion of requests for approval of 
animal tests in relation to the number of registration dossiers 
submitted to ECHA. By May 2013, ECHA had received 33,656 
registration dossiers on 8,469 substances.394  The number of 
dossiers including a proposal for animal testing was modest: 
about 800 tests were proposed (by 2012), 62 percent for a single 
toxicity endpoint (reproductive effects, either developmental or 
two-generation studies).395  Additionally, some of these tests are 
not expected to be conducted because ECHA approval of some 
tests will render other proposed tests unnecessary, since 
registrants will be able to use “read across” techniques to allow a 
test of one substance in a category to satisfy the data requirement 
for other chemicals in that category.396 
One of the innovative features of REACH is the requirement 
that multiple manufacturers of the same chemical join together 
and submit a single dossier (“one substance, one registration”).397 
Companies form Substance Information Exchange Forums 
(SIEFs) and contractual organizations called consortia to 
facilitate information sharing, which means that test data in the 
possession of one company can be used to meet the obligations of 
 
 392. ECHA, HOW TO AVOID UNNECESSARY TESTING ON ANIMALS 12 (2010), 
available at 
http://echa.europa.eu/documents/10162/13655/pg_avoid_animal_testing_en.pdf. 
 393. Gerwin Schaafsma et al., REACH, Non-Testing Approaches and the 
Urgent Need for a Change of Mind Set, 53 REG. TOXICOLOGY & PHARMACOLOGY 
70, 78 (2009). 
 394. Bjorn Hansen & Mike Penman, Is REACH Achieving Its Objectives?, in 
THE EUROPEAN UNION REACH REGULATION: LAW AND PRACTICE 376–77 (Lucas 
Bergkamp ed., 2013). 
 395. Id. at 387. 
 396. Id. 
 397. Registration, ECHA, http://echa.europa.eu/en/regulations/reach/ 
registration (last visited Nov. 5, 2014). 
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all companies in the group.398  A lead registrant may bear the 
brunt of the work but may also collect some fees from other 
companies in the group to defray some of the costs of being a lead 
registrant.399  One company in a SIEF must sell its data to 
others, a pattern that has led to some interesting negotiations 
since there is no obvious way to set a price for data from an older 
toxicity study. Elsewhere, we have written about some of the 
complex financial and legal issues that arose during the initial 
formation and operation of SIEFs and consortia under REACH.400  
The transaction costs were substantial (and arguably greater 
than they needed to be), but there is no question that the 
collaboration between manufacturers (and users) of chemicals has 
reduced the amount of new toxicity tests and other data 
gathering that might otherwise have been necessary.401  Equally, 
the requirement has forced a significant workload on industry. 
Starting with the 2010 registration deadline and now with 
the recent passage of the 2013 registration deadline, REACH has 
stimulated the assembly of a massive electronic database of 
chemical properties, uses, exposure pathways, and risk 
management measures. The huge inventory is housed at 
ECHA.402  Thus, some of the data gaps on chemicals in commerce 
have been filled, and more data gaps on lower-volume chemicals 
will be filled by the next registration deadline in 2018. 
There is some evidence that the actual act of gathering and 
submitting the data has produced some positive benefits.403  
Registration has not only facilitated communication among risk 
 
 398. See Adam D.K. Abelkop et al., How can REACH be Improved?, in THE 
EUROPEAN UNION REACH REGULATION: LAW AND PRACTICE 390, 393–94 (Lucas 
Bergkamp ed., 2013). 
 399. See Mike Penman & Martin Richards, REACH Consortia, in THE 
EUROPEAN UNION REACH REGULATION: LAW AND PRACTICE 185, 191 (Lucas 
Bergkamp ed., 2013). 
 400. Abelkop et al., supra note 79, at 11051-53. 
 401. Mike Penman & Martin Richards, REACH Consortia, in THE EUROPEAN 
UNION REACH REGULATION: LAW AND PRACTICE 186 (Lucas Bergkamp ed., 2013). 
“If each stakeholder had to submit their own intrinsic hazard data, . . . a large 
amount of unnecessary animal testing [could occur].” Id. Hungary and the UK 
succeeded with an amendment to REACH calling for “one substance, one 
registration.” Id. 
 402. See Registered Substances, supra note 189. 
 403. Abelkop et al., supra note 79, at 11056. 
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managers and other professionals within different branches of 
large companies, but it has also facilitated communication 
between different companies throughout the supply chain of 
chemical products. Stakeholders have indicated that this 
communication has allowed them to achieve some efficiencies in 
operations, data gathering, and decision-making on chemical uses 
and product design.404  In addition, a large portion of registration 
information is now publicly available on the Internet, through 
ECHA’s website, for examination by governments around the 
world, public interest organizations, consumers, processors, 
retailers, and companies throughout the chemical industry.405 
A challenge for the EU is to ensure that the information is 
put to good use in risk management. European Authorities 
indicate that registration dossiers require registrants to make 
affirmative safety determinations that risks of chemicals are 
“adequately controlled.”406  Thus, REACH is said to reverse the 
burden of proof of safety onto industry. 
In our view, the ideal of reversing the burden of proof is 
commendable. It should be the responsibility of companies to 
ensure the safety of the products that they place on the market. 
In practice, however, the implementation of the reversed burden 
of proof has presented challenges. EU Authorities indicate that a 
finding of “adequate control” is a central part of some registration 
dossiers, but stakeholders seem to be less certain of this 
obligation, perceiving registration as more of a data collection 
process than a risk management process. Part of the difficulty 
might be traced to some ambiguity as to the meaning of 
“adequate control,”407 but the bigger issue may be a perception 
that EU Authorities must ultimately take action under the 
authorization or restriction processes to ensure adequate control 
 
 404. See id. at 11046–47. 
 405. Registered Substances, supra note 189. 
 406. Abelkop et al., supra note 398, at 390–93. 
 407. See id. at 390; David Santillo & Paul Johnston, Effect Thresholds and 
‘Adequate Control’ of Risks: The Fatal Flaws in the EU Council’s Position on 
Authorisation Within REACH, 13 ENVTL. SCI. & POLLUTION RESEARCH INT’L 425, 
429 (2006). But see REACH, Annex I § 6.4 (describing how adequate control is 
defined and ECHA’s guidance on how it is defined in practice); ECHA, GUIDANCE 
IN A NUTSHELL: CHEMICAL SAFETY ASSESSMENT, 18–19 (2009), available at 
http://echa.europa.eu/documents/10162/13632/nutshell_guidance_csa_en.pdf. 
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of exposures (e.g., ECHA cannot pull a registration because it 
believes risk management measures are inadequate).408 
Moreover, the safety determinations made by registrants 
within registration dossiers might not always be the same 
determinations that a regulator would make. As an example, the 
ECHA PBT Expert Group concluded that Siloxane-D5 is a vPvB 
and should therefore be classified as a SVHC and slated for 
authorization.409  However, the registrants have concluded in 
their dossier that it is not a vPvB.410  Substances that are vPvB 
(along with PBTs and CMR substances) are considered “non-
threshold” substances under the statute.411  That is, they are 
substances for which, under REACH, it is assumed that there is 
no safe level of exposure, and hence the risks cannot be 
adequately controlled. For substances that REACH presumes do 
not have a safe level of exposure, it is a mystery how a 
registration dossier could demonstrate adequate control of 
exposure (unless exposures are eliminated). Yet, the registrants 
have determined that risks are, in fact, adequately controlled. 
This apparent inconsistency might not have any practical impact; 
it is entirely plausible that risks are adequately controlled (after 
all, the Canadian Board of Review determined that Siloxane-D5, 
as it is used in Canada, is not CEPA-toxic). However, this case 
raises broader questions about the clarity of regulatory mandates 
under REACH and the potential for contradictory outcomes under 
different parts of the regulation (i.e., registration versus 
authorization).412 
 
 408. See MILIEU ENVTL. LAW & POLICY, supra note 283, at 7. 
 409. ECHA, IDENTIFICATION OF PBT AND VPVB SUBSTANCE: RESULTS OF 
EVALUATION OF PBT / VPVB PROPERTIES 120 (2014), available at 
http://echa.europa.eu/documents/10162/13628/decamethyl_pbtsheet_en.pdf. 
 410. ECHA, PBT Assessment: Overall Result, 
DECAMETHYLCYCLOPENTASILOXANE, http://apps.echa.europa.eu/registered/data/ 
dossiers/DISS-9d82d68d-a71c-2317-e044-00144f67d249/AGGR-987c9eda-73dc-
413e-9d74-c56194ad1383_DISS-9d82d68d-a71c-2317-e044-00144f67d249.html# 
AGGR-987c9eda-73dc-413e-9d74-c56194ad1383 (last visited Nov. 8, 2014). 
 411. See REACH, art. 60(2)–(3). 
 412. Elsewhere we have argued that the REACH’s safety standard under 
authorization is not consistent with the standard under registration because 
registration process does not permit the registrant to consider benefits (under 
the “adequate control” standard) whereas the authorization process permits 
consideration of benefits during socio-economic analysis of specific uses. See 
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Additionally, the concept of “safety” is a social construct and 
different sectors of society have different views about what is 
“safe.” Although the concept of placing the burden of proof on 
industry may be superficially attractive to some, the risk outcome 
is based largely on companies’ determinations of what constitutes 
“safety.” Chemical manufacturers have the most direct control 
over internal safety in handling chemicals and less control over 
the safety in how chemicals are used downstream. More 
importantly, industry can make a safety determination, but 
cannot decide on societal acceptance of its position on risk. 
Acceptable levels of risk may turn on whether emphasis in a risk 
assessment is placed on hazard or exposure data; this has 
historically been a point of contention between industrial 
interests and consumer health and environmental advocates. 
What’s more, the Siloxane-D5 case raises questions about the 
trustworthiness of safety determinations in registration dossiers: 
if Annex XV dossiers rely primarily on data from registration 
dossiers to identify SVHCs, then companies have a strong 
incentive to find that their substances do not have vPvB, PBT, 
CMR, or endocrine disrupting properties. The same can be said of 
the data submitted under CEPA (and indeed any regulatory 
program). The difference is that the volume of data that the 
government must inspect under CEPA is much more manageable, 
and government is not relying on industry to self-regulate. 
REACH does not rely wholly on industry to regulate itself 
through registration; ECHA conducts audits of the registration 
dossiers, often requesting or compelling clarifications or 
additional data/analysis.413 
The EU may also supplement the safety measures in 
registration dossiers by managing risks through the 
authorization and restriction mechanisms under REACH.414  
Recall that once a SVHC is placed on the Authorization List, it 
must be phased out unless the Commission approves 
authorization requests for specific uses.415 As an alternative, the 
 
Abelkop et al., supra note 398, at 390–93; Abelkop et al., supra note 79, at 
11062–64. 
 413. See Herbatschek et al., supra note 175, at 130. 
 414. Id. at 133–152. 
 415. See id. at 136. 
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Commission can establish more targeted restrictions on the 
manufacture, placement on the market, or use of a substance that 
it determines to pose an unacceptable risk to human health or the 
environment.416 
Therefore, the notion that REACH fully reverses the burden 
of proof of safety is a misleading oversimplification. Under 
authorization and restriction, the burden shifts to the 
government to identify SVHCs, place chemicals on the Candidate 
List and then the Authorization List, or apply restrictions. After a 
chemical is placed on the Authorization List, the burden shifts to 
industry to apply for use-specific authorizations.417  Each 
authorization request must certify either that adequate control of 
risks for threshold substances has been accomplished or that 
benefits exceed risks in the case of non-threshold substances 
(socio-economic analysis).418  If a company chooses the socio-
economic route of justification, it must also demonstrate that no 
suitable alternatives to the SVHC are available for the specific 
use.419 
In December 2013, Rolls-Royce was the first company to gain 
an opinion from ECHA that the Commission should approve an 
authorized use of a substance (DEHP) on the Authorization List 
by making the case that risks are adequately controlled in a 
specific aerospace application: the seven-year authorization is for 
the use of DEHP—short for Bis(2-ethylhexyl) phthalate, a 
reproductive toxin—in the manufacture of aero engine fan 
blades.420  In 2013, ECHA received a total of eight authorization 
requests covering two phthalates in seventeen different uses.421  
In 2014, ECHA received nineteen authorization requests.422  
 
 416. See id. at 145. 
 417. See id. at 139. 
 418. Id. at 140. 
 419. Herbatschek et al., supra note 175, at 140. 
 420. Press Release, ECHA, Authorisation to Use a Substance of Very High 
Concern - First Opinions Adopted (Jan. 3, 2014), available at http://echa.europa. 
eu/view-article/-/journal_content/title/authorisation-to-use-a-substance-of-very-
high-concern-first-opinions-adopted. 
 421. Id. 
 422. Statistics on Received Applications, ECHA, http://echa.europa.eu/ 
web/guest/addressing-chemicals-of-concern/authorisation/applications-for-
authorisation/received-applications (last modified Mar. 20, 2015). 
100http://digitalcommons.pace.edu/pelr/vol32/iss1/3
3_ABELKOP&GRAHAM FINAL 8/24/2015  12:05 PM 
208 PACE ENVIRONMENTAL LAW REVIEW [Vol.  32 
 
Prior to the first authorization decision, the common perception 
among industry stakeholders was that the authorization process 
would be strict, onerous, and unpredictable with regard to 
outcome.423  Such perceptions are likely to evolve as practical 
experience with the authorization process is accumulated. There 
is no precedent yet for an authorization based on socio-economic 
analysis. 
Overall, the REACH regulation imposes burdens of proof on 
both industry and government. Those burdens are sometimes 
independent of each other, but in some cases (e.g., authorization) 
the sharing of burdens is an iterative process. Both stakeholders 
and government have experienced “growing pains” in the first 
years of REACH implementation, but the statute has so far 
proven to be workable, despite its complexity. In the years ahead, 
the inspection of a greater volume of registration dossiers, along 
with more experience with the authorization process, will yield 
additional insight into the workability of REACH’s approach to 
chemicals management. 
C. Lessons 
1. Industry Should Be Required to Produce and 
Supply Safety Data 
In addition to accepting some level of responsibility for 
placing a chemical in the marketplace, manufacturers and 
processors are likely the least-cost providers of safety 
information.424  Many jurisdictions, including the EU, U.S., and 
Canada, have pre-manufacturing or pre-marketing notification 
requirements for new substances. The European and Canadian 
laws include specific data requirements to accompany the 
registration package. Hence new substances introduced into 
commerce may have a more extensive database than many 
existing (legacy) chemicals. Given this precedent, it is not 
unreasonable to expect industry to generate and provide similar 
 
 423. Herbatschek et al., supra note 175, at 134, 139–45. 
 424. See GUIDO CALABRESI, THE COST OF ACCIDENTS 135–97 (1970); Jonathan 
B. Wiener, The Real Pattern of Precaution, in THE REALITY OF PRECAUTION: 
COMPARING RISK REGULATION IN THE UNITED STATES AND EUROPE 519, 529 
(Jonathan B. Wiener et al. eds., 2011). 
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databases for existing chemicals; and the industry’s response to 
recent challenges such as the various High Production Volume 
initiatives425 tend to confirm that it understands these 
expectations, although there is still a long way to go before the 
entire spectrum of legacy chemicals has been dealt with. On the 
other hand, the careful use of limited data and modeling—
coupled with safe experience to date—argues against broadly 
applicable data requirements. 
Both CEPA and REACH place the burden of data production 
primarily on industry.426 TSCA section 2 also states, “the 
development of such data should be the responsibility of those 
who manufacture and those who process such chemical 
substances and mixtures.”427  Government as well as 
stakeholders in industry and public interest organizations 
engaged in the TSCA reform debate all contend that the 
placement of the burden of data production should be on industry. 
One of the reasons for the broad consensus is 
straightforward: the chemicals marketplace is characterized by 
an information asymmetry in favor of industry. Manufacturers, 
processors, and users are in the best position to obtain data on 
intrinsic properties, uses, releases, exposure scenarios and 
pathways, and risk management measures.428  They can do so at 
a lower cost than government can because they already have 
established commercial relationships with each other and 
because government is in a poor position to appreciate the wide 
variety of uses throughout industry, the many possible exposure 
scenarios, the numerous opportunities for chemical releases into 
 
 425. See High Production Volume (HPV) Challenge, EPA, 
http://www.epa.gov/hpv/index.htm (last updated Apr. 22, 2013). 
 426. However, EC and HC have also spent significant resources and time 
mining existing data and developing predictive tools. See generally The Health-
Related Components of Categorization of the Domestic Substances List (DSL): 
Approach, Results, and Next Steps, HEALTH CAN., http://www.hc-sc.gc.ca/ewh-
semt/contaminants/existsub/categor/approach-approche-eng.php (last modified 
Jan. 31, 2008). 
 427. 15 U.S.C. § 2601(b)(1) (2012). 
 428. See Applegate, RESCUING, supra note 87, 263–65. 
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the environment, and the wide range of risk management 
measures that are already employed by companies.429 
The approval processes for agricultural chemicals and 
pharmaceuticals also place the burden of data generation on the 
private sector, as do the various permit processes under the Clean 
Air Act and Clean Water Act and those applicable to many other 
industrial facilities such as oil and gas development, mining 
operations, and waste disposal (e.g., incinerators and landfills). 
Thus, there is plenty of regulatory precedent for placing the 
burden of data generation on industry. 
Some scholars have raised issues about the trustworthiness 
of data generated by industry.430  After all, companies may 
perceive that they have little to gain and much to lose by 
providing regulators with information about the potential risks of 
using their chemicals. Since only a small percentage of 
registration dossiers are checked fully by ECHA, registrants may 
perceive that they can “cut corners” in the registration process.431 
The use of SIEFs under REACH may create an informal 
policing of information quality in registration dossiers. If a SIEF’s 
lead registrant proposes to submit low-quality or misleading 
information to ECHA, the other registrants in the SIEF who 
placed their trust in the lead registrant may lose confidence in 
the lead registrant and seek corrective action.432  None of the 
registrants want to be exposed to the risk of potential delays, a 
refusal of registration based on inadequate information, or the 
potential reputation damages caused from submitting misleading 
 
 429. For a discussion of the issues regarding whether data should be 
generated by industry or government, see Applegate, RESCUING, supra note 87, 
at 263–75. 
 430. Id. at 273–75; JOE THORNTON, PANDORA’S POISON: CHLORINE, HEALTH, AND 
A NEW ENVIRONMENTAL STRATEGY 98–99 (2000) (arguing that corporate funding 
of toxicological research has biased thinking in favor of the concept of 
thresholds); Daniel Uyesato et al., REACH’s Impact in the Rest of the World, in 
THE EUROPEAN UNION REACH REGULATION FOR CHEMICALS: LAW AND PRACTICE 
335, 361 (Lucas Bergkamp ed., 2013) (discussing the government of Japan’s 
preference to not rely on industry-generated data). 
 431. See generally Compliance Checks, ECHA, http://echa.europa.eu/ 
regulations/reach/evaluation/compliance-checks (last visited Nov. 6, 2014). 
 432. See generally Lucas Bergkamp & Mike Penman, Conclusions, in THE 
EUROPEAN UNION REACH REGULATION FOR CHEMICALS: LAW AND PRACTICE 410, 
427 (Lucas Bergkamp ed., 2013). 
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safety information to the government. More generally, it is not 
difficult to imagine negative consequences that could result for a 
company that is shown to have submitted incomplete, misleading, 
or fraudulent data to a regulatory body. Under U.S. tort laws, 
such behavior could increase the risk of punitive damage awards 
against a company, assuming that a worker or consumer was 
ultimately harmed by chemical exposure and a jury is made 
aware of the company’s misbehavior.433 
Procedures for review of regulatory data—sometimes called 
“regulatory science” due to the applied nature of the information 
and the possible role of policy drivers or assumptions in the data-
generation or data-analysis parameters—should therefore be 
built into any regulatory system for chemicals.434  Both CEPA 
and REACH have issued guidance concerning the quality of 
submitted data (e.g., the use of Good Laboratory Practices (GLP) 
is required by law and emphasized in guidance), have issued test 
guidelines based on internationally agreed test methods 
(determined by OECD), and have incorporated detailed 
procedures to review industry-generated data.435  On the other 
hand, neither CEPA nor REACH precludes the consideration and 
use of non-GLP studies. 
Since government scientists and their contractors often have 
a crucial role to play in the review of industry-generated data and 
analyses, it is vital that the scientific staff of regulatory agencies 
receive adequate funding and training to perform their quality-
control and data review/interpretation roles. Insofar as data 
 
 433. Under U.S. tort law, a company might face large punitive damages if it 
intentionally misled the government, and this resulted in harm to consumers or 
the environment. Gertz v. Robert Welch, Inc., 418 U.S. 323, 350 (1974) (defining 
punitive damages); ALEXANDER VOLOKH, REASON FOUND., POLICY STUDY NO. 213: 
PUNITIVE DAMAGES AND ENVIRONMENTAL LAW: RETHINKING THE ISSUES 10 (1996), 
available at http://reason.org/files/76a01f43ff7eec045e97b61c0f23caf5.pdf; Rae 
Zimmerman, Governmental Management of Chemical Risk: Regulatory Processes 
for Environmental Health 103–05 (1990) (citing examples of chemical damage 
claims against Monsanto for $16 million in 1983 and $108 million 1986, the 
latter including $100 million in punitive damages). 
 434. Sheila Jasanoff, Watching the Watchers: Lessons from the Science of 
Science Advice, GUARDIAN, Apr. 8, 2013, http.www.theguardian.com/science 
/political-science/2013/apr/08/lessons-science-advice. 
 435. See, e.g., REACH, art. 13(4) (requiring that ecotoxicological and 
toxicological tests be carried out under GLP or other international standards); 
Karalis & Kelland, supra note 346. 
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about chemicals are made publicly available (as is increasingly 
the case in the EU and Canada), public interest groups and 
interested academics and consultants can also serve as informal 
critics of quality and relevance. The more that industry data are 
made available for public scrutiny and are subjected to rigorous 
review by qualified scientists, the more likely it is that the public 
will trust the resulting regulatory outcomes. 
2. Industry Should Be Required to Analyze Submitted 
Data and Make Safety Determinations for 
Envisioned Uses Under the Applicable Standard of 
Safety 
Under U.S. and Canadian law, chemical manufacturers and 
users are already subject to affirmative duties of care that are 
expressed in tort laws.436  TSCA, however, places the burden of 
making the safety determination on the government, as does 
CEPA.437 
European law relies more heavily on administrative 
regulation (than tort law) to impose duties of care on industry, 
and thus it should not be surprising that REACH placed the 
burden of making a safety determination on industry (e.g., in the 
registration process and when use-specific authorizations to 
market a SVHC are requested).438  REACH also places the safety-
determination burden on government under the authorization 
and restriction procedures. Thus, it is more accurate to describe 
REACH as a hybrid statute, where some of the safety-
determination responsibility is placed on industry and some on 
government. 
As TSCA reformers consider this question, it should be 
apparent that either arrangement can be workable, as both the 
Canadian and European safety-determination systems have been 
operational for almost a decade. The harder question to answer is 
 
 436. See Renn & Elliott, supra note 62, at 228 (stating the potential civil 
liability in the United States from chemical risks is at least as important as the 
regulatory system). 
 437. Denison, Ten Essential, supra note 75, at 10020. 
 438. See Lucas Bergkamp, Does REACH Present a Business Opportunity?, in 
THE EUROPEAN UNION REACH REGULATION FOR CHEMICALS: LAW AND PRACTICE 
396, 408 (Lucas Bergkamp ed., 2013). 
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which safety-determination approach—or what form of hybrid 
model—is preferable in the U.S. under a reformed TSCA, given 
the nature of our legal system, the track record of our regulatory 
authorities in risk assessment and management, the likely 
constraints on public funding of U.S. regulators, and our political, 
commercial, and scientific cultures. 
Although either burden location in TSCA reform could work, 
we are inclined to favor a reversal of the burden in the United 
States as has been implemented in the REACH registration 
system—companies should be compelled to make a safety 
determination for specific uses under a statutory standard; 
determinations should then be reviewed by government 
regulators. Elsewhere we have argued that the safety standard in 
REACH is not clear and consistent,439 but we do believe that a 
clear and consistent safety standard should be politically 
determined. Once the safety standard is established, it should be 
the responsibility of industry to make the initial showing that 
they have complied with the standard, and the government 
should be the final arbiter as to whether industry has complied 
with the standard. We offer four practical reasons for this policy 
preference, in addition to our philosophical preference that those 
who market products have an ethical responsibility to vouch for 
their safety on the basis of evidence. 
First, if the federal government, through EPA risk 
assessments and management decisions, shoulders the burden of 
accomplishing chemical safety evaluation, we fear that the risk-
assessment work will be performed slowly, and in some cases, it 
will simply not get done. The result may be insufficient protection 
of the public and a resulting lack of public trust in the reformed 
regulatory system. Despite the positive experience in Canada 
under the CMP as discussed above, our fear is rooted in the well-
documented (glacial) pace by which EPA completes hazard 
assessments under the Integrated Risk Information System and 
the limited number of risk assessments completed under 
TSCA.440  Moreover, EPA has experience in developing a wide 
 
 439. Abelkop et al., supra note 398, at 390. 
 440. On EPA’s slow pace of issuing risk assessment guidelines and performing 
hazard assessments for specific chemicals, see E. Donald Elliott & Gail 
Charnley, Private Product-Risk Assessment and the Role of Government, 23 
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variety of risk assessment guidelines that could be applied to 
industry risk assessments.441  We have reason to be confident in 
EPA’s ability to review risk assessments and safety 
determinations made by industry. 
The new role we propose for EPA as reviewer of industry risk 
assessments approximates the role of U.S. regulators in many 
other health, safety, and environmental programs ranging from 
pharmaceuticals and medical devices to nuclear reactor safety. 
Indeed, EPA already plays this reviewer role in a variety of its 
own programs. For example, when agricultural chemical 
companies make a case for “reduced risk” pesticides under the 
Federal Insecticide, Fungicide, and Rodenticide Act (and thus 
become eligible for accelerated registration decisions), EPA is put 
in the role of reviewing the risk assessments prepared by 
industry.442  Likewise, although EPA does not routinely review 
industry risk assessments under TSCA’s new chemical program, 
the agency does have relevant experience reviewing TSCA section 
5(h)(4) exemption requests, where it must grant or deny a 
requested exemption to the requirement that a company prepare 
a pre-manufacturing notice (PMN) package for a new chemical. 
EPA in effect must evaluate the company’s claim that there will 
not be an unreasonable risk with the new chemical without a 
PMN. To better ensure that safety is provided, EPA may insist 
that amendments be made to the exemption request, and then 
those amendments are treated as kind of a binding PMN on the 
company. More generally, the company’s general obligation to 
prepare a PMN (an organized package of technical and 
commercial information) under TSCA has proven to be a very 
valuable starting point for EPA review rather than being 
compelled to create a dossier from scratch (as they are currently 
expected to do for existing chemicals). 
Another illustration of EPA acting as a reviewer of industry 
information occurred in the Organization for Economic 
 
JOHN LINER REV. 73, 77 (2009). See generally NRC 2009, supra note 38, at 45–47, 
56–57. 
 441. See Guidance & Tools, EPA, http://www.epa.gov/risk_assessment 
/guidance.htm (last updated Apr. 28, 2014). 
 442. See Conventional Reduced Risk Pesticide Program, EPA, 
http://www.epa.gov/opprd001/workplan/reducedrisk.html (last updated Mar. 4, 
2014). 
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Cooperation and Development’s Screening Information Data Set 
(SIDS) program.443  Companies prepared an initial package of 
information—the SIDS Initial Assessment Report—that could be 
used by EPA in the OECD’s international dialogue. EPA reviewed 
the package and, where appropriate, requested revisions, prior to 
the package being submitted by EPA to the OECD’s international 
review.444 
We recognize that EPA has recently pledged445 (and indeed 
has made some) significant progress in the preparation of risk 
assessments under the current TSCA regime,446 though the scope 
of the activity is modest compared to what has happened in 
Europe since 2006.447  At its recent accelerated pace, it would 
take EPA ten years to complete risk assessments for the 83 
chemicals in the current TSCA Work Plan.448  If EPA faces 
hundreds of priority chemicals under a reformed TSCA, as should 
be expected given the experiences in Canada and the EU, it is 
difficult to have confidence in its ability to get the job done. 
Second, U.S. policymakers should strongly consider formally 
incorporating external peer review of risk assessments into TSCA 
reform. With industry-produced assessments, external peer 
review overseen by EPA (i.e., EPA would choose the reviewers) 
could facilitate public confidence in the quality of the 
assessments. 
 
 443. See OECD SIDS Voluntary Testing Program for International High 
Production Volume Chemicals, EPA, http://www.epa.gov/oppt/chemtest/ 
pubs/oecdsids.html (last updated Apr. 27, 2011). 
 444. See generally Robert Diderich, The OECD Chemicals Programme, in RISK 
ASSESSMENT OF CHEMICALS: AN INTRODUCTION 623, 633 (C.J. van Leeuwen & 
T.G. Vermeire eds., 2007). 
 445. Cheryl Hogue, Assessing Chemicals: New EPA Effort Targets Dozens of 
Substances Already on the Market for In-Depth Scrutiny, CHEMICAL & 
ENGINEERING NEWS, Apr. 30, 2012, at 28–30. 
 446. See Assessments for TSCA Work Plan Chemicals, EPA, 
http://www.epa.gov/oppt/existingchemicals/pubs/riskassess.html (last updated 
Oct. 23, 2014). 
 447. U.S. GOV’T ACCOUNTABILITY OFFICE, GAO-13-249, TOXIC SUBSTANCES: EPA 
HAS INCREASED EFFORTS TO ASSESS AND CONTROL CHEMICALS BUT COULD 
STRENGTHEN ITS APPROACH 16 (2013). 
 448. U.S. GOV’T ACCOUNTABILITY OFFICE, GAO-13-696T, CHEMICAL 
REGULATION: OBSERVATIONS ON THE TOXIC SUBSTANCES CONTROL ACT AND EPA 
IMPLEMENTATION 13 (2013). 
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Third, placing a regulatory obligation on industry to make a 
finding of safety prior to placing—or continuing to place—a 
chemical on the marketplace might not be as onerous as some in 
industry fear, especially since many companies in the industry 
already have hands-on experience preparing dossiers and making 
such determinations under REACH. Rather than expect EPA risk 
assessors to reinvent the wheel based on a similar body of data, it 
may make sense for companies doing business in the United 
States to provide what they have done in Europe for submission 
to EPA, with appropriate adaptations as determined by EPA. 
Even if TSCA reform would not grant REACH registration 
dossiers or responses to CEPA section 71 surveys complete 
reciprocity, the data burdens on U.S. companies would not be as 
great as those under REACH and CEPA. Over the last decade, 
regulatory efforts in Europe, Canada, and elsewhere have 
facilitated an enormous increase in information on chemical 
hazards and exposures as well as advancements in risk 
assessment techniques. To most effectively take advantage of this 
changing landscape, a reformed TSCA should apply dynamic, 
adaptive assessment and management decision-making 
processes. 
Nonetheless, it may not be wise for U.S. policy makers to 
apply a formal registration system to as many chemicals as in 
Europe. There are small and medium-sized businesses in the U.S. 
that do not do business in Europe, and they would have a steep 
learning curve under a proposal to transfer a REACH-like 
registration system to the U.S. TSCA reform should attempt to 
minimize rent seeking by multinational firms that have 
experience under REACH. Even under our modest registration 
recommendation (focused on high priority chemicals), federal 
programs for compliance assistance may be necessary for small 
and medium-sized American companies and their customers. 
A registration program under a reformed TSCA does not 
necessarily need to contain the same data elements that are 
specified under REACH, but the presumption should be in favor 
of international harmonization. Careful justification needs to be 
provided for each departure from the REACH requirements 
(addition or exclusion). A key question will be what information 
will be required about production volume, uses, and exposure 
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scenarios, given that EPA already has a Chemical Data Reporting 
rule that is compelling companies to submit some of this 
information.449  Registration would be valuable in confirming the 
quality of the existing information and in generating more 
detailed information from companies (manufacturers, processors, 
and users) to support exposure and risk assessment on a use-by-
use basis. More detailed information on implementation of risk 
management measures would also be highly desirable compared 
to the rudimentary information required under REACH. The 
TSCA registration could call for such information as part of a 
REACH-like Chemical Safety Report. 
There will be a natural tendency for U.S. companies to fear 
SIEF-like processes that compel collaboration among multiple 
companies that are usually in the business of competition. 
However, as we have documented elsewhere, many of the 
problems with formation of SIEFs in Europe can now be 
prevented in the U.S., since we know what caused problems in 
Europe and many of those issues were preventable. If Congress 
tries to engineer a registration process without any SIEF-like 
entities, the risk of unintended consequences and bureaucratic 
snafus is greater than if U.S. legislation builds on the experience 
(“warts and all”) of REACH. 
Fourth, a registration system under a reformed TSCA could 
apply exclusively to high priority chemicals—identified through a 
Canadian-style prioritization process—rather than nearly all 
chemicals, as is the case in Europe. Under such a system, the 
sheer number of registration dossiers we have in mind is vastly 
smaller than the volume that ECHA must process under REACH. 
If, as we expect, a U.S. registration system for high-priority 
chemicals proves to be workable for government and the 
stakeholders, Congress (or EPA) could then decide at a later date 
whether it is worthwhile to extend the registration system to 
lower-priority chemicals. Since the last REACH registration 
deadline is not until 2018 (when many small and medium-sized 
European companies will be required to register), it certainly 
makes sense—on the merits, and as a matter of prudent political 
 
 449. See TSCA Inventory Update Reporting Modifications; Chemical Data 
Reporting, 76 Fed. Reg. 50, 816 (Aug. 16, 2011) (codified in 40 C.F.R. pts. 704, 
710, and 711). 
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judgment—to wait until after 2018 to decide whether, given the 
experience of small companies in Europe, low-volume chemicals 
should be included in a U.S. registration system. 
IV. CONCLUSION 
We conclude by describing a practical approach to TSCA 
reform that can draw from what we regard as the best of both the 
Canadian and European experiences. First, Canada has 
demonstrated that a manageable number of high-priority 
chemicals can be identified based on limited data and 
screening/modeling exercises. TSCA reform could pursue 
promptly in that fashion, without forcing the assembly of 
thousands of electronic dossiers by industry that have been 
required under REACH. Indeed, we have already noted that EPA 
has a well-developed scoring system that could be used to identify 
a manageable number of existing chemicals for high-priority risk 
assessment and management. 
Second, for the high priority chemicals, TSCA reform could 
pursue a targeted registration system that places the burden of 
data generation and safety determination (for specific uses) on 
industry. This registration system could draw on the key 
innovations from the European experience: no data, no market; 
and one substance, one registration. A reformed TSCA should 
include a clear, consistent, and workable safety standard. The 
role of EPA would be to review the industry’s safety 
determinations under that standard on a case-by-case basis, 
exercising ultimate authority to reject the registration or to insist 
on more information or stronger risk management measures. 
Industry would have strong incentives to meet registration 
deadlines, as they have under REACH, because companies would 
not be permitted to market high-priority chemicals without the 
registration. Registrants could pay registration fees as well as 
continual user fees to fund the assessment and management 
processes. 
Third, the burden of making safety determinations could 
then flip back to EPA. The agency could utilize registration data 
to determine whether a clear, risk-based safety standard is met, 
requiring industry to provide additional data if necessary. If EPA 
finds that the standard is not met, EPA should be given 
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discretion to apply a wide variety of risk management 
instruments through informal rulemaking. Risk assessment as to 
whether the standard is met should be separate from a 
determination of which risk management instrument to apply. 
EPA’s burdens of proof for finding that the safety standard is not 
met and for determining which risk management tool(s) to apply 
should be permissive. 
One of the advantages of a focus on high priority chemicals is 
that it can be aligned with the growing market forces for safety 
that are already at work in the United States. Chemical 
manufacturers are facing market de-selection of the chemicals 
that present the greatest concern, with encouragement to 
compete on the basis of green and sustainable chemistry for safer 
substances.450  Already, retailers like Target and Wal-Mart are 
requesting greater information on chemicals from products 
manufacturers and restricting sales of products with worrisome 
chemical inputs.451 
The TSCA reform approach that we have suggested will 
accelerate green market forces for chemical uses that cannot be 
defended through registration while reassuring retailers that 
some uses of hazardous chemicals do not, due to little or no 
exposure, pose significant risk and can safely be continued. TSCA 
reform should support these efforts to increase the amount of 
information available to retailers and consumers, regardless of 
where the burden of proof is placed. 
Because the TSCA reform process is ongoing, we believe that 
it is most productive to highlight general lessons that policy 
 
 450. The burden of producing registration dossiers under REACH has not 
necessarily spurred innovation in green chemistry. In fact, the early years of 
REACH implementation have witnessed a shift of highly skilled scientists in the 
industry from research and development to regulatory compliance. The result 
may be more data generation and warehousing than innovations in green 
chemistry. CTR. FOR STRATEGY & EVALUATION SERVS., INTERIM EVALUATION: 
IMPACT OF REACH REGULATION ON THE INNOVATIVENESS OF THE EU CHEMICAL 
INDUSTRY, REPORT TO EUROPEAN COMMISSION, ENTERPRISE AND INDUSTRY, at iii 
(2012), available at http://ec.europa.eu/enterprise/sectors/chemicals/files/reach/ 
review2012/innovation-final-report_en.pdf. 
 451. See Melody M. Bomgardner, Walmart and Target Take Aim at Hazardous 
Ingredients, CHEMICAL & ENGINEERING NEWS, Feb. 17, 2014, 
http://cen.acs.org/articles/92/i7/Walmart-Target-Take-Aim-Hazardous.html; 
Bomgardner, supra note 306. 
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makers should take away from the Canadian and European 
experiences rather than comment on a particular draft bill. It is 
noteworthy, however, that the most recent draft bills that have 
been presented in committees in the Senate (Chemical Safety 
Improvement Act) and the House of Representatives (Chemicals 
In Commerce Act) do in fact include several of the elements that 
we suggest. Both include prioritization mechanisms as an initial 
step to identify high priority chemicals, and both separate risk 
assessment from risk management decisions.452  However, 
neither includes a registration mechanism. We recognize that the 
concept of registration may not seem desirable given the complex 
and burdensome European experience, but we suggest the hybrid 
approach nonetheless in the spirit of generating some productive 
dialogue on a new idea in the TSCA reform debate. 
Although we have tackled some of the critical issues in the 
TSCA reform debate by drawing lessons from Canada and 
Europe, we conclude by acknowledging some key issues that this 
Article has not addressed. We have not covered how extensive the 
ecological and human health data requirements for high-priority 
chemicals should be; what the safety standard under TSCA 
reform should be; how non-threshold chemicals should be 
regulated; whether and how state and local regulation of 
chemicals should by preempted under TSCA reform; whether and 
how the United States should participate in international 
chemicals treaties; and how confidential business information 
and public disclosure of data should be handled in TSCA reform. 
Though we have commented on judicial review, the particular 
role that it should play under a reformed TSCA statute is a 
significant open question as well. We encourage scholars and 
practitioners interested in TSCA reform, and chemicals 
regulation in general, to critique our suggested directions and 
tackle some of the hard issues that we have not addressed. 
 
 452. S. 1009, 113th Cong. § 6(c)(1), (2), (9) (2013); STAFF OF H.R. ENERGY & 
COMMERCE COMM., 113TH CONG., DISCUSSION DRAFT ON CHEMICALS IN COMMERCE 
ACT § 6(b), (c) (Comm. Print 2014), available at http://docs.house.gov/meetings 
/IF/IF18/20140429/102160/BILLS-113pih-TheChemicalsinCommerceAct.pdf. 
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